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Dankwoord
Met de afronding van dit proefschrift eindigt een periode 
van ruim 8 jaar, waarin talloze mensen een bijdrage hebben geleverd aan het 
eindresultaat.
Z e e r g e l e e r d e  H e n d r i k s ,  beste Thijs, toen ik als student 
in 19 9 1 bij je langskwam om te vragen of ik “onder uw leiding eens wat 
onderzoek kon komen doen” , wist ik eigenlijk niet waaraan ik begon; maar jij 
waarschijnlijk ook niet. A l snel wist je mijn jeugdige overmoed op passende 
wijze aan te pakken: mijn initiatieven werden immer kritisch onder de loep 
gehouden. Je  vermogen tot het maken van relativerende opmerkingen heeft 
mij er niet van kunnen weerhouden om door te gaan. Je  gaf me ruimschoots 
de gelegenheid om zelfstandig te knutselen in het lab. Wanneer ik m ijzelf 
weer eens dreigde te verliezen in details, wist je mij feilloos te wijzen op het 
(on)doelmatige aspect van mijn handelingen en reikte je me de rode draad 
steeds weer aan. Met dit laatste doel ik dus niet op de kleur die mijn 
verhandelingen kregen nadat jij ze had gecorrigeerd. Gelukkig deed de rode 
kleur ook jouw ogen pijn en verbeterde je mijn latere geschriften maar direct 
in de computer. Helaas moest ik vaak erkennen dat jouw manier van 
formuleren helderder en korter was. Tijdens mijn klinische jaren werd je in 
toenemende mate de motor achter mijn onderzoeksactiviteiten. Het moet dan 
ook een opluchting voor je geweest zijn toen ik, na vertrek uit Nijm egen eind 
vorig jaar, ineens haast kreeg met het afronden van het manuscript. Thijs, met 
name dankzij jou is het dan toch nog afgekomen vóór de eeuwwisseling!
H o o g g e l e e r d e  W o b b e s ,  beste Theo, ook jij hebt 
impliciet aan de wieg gestaan van dit proefschrift. M ijn keuze om dit 
onderzoeksproject, in plaats van jouw voorstel om proteolytische activiteit 
van tumoren te bestuderen, had je me al snel vergeven. Je  bleef mijn 
onderzoeksactiviteiten in de loop der jaren op de voet volgen. Geleidelijk 
voerde je de interesse op tot pressie, zoals dat een promotor in spé waardig is. 
Wanneer ik dacht alle puntjes op de i ’s gezet te hebben, ook in de kliniek, 
wist je me altijd nog wel te wijzen op een aantal onvolkomenheden. Bedankt!
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[IX]
D i a b e t e s  a n d  a n a s t o m o t i c  h e a l i n g  in t h e  i n t e s t i n e
Beste B e n  d e  M a n ,  de wijze waarop jij me van begin tot 
eind begeleid hebt bij de uitvoerende werkzaamheden getuigt van grote 
klasse. Een paar practica biochemie tijdens mijn studie was alles waarmee ik 
instapte: ik wilde veel, maar kon eigenlijk niks. J i j ,  en aanvankelijk ook 
K a r i n  H u y b e n ,  hebt mij de meeste laboratoriumtechnieken zoals die in het 
[X] manuscript zijn verwerkt aangeleerd. Je  bleef zelfs geduldig wanneer mijn
celkweken voor de zoveelste keer geïnfecteerd of anderszins mislukt bleken. 
R o g e r  L o m m e , jouw bijdrage aan met name hoofdstuk 6 waardeer ik zeer.
Je  stoïcijnse blik “dan doen we het héle experiment toch gewoon over” zal 
me bijblijven. M i k e  M a r t e n s ,  M o n i q u e  J a n s e n ,  W i l f r i e d  S e i f e r t  en 
A r j a n  N o o t e b o o m  worden bedankt voor de flexibele wijze waarop toch nog 
een plaats gecreëerd kon worden voor mij in die ene, véél te kleine werkkamer. 
T a n y a  B i s s e l i n g  en E l o y  H a a n s ,  misschien had ik jullie moeten 
waarschuwen voor de weerbarstigheid van de celkwekerij vóór aanvang 
van jullie wetenschappelijke stage. Maar dankzij jullie inspanningen en 
frustraties heeft hoofdstuk 7 zijn huidige vorm gekregen. W i l  L a n g e  en 
J e r o e n  v a n  d e r  L a a k ,  jullie betrokkenheid bij mijn onderzoek en jullie 
creatieve oplossingen voor mijn steeds wijzigende wensen zijn niet 
onopgemerkt gebleven. Het resultaat is er dan ook naar (in kleur!).
L i e u w e  v a n  d e r  H e m  en D a a n  v a n  d e r  V l i e t ,  de kruising van onze 
onderzoekslijnen heeft een heel origineel hoofdstuk opgeleverd. Dank jullie 
wel. Medewerkers van het centraal dierenlaboratorium, in het bijzonder 
J a n  K o e d a m ,  A l e x  H a n s s e n ,  G e r r i e  G r u t t e r s ,  G e e r t  P o e l e n ,
B i a n c a  v / d  W e e m ,  A n n e t  V e r l e g  en H e l m a  J a n s e n ,  het was me 
een genoegen om in de loop der jaren met jullie samen te werken. Tevens 
heb ik veel over proefdieren en dierproeven van jullie geleerd. Bedankt!
De chirurgische staf van het Radboud-ziekenhuis Nijm egen 
wordt bedankt voor de mogelijkheid om het klinische met het wetenschappe­
lijke te verbinden. De remmende invloed op de totstandkoming van dit 
proefschrift van de assistentengroep en secretariaat van diezelfde afdeling 
heb ik bijzonder gewaardeerd omdat het leven daardoor een stuk aangenamer 
werd, met name op vrijdagavond. Staf en assistenten heelkunde van het Sint 
Elisabeth ziekenhuis Tilburg: jullie geduld zal ik niet langer op de proef 
stellen. De ‘dubbele baan’ van het afgelopen jaar heeft een duidelijke wissel 
getrokken op mijn functioneren binnen de groep. Dat is nu afgelopen!
F r i t s  en A r n o ,  vrienden en paranimfen, ik durf jullie 
op voorhand te bedanken voor de ongetwijfeld perfecte organisatie van 
‘alles eromheen’ . Toch hoop ik geen gebruik te maken van jullie wijze raad 
tijdens de verdediging zelf, als jullie dat niet erg vinden. H a n s ,  jij leerde 
me dat nil volentibus arduum. Dat klopt inderdaad. M a r i j  en M i l o u ,  met 
enige weemoed denk ik terug aan waar het begon, Huize Ruusbroec.
Op de achtergrond hebben tal van vrienden op niet wetenschappelijke wijze 
meegeholpen aan de totstandkoming van het geheel. Door de afwezigheid 
van enige belangstelling voor de inhoud van mijn onderzoek hebben jullie 
mij behoed voor een kluizenaarsbestaan. Proost!
Lieve p a  en m a , ik ben jullie dankbaar voor alle 
mogelijkheden die ik gekregen heb om me te ontplooien. Ma, je hebt 
me altijd gesteund, ook wanneer ik me weer eens als een verloren zoon 
gedroeg. Pa, we begrijpen mekaar meestal met een half woord, heerlijk.
Ik  ben trots op jullie!
Allerliefste M a r i k e ,  bedankt voor het engelengeduld.
Een volgend levenswerk doen we samen. Ik  hou van jou!
Pr
ef
ac
e
[XI]

D iabetes and anastomotic healing in the intestine
An experimental study

Chapter 1
M  eneral introduction
D i a b e t e s  a n d  a n a s t o m o t i c  h e a l i n g  in t h e  i n t e s t i n e
DIABE TES  M E LL IT U S
[2] General aspects
Diabetes is a junction of the greek words 5i a  (through) and 
Paivra (to go), referring to frequent urination. M ellitus refers to the honey-like 
taste of the urine. In former times, tasting urine was the only method to 
distinguish diabetes mellitus from diabetes insipidus, characterized by taste­
less urine. In 1889 , Von Mering and M inkowski in Strassbourg established the 
relation between diabetes and the pancreas after they serendipitously observed 
a swarm of flies around the urine of a dog that had its pancreas removed1-3.
A  possible relation with the pancreatic islands, first described by Paul 
Langerhans in 18 6 9 4, was suggested a few years later. After many negative 
experiments on treating diabetic dogs with pancreatic extracts, Banting and 
Best in 1 9 2 1  finally succeeded to isolate the crucial hormone they called 
insulin5,6. It is interesting to note that Banting was a surgeon (!) and Best 
a student7. After successful treatment of pancreatectomized dogs with this 
hormone, the first application of insulin to a human being was announced 
in 19 2 2 . Banting and his boss, Professor J .  Macleod, were awarded the Nobel 
Prize in Physiology and Medicine in 19 2 3 . Despite many improvements 
in treatment, a final solution for the diabetic problem has not yet been 
discovered.
Diabetes is the most common endocrine disease, 
characterized by metabolic abnormalities and by long-term complications 
involving eyes, kidneys, nerves and blood vessels. The definition of diabetes 
and criteria for diagnosis have been revised by the American Diabetes 
Association in 1997 : the diagnosis of diabetes requires fasting plasma glucose 
concentrations of 7.0 mmol/l or higher on at least two separate occasions8. 
However, the cut off points used for diabetes in clinical practice vary often. 
Since the disorder is not homogenous, several distinct diabetic syndromes have 
been delineated. Primary diabetes can be divided into type-1 disease, resulting 
from an immune-mediated disorder in the pancreas, and type-2 disease, which 
is not a result from such an immune disorder. Secondary diabetes has many 
causes among which pancreas disease (e.g. chronic pancreatitis), hormonal
disorders (e.g. pheochromocytoma), drug-induced side effects (e.g. steroids) 
and certain genetic syndromes are most common. Also, specific agents can
be cytotoxic for pancreatic P-cells and induce type-1 diabetes. The terms ^
insulin-dependent and non-insulin-dependent do not refer to the pathogenetic ^
mechanisms and should therefore no longer be used as a classification of 'o
diabetes, but only be reserved for description of the physiological state [3]
of the diabetic patient. g
The prevalence of diabetes is difficult to estimate, since various criteria have 1
been used. Application of the most recent criteria w ill result in a prevalence of ]|
1-2  per cent in the u s a .  However, using other criteria, prevalence of diabetes ^
increases up to 10  per cent. It is known that large differences exist between |
various subsets of populations. ^
Pathogenesis and symptoms
The pathogenesis of type-1 diabetes is multifactorial9.
Presumably, various distinct genotypic abnormalities can cause a common 
result, namely destruction of pancreatic P-cells. Inheritance certainly is a factor 
but the exact mechanisms have not yet been elucidated. Much research efforts 
nowadays focus on localization of the responsible genes. Next to a genetic 
predisposition environmental factors are instrumental in inducing the onset of 
diabetes. This has been known for a long time since monozygotic twins have 
a concordance of less than 50 per cent for the development of diabetes. From 
many studies a viral etiology has been proposed but never unequivocally 
proven. Whatever the underlying etiological factors may be, type-1 diabetes 
is a direct result from destruction of pancreatic P-cells, which leads to insulin- 
deficiency. The pathogenesis of type-2 diabetes is less well understood, 
although it is more frequent10’1 1 . Genetic factors must play a role, since 
the concordance rate for type-2 diabetes in monozygotic twins exceeds 80 per 
cent. Type-2 diabetes is characterized by both abnormal insulin secretion and 
abnormal resistance in its target cells. It is believed that peripheral insulin 
resistance is the primary cause of hyperglycemia. Since glycogenesis does not 
result, insulin production is further enhanced, finally resulting in hyper- 
insulinemia. However, despite the hyperinsulinemia in absolute terms, 
a relative insulin deficiency often exists, with respect to the actual blood 
glucose levels. This is the reason why type-2 patients may require exogenous 
insulin treatment. Although the main environmental factor is obesity, it has
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been demonstrated that non-obese relatives of type-2 diabetic patients also are 
at risk for increased insulin resistance.
Complaints and symptoms may vary between patients. 
Classically, the onset of type-1 diabetes is sudden. The patient, mostly below 
[4] the age of 40, complains of thirst (polydipsia), excessive urination (polyuria),
increased appetite (polyphagia) and rapid loss of body weight. The symptoms 
merely result from a shortage of glucose reabsorption in the kidney inducing 
strongly elevated osmotic diuresis. A  ketoacidosis can be the presenting 
symptom during an intercurrent disease or following surgery. Treatment can 
be started early after onset. On the other hand, type-2 diabetic patients are 
often free of symptoms since the onset is gradual. An increased plasma glucose 
level is often found on routine laboratory examination. Initial symptoms 
might be the result of increased blood glucose per se, but often the disease is 
only diagnosed from its late complications, such as retinopathy or neuropathy. 
For unknown reasons, type-2 diabetic patients do not develop ketoacidosis.
Therapy
Rigid  diets and oral anti-diabetic agents are the keystones 
for treatment of type-2 diabetes. Administration of insulin is the treatment of 
choice for type-1 diabetic patients. For many years, the effect of this treatment 
was estimated using clinical symptoms and glucose measurement in urine as 
parameters. The development of human recombinant insulin, intermediate and 
slow-release preparations and equipment for self-measurement of the capillary 
blood sugar have greatly contributed to improved quality of life and increased 
life-expectancy of the diabetic patient. The goal of therapy is to keep the blood 
glucose levels as near normal as possible. Therefore, a standard regimen does 
not exist and treatment strategies must be individualized. Research efforts on 
new treatment strategies for diabetes mainly concern transplantation of whole 
pancreas and pancreatic islets. Although results from animal studies and 
clinical trials are promising, this therapy must be regarded to as experimental 
for the time being12 .
Complications
Diabetes is feared most for its complications. M ortality from 
acute complications, because of ketoacidosis and diabetic coma, has decreased 
dramatically since the discovery of insulin. Therefore, diabetic patients live
longer and are susceptible to a series of complications that develop approxi­
mately 15 -2 0  years after the onset of hyperglycemia. These late complications 
of diabetes cause immense morbidity, premature death and health care costs. ^
Although diabetes affects every organ system, retinopathy, nephropathy, ^
neuropathy and atherosclerosis are among the best known late complications.
Presumably, all late complications are caused by (a) common biochemical [5]
mechanism(s). Retinopathy and nephropathy result from thickening of the g
capillary basement membrane (microangiopathy). The main functional 1
abnormalities include increased capillary permeability, blood flow and ]|
viscosity, and disturbed platelet function. Changes in capillary basement ^
membrane composition result from increased type i v  collagen production, |
the polyol pathway and non-enzymatic glycation. Prolonged exposure to ^
hyperglycemia leads to increased metabolism of glucose to sorbitol catalyzed 
by the enzyme aldose reductase. Sorbitol does not easily cross cell membranes 
and its accumulation may cause osmotic effects. Glucose attaches to amino 
acids non-enzymatically. These early glycation products (Schiff base adducts) 
undergo ‘Amadori’ rearrangement to form a more stable product (e.g. glycated 
hemoglobin). In long-lived molecules, such as collagen, early glycation 
products slowly and irreversibly form complex crosslinking called advanced 
glycation end-products ( a g e s ) .  Pathological consequences of a g e  crosslinking 
include covalent binding of proteins (e.g. igG and albumin) to vessel walls, 
crosslinking of matrix components in vessel walls causing resistance to 
enzymatic degradation and disturbed three-dimensional structure. These 
dysfunctions, together with platelets that show an exaggerated tendency to 
aggregate, may cause stasis in the microvasculature, leading to hypertension 
and tissue hypoxia13. Neuropathy affects up to 40 per cent of patients with 
long-lasting diabetes14. It may affect every part of the nervous system, but is 
most common seen in the longest peripheral nerves. Although its pathogenesis 
is not fully understood, similar biochemical dysfunctions may play a role in its 
etiology15 .
Recent clinical studies have unequivocally proven that 
early intensive insulin therapy effectively delays the onset and subsequent 
progression of these late complications14. Moreover, it has very recently been 
established that glycated skin collagen is a more reliable predictor of the 
future risk of developing late complications than glycated hemoglobin, 
which is widely used for this purpose up to now16.
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A nim al models for diabetes mellitus
Research on diabetes has been performed on animal models 
for more than a century. M inkowski and Von M ering1’2 described perhaps the 
most famous animal model: the pancreatectomized dog. For more than 50 
years pancreatectomy was the only way to induce diabetes in animals. The first 
[6] chemical agent discovered to produce diabetes was alloxan. In 19 3 7 , Jacobs17
surprisingly reported on the hypoglycemic action of alloxan. Six years later,
Dunn et a l.lS accidentally observed islet-cell necrosis and subsequent hyper­
glycemia in rabbits while investigating the nephrotoxicity of uric acid 
derivatives. Since Jacobs did not follow up his observations, he only observed 
a hypoglycemia, due to immediate release of insulin from necrotic pancreatic 
P-cells. Although alloxan exerts specific action on P-cells, as compared to other 
islet cells, it has also toxic effects on other organs19 and is highly unstable at 
physiological levels20. In search for new antimicrobial drugs streptozotocin, 
a metabolite of the soil fungus Streptomyces achromogenes, was first discovered in 
i9 6 0 21. N ext to its antibiotic and anti-tumor effects, its diabetogenic property 
was revealed in 19 6 3 22. It is directly cytotoxic for the pancreatic P-cells 
through damage to the plasma membrane, a decrease in n a d  levels and 
possibly free radical production23. As a consequence, several clinical trials have 
studied its chemotherapeutic effect on pancreatic islet cell carcinoma24,25. 
Although both alloxan and streptozotocin induce hyperglycemia in animals, 
the mechanisms and side effects differ considerably26. Streptozotocin instead of 
alloxan is now generally preferred for induction of type-i diabetes in animals, 
and such models are widely accepted. N ext to these chemically-induced 
animal models, spontaneously diabetic rats exist. This rat was first discovered 
in 19 7 4  in a commercial rodent breeding company (BioBreeding Laboratories) 
in Ottawa. Since the diabetic syndrome in these commercially available rats 
share many characteristics with human type-i diabetes, they are often used for 
etiological research. This b b  rat is an accepted model for diabetes, but is still 
quite expensive. Experimental research on wound healing is almost unvariably 
performed on chemically-induced diabetic animals. In this respect, similar 
cutaneous wound healing has been observed in alloxan- and streptozotocin- 
treated animals27, but diabetes of endogenous origin appears to be more 
detrimental than streptozotocin-induced diabetes28. W hether this is due to 
basic differences in the models or to differences in duration of diabetes is not 
known. However, short-term, and therefore chemically-induced, animal 
models of diabetes, provide the possibility to investigate the effect of
hyperglycemia per se. Wound healing studies described in this thesis have
been performed one week after the induction of diabetes. After such a short
period late complications of diabetes are absent: microangiopathy is only ^
detectable 6 weeks after the induction of diabetes, with a similar dosage ^
of streptozotocin in wistar rats of approximately the same age as those used
in our studies29. In another study, hematologic parameters and the oxygen- [7]
carrying capacity of the blood were still unaffected by diabetes in rats 6 weeks g
after induction using streptozotocin30. 1
W O U N D  H EA L IN G
Wound healing and surgery
Surgeons would not be able to operate, if  their patients did 
not react with a healing response. Since patients heal despite and not because 
of the surgeon, it is his major responsibility to avoid wound problems as much 
as possible. Prevention of wound healing disorders is more than atraumatic 
tissue handling and suturing in the operating theatre. It consists of pre- and 
postoperative care for the entire patient including his concomitant diseases. 
Although most wounds heal without adverse events, the surgeon spends much 
time and energy on wound problems. Moreover, both emotional impact for the 
patient and health care costs from wound problems are huge. For the optimal 
prevention and treatment of wound problems, the surgeon must have a good 
insight into the physiological and eventual pathophysiological mechanisms of 
wound repair. Surprisingly, many clinicians have poor knowledge of such 
pathophysiological mechanisms and persist in working from their personal 
clinical experience. In this respect, improved education would presumably be 
beneficial.
General aspects of wound healing
Tissue repair, starting immediately after wounding, is 
a continuous process which can be divided into three distinct but often 
overlapping phases: hemostasis and inflammation, proliferation and maturation and 
remodeling31-33 (Figure 1). This concept is considered to be generally applicable,
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Time
A  s c h e m a t ic  t im e  co u rse  o f  th e  d if fe r e n t  p h a se s  d u r in g  th e  h e a l in g  
p ro c e ss  in  re la t io n  to  th e  c e lls  in v a d in g  th e  w o u n d  a n d  w o u n d  c o l la g e n  
m e ta b o lis m . T h e  in f la m m a to r y  p h a s e  is  d o m in a te d  b y  p m n s  a n d  
m a c r o p h a g e s . F ib r o b la s t s  a n d  ly m p h o c y te s  a p p e a r  d u r in g  th e  
p r o li fe r a t iv e  p h a se . C e lls  g r a d u a l ly  d is a p p e a r  d u r in g  th e  m a tu r a t io n  
p h a s e . W o u n d  s t re n g th  is  in i t ia l ly  d e te r m in e d  b y  e x is t in g  c o lla g e n  
f ib e r s . L a te r , s t r e n g t h  is  ta k e n  o v e r  b y  n e w ly - fo r m e d  c o l la g e n  fib e r s .
regardless of the type of tissue injured. Prolongation or failure in a certain 
phase results in delayed healing or completely non-healing wounds. Basic 
research efforts on normal wound healing provide a better insight in the 
physiological processes of tissue repair and are a prerequisite to a better 
understanding of pathophysiological aspects that impair healing. Only then, 
optimal therapeutic modalities to improve disturbed healing can be developed. 
Despite many basic research efforts over the last decades and great advances in 
clinical opportunities for wound management, a significant problem remains 
in terms of impaired quality of life and high economic costs.
Inflammatory phase
The primary phase, often referred to as the inflammatory 
or exsudative phase, starts immediately after injury or tissue damage. The ^
body starts its defense mechanisms to control and prevent further harmful ^
events. Disruption of blood vessels leads to bleeding in the wound. Potential 
detrimental pathogens are washed out mechanically. To arrest further [9]
unnecessary blood loss severed vessels are sealed off by vasoconstriction g
and platelet-activation results in blood clot formation. Subsequently, vaso- 1
constriction is followed by vasodilatation and increased capillary permeability, ]|
allowing cells and other components necessary for healing to invade the wound ^
area. As a consequence of increased vascular permeability, substances of large |
molecular weight (e.g. albumin and fibrinogen) diffuse into the extracellular ^
space, leading to edema. Platelets play a key-role during this phase. They 
contain three types of granules involved in hemostasis and initiation of 
inflammation. Release of the contents of the granules occurs after activation by 
fibrillar collagen present in the extracellular matrix. Some of the compounds 
liberated are thromboxane a 2 and serotonin that initiate vasoconstriction.
Subsequent vasodilatation is mainly caused by histamine, a content of mast 
cells. Serotonin also increases vascular permeability. Thromboxane a 2 and 
prostacyclin play an important role in the balanced mechanism that controls 
the rate and extent of platelet activation. Formation of the primary hemostatic 
clot is secondary to the release of serotonin and adenosine diphosphate, 
resulting in platelet aggregation. N ow intrinsic and extrinsic coagulation 
pathways are activated. Finally, both pathways activate factor x ,  which 
converts prothrombin into thrombin, which in turn converts soluble 
fibrinogen to a fibrin monomer. After crosslinking of individual fibrin chains 
by factor x i i i  polymers are formed and an insoluble gel develops. This process 
is known as secondary hemostasis. This strong fibrin network is capable of 
capturing erythrocytes and serves as a scaffold for invading leukocytes and 
fibroblasts. Primary and secondary hemostatic clot formation are not separate 
pathways, but occur at the same time and mutually affect each other 
(e.g. thrombin induces platelet aggregation). During degranulation of 
thrombocytes chemoattractive agents are released, such as platelet-derived 
growth factor ( p d g f ) ,  transforming growth factor-a and -P (TGF-a and t g f - P )  
and platelet factor iv .  Some factors, such as serotonin, thromboxane a 2 , fibrin, 
factor x i i i  and certain complement factors, exert both hemostatic and 
chemoattractive functions. After this initial period of hemostasis invasion of
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Table 1 M a t r i x  M e t a l l o p r o t e i n a s e s
Enzyme___________________________  mmp no. ______
Collagenases
Interstitial collagenase
Neutrophil collagenase
Collagenase 3 
Collagenase 4
Gelatinases
Gelatinase A
Gelatinase B
mmp-8
mmp- 13  
mmp- 18
mmp-9
Stromelysins
Stromelysin 1
Stromelysin 2
Membrane-type MMPs 
mTi-mmp
MT2 -MMP
MT3-MMP
MT4-MMP
Others
Matrilysin
mmp-3
MMP-14
MMP-15 
MMP-16 
MMP-17
MMP-7
mmp- i
MMP-2
mmp- io
Stromelysin 3 mmp- i i
Metalloelastase mmp- 12
(Unnamed) mmp- 19
Matrix substrates or functions.
Collagens i , ii , iii, vii and x , 
gelatins, entactin, aggrecan, link 
protein
Collagens i , ii , iii, aggrecan, link 
protein
Collagens i , ii , iii 
Collagen i
Gelatins, collagens i , iv , v , v ii, x  
and x i , fibronectin, laminin, 
aggrecan, elastin, large tenascin c , 
vitronectin, ß-amyloid protein 
precursor (ß-secretase-like activity)
Gelatins, collagens iv , v , x iv , 
aggrecan, elastin, entactin, 
vitronectin
Aggrecan, gelatins, fibronectin, 
laminin, collagens iii, iv , ix  and x , 
large tenascin-c, vitronectin
Aggrecan, fibronectin, collagen iv
Collagens i , ii and iii, fibronectin, 
laminin-1, vitronectin, dermatan 
sulfate proteoglycan: activates 
proMMP-2 and pro mmp- 13  
Not known
Activates mmp-2
Not known
Aggrecan, fibronectin, laminin, 
gelatins, collagen iv , elastin, 
entactin, small tenascin-c, 
vitronectin
Weak activity on fibronectin, 
laminin, collagen iv , aggrecan, 
gelatins
Elastin
Not known
polymorphonuclear cells (p m n s ) , monocytes, fibroblasts and endothelial cells 
occurs. p m n s  are the first group of cells invading the wound, led along by 
local and systemic factors increasing vascular permeability and a concentration 
gradient of chemotactic agents. Infiltration starts with increased adherence to 
the endothelial surface, followed by migration through the basal membrane 
(diapedesis) into the wound area. p m n  infiltration is stimulated by many 
factors such as complement factors 03a and 05a, kallikrein, interleukin-i 
(i l - i ), tumor necrosis factor-a (TNF-a), t g f -P  and platelet factor i v 34-37.
Also bacterial products like lipopolysaccharides are strong chemoattractants for 
p m n s . Although these cells are the initial phagocytes of the wound area their 
function is not essential for normal wound healing38. I f  immunoglobulins and 
complement cover foreign material like bacteria - this process is known as 
opsonization - recognition and adherence by phagocytes is facilitated. p m n s  
ingest this foreign material by the formation of phagosomes. After fusion 
with preexisting lysosomes, which contain a variety of proteolytic enzymes, 
into newly formed intracellular phagolysosomes it is destroyed by oxygen 
metabolites such as hydroxyl radicals, hydrogen peroxide and the superoxide 
ion. Furthermore, p m n s  are an important source of extracellular matrix 
degrading enzymes, so called matrix metalloproteinases (m m p s ). The m m p - 
family is listed in Table 1 .  These enzymes are necessary for diapedesis and 
responsible for the initial breakdown of damaged wound matrix. Since p m n s  
are no longer capable of producing proteolytic enzymes, they kill themselves 
after phagocytosis (apoptosis). p m n  turnover in the wound area is therefore 
large. Apoptotic p m n s  are removed by phagocytosis of macrophages. The 
process of phagocytosis and killing in p m n s  is aerobic. As a result wound 
oxygenation decreases. After a few hours monocytes start to migrate into the 
wound area, attracted by the same agents as p m n s , but also by p d g f 39,4°. After 
migration into the wound area monocytes are transformed into macrophages. 
This differentiation is promoted by the binding of fibronectin to the surface 
receptors on monocytes, inducing an activation of the receptors for phago­
cytosis. Macrophages substitute p m n s  as the primary wound phagocytes. Next 
to antimicrobial functions, similar to p m n s , macrophages play a central role in 
the repair sequence. They provide wound debridement, regulation of matrix 
synthesis and angiogenesis and finally recruitment and, most importantly, 
activation of other cells involved in wound healing. Phagocytosis and killing 
within the macrophage is mediated by the same oxygen-dependent pathways 
as in p m n s . Moreover, it has recently been established that macrophages are a
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major source of nitric oxide, which has also antimicrobial properties41,42. 
Macrophages synthesize a variety of proteolytic enzymes such as collagenase 
( m m p - i ) ,  gelatinase b  (m m p -9), stromelysins (m m p -3 and m m p - i o )  and elastase 
(m m p -1 2 ), necessary for wound débridement43,44. Macrophages also produce 
growth factors such as t g f - P ,  epidermal growth factor ( e g f ) ,  p d g f ,  insulin­
like growth factor ( i g f ) ,  basic fibroblast growth factor (bFGF) and vascular 
endothelial growth factor ( v e g f ) ,  cytokines such as TNF-a, i l - i ,  interleukin-6 
( i l - 6 )  and interferon-y ( i f n - y ) ,  prostaglandin e 2 ( p g e 2) and fibronectin. These 
agents activate or inhibit functions of fibroblasts, endothelial cells, p m n s ,  
lymphocytes and monocytes, which in turn also produce cytokines and growth 
factors. In this way various cells involved in the complex healing process 
communicate under the orchestration by the macrophage. In contrast to p m n s ,  
optimal presence and function of macrophages are considered a prerequisite for 
a normal outcome of wound healing45. Evidence for this key role is mainly 
derived from experiments in which the number of macrophages was reduced or 
increased46-48. After the invasion of monocytes, lymphocytes enter the wound 
reaching their maximum number around day 5 to 749. Although lymphocytes 
are not necessary for the initial steps of wound healing, they provide essential 
antimicrobial functions in the cellular immune response, which is required for 
a normal outcome of wound healing50. T-lymphocytes clearly play a modula­
tory role in wound healing. Any role for B-lymphocytes during wound healing 
has not yet been established5i. Via cytokines wound macrophages can activate 
lymphocytes, which in turn can respond through production and release of a 
variety of paracrine agents, called lymphokines. Studies examining the effects 
of T-cell depletion on wound healing revealed that T-lymphocytes must be 
divided into various subsets, each exerting distinct upregulating or down- 
regulating effects on wound healing52. Next to antimicrobial functions, 
lymphocytes can modulate fibroblast and endothelial cell activity. Although 
the process is not fully elucidated, much progress has been made over the last 
decades in understanding cellular communication. The initiation of the 
processes mentioned above characterize the inflammatory phase of wound 
healing, clinically accompanied by signs of calor, rubor, tumor, dolor and 
functio laesa. Understanding of these mechanisms is rapidly evolving and it 
seems likely that this knowledge w ill point the way towards future treatment 
modalities. A  few days after wounding, when the number of macrophages is 
maximal and fibroblasts start invading the wound, the second phase of wound 
healing begins.
“1
Proliferative phase
This phase is mainly characterized by invasion and 
proliferation of endothelial cells and fibroblasts. Endothelial cells proliferate ^
and migrate from intact venules in the wound edges and form new capillary ^
loops. Complete arterioles and venules develop from these prim itive capilla- ^
ries. This process is known as angiogenesis. Major stimuli for angiogenesis [13]
are tissue hypoxia and a high lactate, both resulting from increased aerobic g
metabolic activities, eventually followed by an anaerobic metabolism in the 
wound area. Various growth factors, present in the blood clot or derived from 
activated macrophages, like v e g f 53, TGF-a31, t g f -P 54 and bFGF55, have also ^
strong angiogenic properties. Wound fibroblasts, proceeding from activated |
undifferentiated mesenchymal cells in the surrounding tissue, migrate into ^
the wound via the fibrin scaffold, attracted by collagen, fibronectin, hypoxia, 
lactate and similar cytokines and growth factors as are chemotactic for 
endothelial cells. Many growth factors, such as p d g f 5<6,57, bFGF57,58 and 
e g f 5 6>57,59, stimulate fibroblast proliferation. Interferon-y, t g f - P 6° and t n f -  
a 58,6i exert stimulatory properties in low concentrations, but act inhibitory in 
high concentrations. Activated fibroblasts also produce cytokines and growth 
factors influencing their own activity in an autocrine manner. N ext to massive 
proliferation, wound fibroblasts are activated to produce extracellular matrix 
components, such as fibronectin, proteoglycans and collagen. These compo­
nents are essential in restoring the continuity of tissue. The newly formed 
connective tissue has a loose architecture and is well-vascularized. It is referred 
to as granulation tissue because of its granular appearance. Fibroblasts not only 
synthesize matrix components, but are also an important source of matrix 
degrading enzymes, such as m m p - i ,  m m p -2 , m m p -3 and MMP-9. A  certain 
amount of extracellular matrix degradation is inherent to wound healing.
Thus, preexistent damaged and excessive newly-formed matrix components 
can be removed and newly-formed matrix can be remodelled. Similar to proli­
feration, these metabolic activities of wound fibroblasts are also regulated by 
various signal molecules62. Although most research on the effects of cytokines 
and growth factors on fibroblast proliferation has been performed in vitro and 
some authors describe conflicting results, it can be stated that activation and 
proliferation of wound fibroblasts is a highly regulated process in which both 
cell-cell and cell-matrix interactions, as well as protein messengers play 
specific roles. Not only fibroblasts, but epithelial cells too start proliferating at 
the wound edges, re-establishing the natural barrier between the organism and
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its environment. Activation of these cells is also subject to cytokines and 
growth factors in a paracrine and autocrine fashion. From clinical experience it 
is well known that formation of granulation tissue is only terminated when 
the wound is completely covered with epithelium. Although many research 
efforts have focused on cells and signals initiating the proliferative phase, 
little is known about signals that bring this phase to a controlled end.
Maturation and remodeling phase
The final phase of wound repair consists of matrix 
remodeling. The transition from proliferative to remodeling phase is arbitrary. 
From a clinical point of view this is the most important phase of healing 
because quantity, quality and rate of matrix deposition w ill ultimately 
determine the strength of the scar. Particularly in this phase both decreased 
collagen deposition, due to factors that reduce inflammation, and excessive 
collagen deposition, such as in keloid or hypertrophic scar, become manifest. 
At the beginning of this phase collagen accumulates and wound strength 
increases. Net collagen synthesis remains elevated for at least 4  to 5  weeks 
after wounding63-65. Subsequently, an equilibrium is reached between collagen 
production and breakdown and the matrix structure matures further in a 
qualitative manner. Normal mammalian skin contains approximately 80-9° 
per cent type i  collagen and 10 -20  per cent type i i i  collagen66,67. It is well 
known that in early wound healing mainly type i i i  collagen is present (30%), 
whereas in the mature scar type i i i  collagen has decreased to pre-existent levels 
( i ° % ) 68,69. Type i  collagen now becomes the most prominent extracellular 
connective tissue protein in the healing wound. Collagen fibrils mature by 
the formation of crosslinks and organize parallel to the stress forces of the 
tissue, resulting in increased wound strength. Other matrix components such 
as proteoglycans and glycosaminoglycans disappear. Fibroblasts change 
phenotypically into myofibroblasts, expressing contractile proteins such as 
a-keratin. Presumably, wound contraction results from this alteration. 
Fibroblasts slowly disappear by necrosis and apoptosis. Macrophages might 
share the same destiny, but recently it has been shown that peritoneal 
macrophages drain via local lymph nodes and do not undergo apoptosis70.
This process of scar remodeling can last for up to i  year after wounding. 
Although tissue structure increasingly resembles its original structure before 
wounding, its components and composition always remain different, visually 
resulting in a scar. Scar strength increases to a maximum of approximately 
80 per cent of unwounded skin71.
Collagen
Collagen is the most abundant protein in mammals, 
constituting approximately 25 per cent of their total protein, and the major 
structural component of connective tissue72. It consists of a family of at least
19  distinct proteins, each with its own biochemical structure and tissue 
distribution73,74. An additional 10  proteins have collagen-like domains. The 
most abundant collagens form extracellular fibrils and network-like structures, 
providing consistency to the tissue, but the others fulfill a variety of functions. 
Mutations in collagen genes or deficiencies in the activities of specific post- 
translational enzymes of collagen synthesis have been characterized in many 
heritable disorders such as osteogenesis imperfecta and several types of Ehlers- 
Danlos syndrome. However, collagen mutations have also been found in 
certain common diseases, like osteoporosis75 and aortic aneurysms76.
Healing wounds contain predominantly fibril-forming 
collagens type i  and type i i i . The basic structural unit of collagen, called 
tropocollagen, consists of three polypeptide chains, that are coiled clockwise 
into a rope-like structure. Each polypeptide, called an a-chain, contains 
approximately 10 00  amino acids, that are coiled into a counter-clockwise 
helical manner. Although new a-chains are still characterized and the various 
combinations theoretically allow the production of hundreds of different types 
of triple helices, relatively few combinations have been discovered yet. The 
triple-helix is 300 nm long and has a diameter of 1 ,5  nm. Type i  collagen, 
the most prevalent species, consists of two a i( i)  chains and one a2(i) chain. 
Type i i i  collagen consists of three a i( iii)  chains. The a-chains consist of a 
repeating sequence: every third amino acid is glycine. This unusually high 
glycine content, combined with the fact that it is a very small amino acid, 
allows the chain to fold very tightly. Both 4-hydroxyproline and 5-hydro- 
xylysine, initially incorporated as proline and lysine, are frequently found and 
relatively specific for collagen. Hydroxyproline is often measured to quantify 
collagen. The sequence glycine-proline-hydroxyproline is often present. Thus, 
polypeptides produced in ribosomes, enter the endoplasmatic reticulum where 
enzymatic hydroxylation of proline and lysine and glycation of hydroxylysine 
take place. These steps are essential before the polypeptide becomes a helical 
a-chain. Subsequently, careful helical folding of three a-chains, stabilized with 
hydrogen bonds, occurs in the endoplasmatic reticulum or golgi apparatus, 
resulting in procollagen. The fibroblast excretes these molecules by exocytosis
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into the matrix. Only after the enzymatic removal of the n - and c-terminal 
pro-sequences functional procollagen results. Now, the collagen molecules can 
assemble into larger fibrils, which in turn can aggregate to form a much larger 
collagen fiber. This process is presumably guided by the tendency of the 
collagen molecules to self-assemble. Moreover, the enzyme lysyl oxidase 
converts some lysine and hydroxylysine residues to aldehyde residues. 
Crosslinking occurs between these aldehyde groups and amino acid groups of 
nontransformed lysine or hydroxylysine residues. Maturation of the crosslinks 
allows the formation of fibrils of increasing size and stability which confer 
strength to developing or healing tissues.
Since fibrillar collagen is very stable and compact, highly 
specific enzymes are required for its degradation. These enzymes, known as 
m m p s, specifically degrade extracellular matrix (Table 1). m m p s are produced 
by p m n s ,  macrophages, endothelial cells and fibroblasts43,77,78. m m p s have 
been defined as proteinases that (i ) degrade at least one component of the 
extracellular matrix; (2) contain a zinc ion at their active site; (3) are secreted 
in a latent form, requiring activation for proteolytic activity; (4) are inhibited 
by chelating agents and specific tissue inhibitors of metalloproteinases ( t im p s )  
and (5 ) share common amino acid sequences79,80. Collagenases are capable of 
cleaving the collagen molecule at specific sites, thus unravelling its tight 
structure. Two distinct collagenases exist: interstitial collagenase ( m m p - i )  
produced by fibroblasts, endothelial cells and macrophages, and neutrophil 
collagenase (m m p -8 ) . Once the higher order structure of collagen is destroyed, 
the substrate becomes more susceptible to degradation by many other 
proteases, including gelatinases (m m p -2  and MMP-9) and stromelysins (m m p -3 , 
MMP-7 and MMP-10)81,82. Research into m m p  activity during wound healing 
has mostly been directed at m m p - i ,  m m p -2 and MMP-9. These enzymes have 
indeed important matrix degrading functions, but the role of other m m p s is 
unclear and probably underestimated. For example, it has only recently been 
reported that collagenase activity observed in early wound healing is mainly 
m m p -8 , derived from p m n s 83.
Both collagen synthesis and degradation in the healing 
wound are tightly regulated by cytokines and other mediators. Although 
much progress has been made in our understanding of the regulatory 
mechanisms over the last decade, they are not yet fully understood and results
from separate studies may differ. Data are often derived from in vitro studies. 
The in vitro effect of mediators may also depend on the cell lines studied. 
Direct extrapolation of such data to in vivo situations may be incorrect. Wound 
fluid analysis is another method often performed for the detection of cytokines. 
However, the presence of a cytokine in wound fluid not always reflects its 
biological activity. Cytokines may be inactive because of degradation or 
secretion in inactive forms. Furthermore, mediators in vivo may be synergistic 
or antagonistic, finally resulting in opposite effects from studies in vitro. 
Currently, therapeutical options of modulating wound healing with cytokines 
and growth factors are being widely investigated. N ext to topical and systemic 
administration of these agents, treatment with inhibitors of m m p s  might 
improve wound healing84.
Intestinal wound healing
Patients benefit from enormous research efforts, performed 
in the field of surgical technique and intestinal wound healing. Despite the 
fact that our knowledge has greatly enhanced, the frequency of anastomotic 
failure remains high, up to more than 10  per cent85-87. Leakage is associated 
with additional morbidity resulting in a four-fold increase in hospital stay 
which, in this era of cost-effective medical care, is an important issue88. In 
a recent retrospective study of 2,842 patients, overall mortality of patients 
sustaining an anastomotic leak was 24 per cent89. M orbidity and mortality 
rates have not dramatically decreased over the last decades. Therefore, research 
on the pathophysiological mechanisms of intestinal healing remains of 
profound interest. In contrast to skin wounds, it is difficult to examine the 
mechanisms of intestinal healing in human models, except by retrospective 
analysis. Much has been learned by studying animal models, within their 
accepted limitations90,91.
Anatomical considerations
The gut consists of distinct circular layers (Figure 2). The 
inner layer is mucosa. Repair of this layer is essential since it forms the natural 
defense barrier to the luminal contents. Its continuity is restored by migrating 
epithelial cells from both sides of the anastomosis92. The role of the lamina 
propria in healing is unknown. The next three layers, the muscularis mucosa, 
submucosa and muscularis propria, are essential for restoration of anastomotic 
strength. The submucosa provides the uninjured intestine with most of its
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F igure 2 A n a t o m y  o f  t h e  i n t e s t i n a l  w a l l
Serosa Peritoneum
Epithelium Lamina propria
Cross-section of the intestinal wall illustrating its basic architecture. 
The submucosal layer consist mainly of collagen and provides the 
predominant suture-holding capacity.
(From Fenglio-Preiser CM et a l. Gastrointestinal Pathology - An Atlas 
and text. New York: Raven Press, 1989: p.4; with permission)
strength. Collagen is the main structural component in this layer: it is loosely 
woven and consists of type i  (68%), type i i i  (20%) and type v  (12  %)93 (Figure 
3). Furthermore, the submucosa contains the main arterial, venous, lymphatic 
and autonomic nerve structures of the gut94. Surgical hemostasis after 
transverse resection of the intestine is often required, but should be gentle. 
Because sutures must be anchored in the submucosa to provide initial wound 
strength95, they potentially compromise the microvascularization of the 
anastomosis. Therefore, the number and tension of sutures should be kept to 
a minimum, preserving nutrient supply96. Probably, restoration of this layer 
is initiated and maintained by the smooth muscle cells in the adjacent 
muscularis mucosa and muscularis propria and serves as a framework for both 
layers to rely on92. Both fibroblasts and smooth muscle cells migrate into the 
anastomotic region and produce type i , type i i i  and type v  collagen97,98. The
F igure 3 C o l l a g e n  in  t h e  s u b m u c o s a
A scanning electron micrograph showing the collagenous framework of 
the submucosa of the rat small intestine. Collagen fibers are arranged in 
two sets of helices that interweave. The angled architecture of the fibers 
allows distension of the intestine along both the longitudinal and radial 
axis, which are necessary for peristaltic movements. The cord-like 
structures (*) are blood vessels that have penetrated the wall. The 
everted mucosa with villi is seen in the the lower right hand corner. 
From C e ll Tissue Res 1988; 2 5 1: 1 17 - 2 1  (With permission)
role of the intestinal sympathic nervous system and its disorders on anasto­
motic healing have never been investigated. However, from a theoretical point 
of view it might affect the outcome of repair since it influences blood supply 
by endothelial and smooth muscle cell contraction. The serosa is a thin layer 
of connective tissue covered by muscularis externa and peritoneum. It is well 
known that good apposition of the serosal layer is essential to avoid anasto­
motic failure99. Nowadays, it is believed that this is best achieved using a one- 
layer inverting type of suture technique, although conflicting experimental 
results have been published100-104. Consequently, the absence of serosa in 
extraperitoneally located anastomoses in esophagus and rectum increases the 
risk of leakage105. This mechanism of anastomotic protection by serosa is not 
fully understood, but might very well depend on mesothelial cells, which 
possess an enormous capacity to regenerate106. A  final remark concerning the
'S!
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Table 2
Wound environment 
pH
C o m p a r i s o n  o f  h e a l i n g  in  i n t e s t i n e  a n d  s k i n
Intestine_______________________  Skin______________
varies throughout intestinal tract 
in accordance with local exocrine 
secretions
relatively stable except during 
infection
microorganisms aerobic and anaerobic, especially skin commensals rarely cause
in colon and rectum. Problematic problems; infection usually results 
if  they contaminate the peritoneal from exogenous contamination 
cavity
shear stress uncontrolled distracting forces
due to peristalsis and 
intraluminal bulk transit
excess movement is mostly 
prevented by pain
tissue oxygenation depends on intact vascular supply depends on vascular supply,
and neovascularization newly formed vessels and difusion
Collagen metabolism 
cell type 
collagenase
wound strength 
scar formation
fibroblast and smooth muscle cell
increased presence throughout 
intestinal tract after resection and 
anastomosis, decreasing suture- 
holding capacity, thus promoting 
anastomotic leakage
rapid recovery
definite scarring in fetal wounds 
increasing age has no effect
fibroblast
not as significant a role
slow recovery
heal without scarring in fetus 
increased wound strength in elderly
Exogenous factors 
lathyrogens
steroids 
malnutrition
D-penicillamine has no effect on 
crosslinking and strength
no negative effect observed
inhibition of crosslinking and 
reduced wound strength
reduces collagen synthesis
only negative effect under extreme reduces wound strength 
conditions
Modified from ref. 11 0
greater omentum must be made. It can be defined as the goal keeper of the 
abdomen. Each inflammatory process, whether it is infectious or not, is 
surrounded by omentum, in an attempt to form a physical barrier between the 
process and the abdominal cavity. Furthermore, it contains a larger ability to 
supply humoral and cellular blood constituents to the inflamed site. A  few 
days after construction the greater omentum is strongly adhesive to the 
anastomosis, allowing capillaries and fibroblasts to migrate into the actual
wound area107. Intraoperative omental wrapping by the surgeon is a procedure 
that can improve outcome of compromised intestinal anastomoses.
Comparison o f intestinal and cutaneous healing
Although one would like to believe that all wounds heal 
in an identical fashion, this is not true. Various authors have expressed the 
necessity to exert caution in extrapolating the results from studies in skin 
repair to healing of other tissues, such as the intestine81,91’108,109. The 
inflammation-proliferation-maturation concept has been derived from 
observations of the wound repair process in skin. Various histological studies 
have revealed that this ‘three-phase model’ is also applicable to intestinal 
repair91,110-112. However, variations between wound healing in skin and 
intestine exist and may therefore result in altered outcome. Table 2 illustrates 
most differences, although some only result from specific tissue components as 
summarized in the part ‘wound environment’ . N ext to the differences as stated 
in the table, it can be mentioned that several regulatory substances exert 
divergent effects on collagen synthesis in skin and fibroblasts62. Recovery of 
wound strength in the intestine is much faster than in skin9I,II°. Systemically 
administrated D-penicillamine, an agent that can change the structure of 
collagen, decreases wound strength and collagen solubility in skin113 , but no 
effect has been observed in intestinal anastomoses114. The adverse effect of 
steroids on collagen production in wounded skin has been investigated 
extensively115,116, but a detrimental effect on intestinal healing has not been 
proven unequivocally117-119.
Risk factors fo r im paired intestinal healing
Disturbance of the complex healing response may result in 
delayed or incomplete wound repair. In the intestine, impaired healing may 
result in anastomotic leakage, which is a most severe complication. Therefore, 
knowledge of factors and conditions which may compromise anastomotic 
strength is essential to the surgeon. I f  too many factors, known to adversely 
affect the development of wound strength, are present the surgeon may want 
to postpone operation or avoid construction of a primary anastomosis.
Factors contributing to the outcome of the healing process 
can be related to both surgeon and patient. Good surgical practice is a prere­
quisite: it consists of gentle tissue handling, complete removal of necrosis and
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debris thereby creating vital, well-vascularized wound edges and atraumatic 
suturing technique. Excessive use of suture material and excessive mechanical 
tension should be avoided to preserve microvascularization of the wound 
edges. Fielding et al. 120 in the late seventies showed that the individual 
surgeon is an important factor influencing outcome of anastomotic healing. 
Also, the kind of suture material used is important. Patient-related factors can 
be subdivided in local and systemic factors.
Local risk factors
Animal experiments have revealed that suture tension 
resulting in anastomotic ischemia is a local risk factors for the outcome of 
intestinal repair121. Adequate tissue oxygenation is a prerequisite for defense 
and modulatory functions of leukocytes and collagen synthesis by fibroblasts. 
Hypovolemia122 has not unequivocally been found an independent deter­
minant for the outcome of intestinal repair in rats, but m ight be detrimental 
indirectly since it can compromise tissue oxygenation. Postoperative pain 
leading to vasoconstriction is often believed to negatively affect the outcome of 
healing but clinical or experimental proof is lacking123,124.
The role of the intestinal microbial flora is unclear. In germ­
free rats, early collagen loss in anastomoses is less than in normal rats, which 
phenomenon potentially improves early anastomotic strength125. Also, it has 
been widely believed for years that reducing the amount of microorganisms by 
preoperative bowel preparation is essential in preventing infectious compli­
cations of colorectal surgery126,127. Evidence for this belief is mainly derived 
from studies comparing elective versus unprepared emergency resection. Indeed 
emergency resection is associated with increased anastomotic dehiscence128,129, 
but it remains to be established whether this is due to lack of bowel prepa­
ration or not. Few studies indicate that avoidance of bowel preparation per se 
is a risk factor for anastomotic complications130, but in patients suffering from 
additional risk factors failure rates are increased131. Long-term bowel rest, 
using a low residue diet, in rats retarded and diminished postoperative anasto­
motic collagen content and strength132. Moreover, bowel preparation induces 
fluid shifts leading to diarrhea and electrolyte disturbance, which in turn 
might increase leakage rates126. Further studies on the need for preoperative 
bowel preparation are currently performed.
The effects of radiation therapy on anastomotic intestinal 
healing is a topic of ongoing research. Although patients suffering rectal 
cancer may benefit from tumor-downstaging by radiotherapy, curation is still ^
only possible if  it is followed by operation. Preoperative irradiation might be ^
required for reasons of resectability, but is clinically associated with dose- 
dependent anastomotic complication rates up to 28 per cent128,133. In experi- [23]
mental models preoperative irradiation has been shown to leave anastomotic g
healing unaffected134, but also to decrease anastomotic strength and collagen ^
deposition135. Intraoperative irradiation also delays anastomotic repair136,137.
Intraoperative local hyperthermia is another technique for destroying cancer ^
cells. In our experience, it is not detrimental to intestinal repair in rats if  used |
as a single procedure, but in combination with intraoperative irradiation ^
anastomotic healing is impaired138.
Among the local risk factors at time of surgery, peritonitis is 
most feared. Moreover, it is a long-established rule in surgery to avoid primary 
anastomosis in the presence of abdominal sepsis. Clinical88,128,140 studies have 
revealed that sepsis is a major factor for impaired anastomotic healing. W hile 
some experimental studies have confirmed a negative effect of intra-abdominal 
infection on anastomotic strength141-144, others don’t 145,146.
Systemic risk factors
Sepsis, often resulting from peritonitis, is a systemic 
risk factor for anastomotic leakage, since it impairs leucocyte host defense 
functions50. In contrast to the common assumption confirmed in a few risk 
analyses126,128, advanced age alone does not affect intestinal repair experi­
mentally147. However, clinically, advanced age is often associated with diseases 
that may act as confounding factors. Administration of certain medications is 
known to modulate wound healing.
The effect of steroids has been discussed in the previous 
paragraph. Non-steroidal anti-inflammatory drugs (n s a i d s ) are frequently 
administered postoperatively to reduce pain. However, in the early post­
operative phase n s a i d s  inhibit collagen synthesis in rats148,149. Conversely, 
administration of synthetic prostaglandin e i increases collagen content of 
experimental colonic anastomoses119,150^51. Prostaglandin e i analogues, such 
as misoprostol, are clinically often administered to avoid the ulcerative
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complications of n s a i d s . It remains to be seen if  n s a i d s  combined with 
prostaglandin Ei, commercially available nowadays (Arthrotec®), can prevent 
the reduced collagen production from n s a i d s  alone.
Patients suffering colorectal cancer benefit from adjuvant 
chemotherapy with 5-fluorouracil (5-Fu) after tumor resection152. Wound 
repair depends heavily on cellular proliferation and may thus suffer from the 
concomitant administration of drugs which aim to inhibit proliferation and 
protein production of tumor cells. Collagen synthesis and strength in colonic 
anastomoses is indeed reduced in the presence of 5-Fu153. However, the degree 
of impairment may depend on dosage, route and moment of administra- 
tioni54,i55. Administration of 5-Fu in combination with biomodulating agents 
may further impair anastomotic healing156,157. However, colonic healing is not 
impaired if  5-Fu is combined with leucovorin158.
Although perioperative blood transfusions are relatively 
common in intestinal surgery, they should be avoided as much as possible. 
Next to its detrimental effect on survival after curative resection for colorectal 
surgery159, transfusion impairs healing of intestinal anastomoses, as demon­
strated both clinically139 and experimentally101. Blood transfusion directly 
influences T-lymphocyte and macrophage functionsi6o,i6i. This might lead to 
impaired host defense or disregulation of the healing response.
A  final remark concerns the patients nutritional state. 
Although it is generally accepted that malnutrition negatively influences the 
outcome of wound healing, the mechanisms are not fully understood. It 
requires no further argument that all nutritious substances for normal tissue 
repair should be present in sufficient amounts, since the healing response is a 
highly anabolic and complex process. Since a clear definition and measurable 
criterion for malnutrition is absent, comparison of studies is difficult. 
Album in, reflecting protein synthesis in general, is often used as a measure for 
malnutrition. Indeed, an inverse relationship exists between postoperative 
complication rate and serum albumin concentration, especially when serum 
albumin is less than 30 g/li62. This correlation between albumin and anasto­
motic healing has been confirmed in ratsi634,i64. Clinical evidence that 
malnutrition is a risk factor for anastomotic dehiscence has only been obtained 
indirectly. M üller et al. 165 observed that ten days of preoperative parenteral
“1
nutrition in clinically well-nourished patients improves the outcome of bowel 
surgery by a fall of major infectious complications, mainly anastomotic 
leakage, from 32 to 17  per cent and mortality from 19  to 5 per cent. However, ^
it is commonly believed that the use of perioperative parenteral nutrition does ^
not decrease surgical complications or improve patient outcome and is more 
costly than perioperative enteral nutrition166. Most studies on the relation [25]
between nutrition and intestinal healing have been performed in rodents. It g
has been suggested from these studies that the healing response in colon is far 
more refractory to malnutrition than cutaneous repair. For example, Irvin167 
has reported that a preoperative protein-free diet for at least 2 months, ^
resulting in a weight loss of 44 per cent, is required to significantly decrease |
anastomotic strength of colon with only 23 per cent. In contrast, skin wound ^
breaking strength after the same nutritional regimen decreased with 6 I  per 
cent. Irvin speculated from these results that preferential sites for wound 
healing may exist, preservation of visceral healing being of high priority. In 
a study on postoperative starvation during 5 days, anastomotic strength had 
only decreased if  caloric intake fell beneath 50 per cent of the normal daily 
need168. Although immediate postoperative parenteral nutrition and standard 
chow improve collagen content and anastomotic strength, when compared to 
no feeding at all and a low-residue diet, respectively169,170, the best effects are 
obtained by early postoperative enteral feeding with a fiber-enriched diet171.
The effects of vitamin deficiencies have extensively been investigated for skin 
wounds, but not at all for intestinal anastomoses. However, one may assume 
that ascorbic acid (vitamin c ) deficiency is detrimental for intestinal repair, 
since it has an essential function in the production of collagen. Conversely, 
retinol (vitamin a ) improves outcome in animal models for impaired intestinal
healingI53,I72,I73.
Diabetes, generally assumed to be a risk factor for anastomotic repair, w ill be 
discussed later.
Parameters fo r intestinal wound healing
Intestinal healing is a complex process and difficult to study 
in patients. Most knowledge on the basic mechanisms in anastomotic repair 
and factors influencing outcome is derived from experimental work. Para­
meters used for the analysis of repair have been reviewed extensively 
elsewhere91. Here, we focus on the parameters used in the experiments 
described in this thesis.
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Biomechanical parameters
Restoration of tissue continuity with sufficient strength is 
the goal of wound healing. Therefore, biomechanical analysis yields the 
foremost parameters for evaluating repair. Intestinal anastomoses are circular 
and separate bowel contents from peritoneal cavity. Leakage of intestinal fluid 
into the peritoneal cavity is often harmful, and if  peritonitis results mortality 
rates increase strongly. One minor lesion in the entire anastomosis may be 
enough to result in leakage. Therefore, the lowest force to produce such 
leakage is of clinical relevance. From this point of view bursting pressure is the 
parameter that best reflects the chance for anastomotic leakage. Measurement 
of bursting pressure comprises distension of a bowel segment by continuous 
infusion of liquid until a leak develops: the pressure at which disruption 
occurs is recorded as the bursting pressure. During the early postoperative 
phase bursting pressure remains low. Rupture invariably occurs inside the 
anastomosis proper. However, after the third or fourth postoperative day 
anastomotic strength increases rapidly. The clinical chance of anastomotic 
leakage diminishes if  the anastomosis grows more strong than the surrounding 
intestinal wall. From many previous experiments in our laboratory, it has been 
established that around day 7 after operation rupture in normal intestinal 
repair in the rat occurs in the adjacent bowel wall and no longer in the 
anastomosis. Then, bursting pressure no longer reflects actual wound strength. 
However, under adverse conditions the period where the bursting site is 
within the anastomotic area may be extended. Therefore, the bursting site is a 
parameter which always should be recorded. Assessment of bursting pressure 
might falsely be influenced by iatrogenic lesions. Thus, preparation of the 
intestinal segments must be performed very carefully. Tissue adhesive to the 
anastomosis should be left in place, since removal increases the risk of 
iatrogenic lesions and no longer reflects a physiological state. A  final remark 
concerns the diameter of the anastomosis in relation to bursting pressure. 
M ultiplication of diameter and pressure results in bursting wall tension 
(Laplace’s law). Bursting wall tension is a better parameter for comparison of 
healing if  intestinal diameters between specimens vary largely within one 
group, such as in ileus, or between experimental groups. This is not the case 
with the experiments described in this thesis.
Biochemical parameters
Biochemical analysis has been directed mainly to the 
behaviour of collagen, since this protein is crucial to anastomotic strength.
The metabolism of collagen has already been discussed above.
Quantification of collagen in intestinal anastomoses is 
synonymous to quantification of hydroxyproline, since this amino acid is 
unique to the collagenous protein. Collagen concentrations change massively 
in and around intestinal anastomoses: they are lowered transiently during the 
first postoperative days, increasing sharply from three days onwards, particu­
larly in the ileum 174,175. This effect is more explicit in colonic than ileal 
anastomoses. However, if  hydroxyproline levels are expressed as a concen­
tration, such changes do not necessarily represent changes in the amount of 
collagen, but may also result from an increase of non-collagenous protein, 
which in turn m ight be caused by an influx of inflammatory cells and proteins 
into the wound. Therefore, hydroxyproline concentrations yield little infor­
mation on collagen metabolism per se. Collagen levels can also be expressed as 
hydroxyproline content, the absolute amount of hydroxyproline present per 
unit length of the anastomotic segment. Changes in hydroxyproline content 
reflect collagen metabolism more directly than changes in concentration do, 
since this parameter is independent of variations in other anastomotic 
constituents. Since hydroxyproline measurements reflect the net result of 
collagen synthesis and breakdown, it does not allow any quantitative 
conclusions regarding the separate processes. In order to draw such 
conclusions, both processes should be measured separately.
In vivo collagen synthesis in intestinal anastomosis can be 
quantified after injection of radioactively labeled proline and measurement of 
its incorporation into collagen. Utilizing this method, it was shown that the 
collagen synthesis in and around anastomoses in both small and large intestine 
was strongly increased during the first postoperative week176-179. However, 
this technique requires administration of large amounts of expensive labeled 
proline to living animals. For this reason, an ex vivo method was developed 
within our laboratory to measure collagen synthesis in intestinal explants180. 
The changes in anastomotic collagen synthetic capacity measured in this way 
are very similar to those reported for de novo synthesis after in vivo 
labeling18^182. It has also been shown that mRNA for type i and type iii 
collagen is increased in anastomotic tissue112^83.
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Collagen degradation has been studied to a lesser extent. 
W hile the concepts of tissue repair imply that a certain amount of extra­
cellular matrix resorption is an integral part of the process, available data on 
anastomotic collagen content (i.e. hydroxyproline measurements) indicate that 
anastomotic collagen degradation is probably of limited extent under normal 
conditions. However, this does not exclude the possibility that localized 
degradation of collagen, e.g. in the immediate area around the sutures, which 
would not be found with this rather insensitive method, profoundly affects 
wound strength. The probability that collagen degradation occurs to some 
extent can be derived from biochemical measurements of increased collage- 
nolytic and other m m p  activity in anastomotic extracts. Characterization by the 
use of different soluble and fibrillar (type i  and type i i i ) collagen substrates 
and inhibitors and identification of the reaction products by autoradiography, 
indicate the presence of a true vertebrate collagenase184’185. A ctivity of 
collagenase and its specific inhibitor (t i m p ) has been identified immuno- 
histochemically in colonic anastomoses within 12  hours after operation. The 
localization and extent of that collagenase was confined to the immediate 
vicinity of the suture line186. Recently, we developed a zymographic assay for 
identification187 and quantification188 of the various matrix metalloproteinases 
in the intestine and its anastomoses. Indeed, changing patterns of m m p  activity 
have been demonstrated in anastomotic extracts during the first week of 
healing187 and enhanced m m p  activity was observed under circumstances that 
impair anastomotic healing, such as intra-operative irradiation188.
Not only the quantity but also the quality of anastomotic 
collagen changes after operation. In this respect, the collagen types present and 
the stability of the constituting crosslinks are of importance for the strength of 
the collagenous network. Considerable changes have been shown to occur in 
the crosslinking of granulation tissue, which supposedly are reflected in 
wound strength189. Also, the structures mature with aging, the number of 
reducible crosslinks decreasing with increasing ageI9°. It is conceivable that 
maturation of the crosslinks could be delayed under certain conditions, thus 
leading to protracted periods of diminished strength. One way to investigate 
the degree of collagen crosslinking is by means of its solubility. Neutral salt 
solutions w ill solubilize only the least crosslinked (newly formed) molecules 
present, while dilute acid extracts the more crosslinked collagen molecules. 
However, neither of these solvents would be expected to solubilize mature
collagen, which is highly crosslinked. Salt-soluble and acid-soluble 
hydroxyproline of uninjured rat intestine constitutes only 0.4 and 4 per cent, 
respectively191. Solubility is indeed increased in experimental intestinal 
anastomoses192.
In vitro studies
During wound repair the fibroblast is the cell primarily 
responsible for collagen synthesis. However, its behaviour in vivo is severely 
influenced by other cells and surrounding matrix. In order to study the 
specific metabolic properties of the fibroblast in the absence of such cell-cell 
and cell-matrix interactions, in vitro studies with isolated fibroblasts are 
required. Next to conditions that reflect normal physiologic circumstances in 
vivo, cell cultures allow the study of effects of specific agents that m ight either 
impair or improve wound healing. Also, it allows the examination of effects of 
specific conditions on cells from different lineage. For example, collagen 
synthesis in fibroblasts from intestine and skin is affected differently by 
antineoplastic agents193 and regulatory compounds like cytokines62. It goes 
without saying that translation of data from in vitro studies to in vivo situations 
should always be performed with prudence.
Histological parameters
The outcome of the process of wound repair depends on the 
presence and function of a number of cells: fibroblasts, macrophages, p m n s , 
lymphocytes and endothelial cells. Whereas biochemical and biomechanical 
investigations yield data on functional aspects of wound healing, histological 
analysis can provide more precise information on the presence of various 
cellular components. Moreover, specific methods of staining can provide 
information on the presence of various extracellular components. However, 
histological analysis has its limitations from a methodological point of view. 
Firstly, microscopic evaluation is always performed on small slices, while 
conclusions are drawn pertaining to the entire wound. Secondly, adequate 
histological analysis requires experience of the investigator in interpretation of 
the images. Although rapid developments in specific staining techniques and 
computer-assisted image-analysis-systems improve ease and reliability of 
quantifying images, interpretation of microscopic images remains - to a 
certain degree - subject to observer bias. Accepting these limitations, histo­
logical techniques can be valuable tools in the field of wound healing research.
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The degree of anastomotic healing of the intestine can 
grossly be estimated using hematoxylin and eosin112’148,174,183,194’195. The 
number of various cells can be counted in and around the anastomosis. 
Changing patterns between experimental groups and in time can be 
investigated. Such analysis must be kept semi-quantitative196. More precise 
quantification of cells requires more accurate identification using specific 
markers. Although the number of antibodies for specific cells is rapidly 
increasing, their applicability for staining under different conditions must first 
be established to avoid false positive and negative identifications. For example, 
activation of cells during wound healing m ight enhance or, even more 
importantly, reduce expression of membrane-bound proteins, which are stained 
by such an antibody. Moreover, expression of binding sites may differ between 
tissues. A  practical problem in working with a rat model is that specific 
antibodies for the purpose of immunolocalization are mostly developed for use 
in mice and man. Collagen can be selectively stained in various tissues using 
the picrosirius-red dye197. This method has been proven reliable for the 
intestine and intestinal anasomoses in the rat196,198.
D I A B E T E S  A N D  W O U N D  H E A L I N G
Diabetes and surgery 
In general, the incidence of surgical procedures is much higher in diabetic 
than in non-diabetic subjects. During the 19 6 0s, it has been estimated that 
diabetic patients have a 50  per cent chance of undergoing surgery during their 
lifetim e199. Although recent data are absent it is likely that diabetic indivi­
duals have a greater chance of undergoing surgery today due to advances in 
medical and surgical therapies. Indeed, many operations are performed for 
treatment of the late complications, such as vascular surgical operations for 
atherosclerosis and microangiopathy, but diabetic patients also have increased 
risks for development of independent diseases that require surgical treatment. 
It is well-known that pancreatic cancer frequently develops in diabetic 
subjects. According to several risk analysis studies, diabetes predisposes to 
the development of colorectal cancer with a relative risk of approximately 
I .6 200-204 .
“i
The management of diabetic patients undergoing surgery is 
a subject of ongoing discussion. The numbers of opinions expressed and 
options offered are in inverse proportion to the good data available. Also, ^
within the Netherlands many different protocols exist for perioperative ^
management of diabetes. The relevant literature is distributed among 
specialist journals in the areas of anesthesiology, surgery and diabetes, and [31]
tends to be ignored if not in the appropriate sector. In clinical practice, g
perioperative diabetes regulation is performed by the internal medicine 
specialist and controlled by the anesthesiologist only immediately before and 
during operation. Many surgeons are not at all interested in glucose control. ^
The goal of metabolic care during surgery must be to attain at least the same |
outcome in terms of mortality and morbidity as in the non-diabetic patient. ^
For this purpose continuous control and regulation of blood glucose levels are 
necessary to keep them well above the hypoglycemic levels but below those at 
which deleterious effects of hyperglycemia become evident. Surgery is a 
stressful event increasing corticoid and glucagon production. These hormonal 
responses result in elevated blood glucose levels. Thus, the amount of insulin 
required to keep blood glucose levels within the normal range increases.
The perioperative deleterious effects of hyperglycemia 
concern short term complications, such as ketoacidosis, catabolism, hyper- 
osmolarity, impaired host defense and impaired wound healing. R isk reduction 
for development of ketoacidosis, catabolism and hyperosmolar diuresis is 
achieved with moderate treatment: as long as blood glucose levels are kept 
below i i .o  mmol/l, the renal treshold for glucose resorption is not exceeded 
and glucosuria is not observed. Ketoacidosis and catabolism are seldom seen 
below this level. However, prevention of impaired host defense function 
presumably requires near normal blood glucose levels and if  an infection is 
present, treatment with antibiotics may be secondary to insulin205. Data from 
both clinical and experimental studies suggest an inverse linear relationship 
between blood sugar levels and host defense function, without the presence of 
a treshold205-207.
Although prospective controlled studies have never 
been performed, various authors present recommendations on perioperative 
management of diabetes. Most experts agree that operations on diabetic 
patients should be scheduled early in the day, to decrease the risk of
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dysregulation during the starvation period and if  not possible, intravenous 
glucose-insulin infusion is required208. W ith a variable-rate infusion of insulin 
and frequent control (each 1-2  hours) a target blood glucose level of 6.7 - 10 .0  
mmol/l can easily be reached208-210. Postoperative subcutaneous insulin 
administration is not recommended since uptake is highly variable due to 
fluid shifts. Since frequent control is often not feasible for practical reasons 
and enthusiasm of clinicians is often absent, perioperative blood glucose levels 
within a range of 7.0 and 17 .0  mmol/l are accepted.
Diabetes and wound healing
The study of healing in diabetes is complicated by the fact 
that diabetes is a syndrome, not a single disease. It has been known for a long 
time that neuropathy, atherosclerosis and propensity to infection, all frequently 
encountered in diabetic patients, may contribute to wound failure2 ii . In 
clinical practice diabetes-related wound problems must be divided into 
non-healing chronic wounds, known as the diabetic foot, and acute wound 
problems after surgery. Non-healing chronic wounds often develop sponta­
neously or after a minor injury on foot or ankle in both type-i and type-2 
diabetic patients. The late complications of diabetes play a major role in their 
development. Macro- and microangiopathy lead to critical circulation of the 
limb. Neuropathy leads to loss of sensibility, increasing the chance for injury. 
After injury the healing response is slow if  present at all, despite improving 
blood glucose control. Atherosclerosis can lead to ischemia, which results 
in insufficient amounts of oxygen and nutrients, limited access for p m n s , 
macrophages and lymphocytes into the wound and reduced delivery of 
antibiotics to the local wound area. Next to these factors resulting from defects 
in circulation, skin fibroblasts from diabetic patients exhibit a decreased 
capacity for proliferation212, but an increased capacity to synthesize collagen213 
as compared to cells from non-diabetic ulcers in both normo- and hyper­
glycemic environments. Such chronic wounds become frequently infected and 
if  ulceration proceeds instead of decreases, the lim b must often be amputated. 
Approximately 50 per cent of all non-traumatic limb amputations are 
performed in patients with diabetes214. In the Netherlands, for the years 
19 88  and 1989 , the cumulative costs for the diabetic foot were calculated 
to be 76 million e c u 215.
Recent epidemiological data on acute wounds in diabetic 
patients are not present, but in the early 1970s in a prospective study of 
23,649  clean surgical wounds the risk of infection in diabetics was 10 .7  per 
cent versus 1 .8  per cent in non-diabetics216. Although impaired wound healing 
is frequently observed, research on the underlying mechanisms is difficult to 0
perform in a clinical setting. Our current knowledge of the mechanisms [33]
responsible for hyperglycemia-impaired healing is mainly derived from studies g
in animal models and in vitro experiments.
“1
Diabetes affects cellular and humoral components of the ^
inflammatory phase. Immediately after injury, platelets provide hemostasis and |
excrete chemoattractants, such as p d g f . It has been observed that PDGF-levels ^
are severely decreased in early skin wounds from short-term diabetic rats217,218.
Levels of t g f -P , i g f  and i l - 6  are also reduced in wound fluid from diabetic 
rodents217,219,220. Fibrinolytic activity is affected by diabetes221. Chemotaxis of 
p m n s  is impaired in streptozotocin-hyperglycemic hamsters220. Early reports 
revealed that phagocytosis and killing of p m n s  from diabetic patients was also 
reduced223, but more recently it has been observed that these processes remain 
unaffected by hyperglycemia up to 50 mmol/l224. Next to these alterations in 
cellular functions, hyperglycemia affects the complement system225. 
Streptozotocin-induced diabetic rats exhibit a prolonged inflammatory 
response to certain chemical agents226. Apoptosis, probably signalling the end 
of the inflammatory phase, has been delayed in diabetic mice as compared to 
controls227,228.
Numerous experimental studies have revealed that 
uncontrolled or poorly-controlled diabetes delays the proliferative phase of 
wound healing. In short-term animal models for type-i diabetes the amount of
collagen is reduced in linear cutaneous wounds219,220,229,230 and subcutaneous 
wound chambers27,219,231-245, and both early and late wound strength are
reduced28,229,238,246-250. The loss of strength is thus most likely the result of a 
diminished presence of wound collagen, but the exact mechanisms remain to 
be elucidated. It has also been suggested that deficient healing is mediated by 
increased proteolytic activity27,2I9,230,232,233,25r. In animal models for type-2 
diabetes synthesis of wound collagen is reduced252^ 53, but data on wound 
strength are not available.
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The mechanisms by which type-i diabetes affects the 
maturation and remodelation phase of wound healing are only partly 
understood. Next to the accumulation of collagen, this phase is mainly 
characterized by its crosslinking and rearrangement. It is well known that 
diabetes impairs the lysyl-oxydase-mediated crosslinking of collagen 
molecules254. Nonenzymatic glycation of collagen, finally leading to a g e s  is 
a second crosslink pathway during diabetes. Although this pathway has been 
extensively studied in relation to the development of late complications, such 
as nephropathy, its role in wound healing has not been investigated yet. 
Presumably, in the healing wound a distinction must be made between 
existing and newly-formed collagen. Formation of a g e s  in existing, compact 
collagen fibrils requires months of hyperglycemia255,256. These a g e s  exhibit 
increased thermal stability257 and mechanical stiffness258 due to increased 
crosslinking, whereas reversible, early glycation products do not. Newly- 
formed non-fibrillar wound collagen might be more susceptible to this 
biochemical pathway since it is not yet compactly folded. Therefore, fibril 
formation by these structurally different newly synthesized collagen molecules 
might be impaired233,254,259. Moreover, it has been shown that skin collagen 
synthesized after the induction of diabetes is less stable and more susceptible 
to degradation26° ,26\  In one study it has indeed been reported that non­
enzymatic glycation of 3-weeks-old collagen in granulation tissue from 
subcutaneously implanted wound chambers was increased, but in that same 
study solubility of collagen in acetic acid was decreased, reflecting increased 
crosslink formation262. Although the exact mechanisms are not fully 
understood, it seems clear that these processes affect quality of collagen and 
therefore m ight attribute to reduced scar strength.
It seems well proven that insulin therapy may mitigate the 
deficiencies observed in the repair of acute wounds. However, the efficacy of 
insulin treatment depends on its tim ing in relation to the moment of
wounding and the degree of blood glucose control achieved232,234,239,240,243- 
246,249,263. On the other hand, there is evidence that diabetes leads to 
structurally deficient wound healing even when blood sugars are normalized 
with insulin237,249. Topical administration of insulin to the wound is also 
beneficial for wound healing, but control levels are not reached232. Next to 
insulin, many other growth factors and cytokines have been investigated for 
their effect on diabetes-impaired wound repair. Depending on dosage used
e g f 23^ 232, t g f -P 219,241, p d g f 237,264, bFGF24I,265,266, i g f - i 219,245, human growth
hormone (bHGH)247 and nerve growth factor (n g f )267 invariably improve, to
varying degrees, cutaneous wound healing in experimental diabetes. £
Next to these studies in skin, the effect of diabetes has been 
investigated in healing of some other tissues. In vascular anastomoses a severe [35]
delay in re-endothelialization has been found in short-term streptozotocin- g
diabetic rats. Insulin treatment could not prevent this effect268. Impaired 
collagen synthesis in 5-days-old leg skeletal muscle wounds has been observed 
in uncontrolled diabetic rats269. In mesenterial wounds in streptozotocin- ^
diabetic rats, connective tissue contraction270 and fibroblast proliferation271 |
were reduced, but neovascularization was significantly enhanced272. In the ^
only experimental study available concerning the gastrointestinal tract, 
diabetes reduced the breaking strength and collagen content of linear 
incisional wounds in stomach and duodenum in rats with diabetes induced I 0  
days before surgery using streptozotocin273. Insulin treatment started 2 days 
after induction of diabetes prevented these effects of diabetes.
“i
AIM OF  THE S T U D Y
W hile it is generally believed that diabetes adversely affects 
healing of intestinal anastomoses274,275, little factual evidence is available. 
Some retrospective clinical studies indeed show a significant relation between 
diabetes and the occurrence of anastomotic leakage276,277 but others don’t88. 
Moreover, such studies do not yield information on the course of the repair 
sequence. At the start of our studies, no experimental data on healing of 
intestinal anastomoses under diabetic conditions were available.
The investigations which are described in this thesis aim to 
supply knowledge on anastomotic healing under diabetic conditions. We used 
a short-term rat model for type-1 diabetes to avoid late complications, which 
can act as additional risk factors for anastomotic healing. Since clinical leakage 
of intestinal anastomoses almost invariably occurs within the first post-
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operative week, when experimental studies have shown wound strength to be 
low 91, we have limited our studies on anastomotic repair in ileum and colon 
to this time span.
The central questions we attempt to answer are:
- Does diabetes impair the development of anastomotic 
strength ?
- I f  so, can this loss of strength be prevented by treatment 
with exogenous insulin or pancreatic islet transplantation ?
- I f  so, can impaired healing under these conditions be 
attributed to alterations in wound collagen metabolism, 
such as reduced synthesis or increased degradation ?
Chapter 2 describes the initial study into the effect of 
uncontrolled diabetes, induced with streptozotocin one week prior to 
operation, on anastomotic strength and collagen content and synthesis.
Chapter 3 describes the results of insulin treatment, while chapter 4 reports on 
the effects of pancreatic islet transplantation. Next, we have attempted to 
elucidate the mechanisms of impaired healing under diabetic conditions. 
Chapter 5 contains the results of a microscopic study of anastomotic repair 
during the first postoperative week in normal and diabetic rats. In order to 
assess the potential for matrix degradation in the anastomotic area, we have 
examined the presence of matrix metalloproteinase activity in anastomotic 
extracts (chapter 6). Finally, the effect of diabetes-related factors in the 
regulation of fibroblast collagen synthesis has been studied in vitro. Chapter 7 
describes regulation of collagen synthesis in fibroblasts grown from rat 
intestine and skin. The results from all studies are discussed in chapter 8.
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Chapter 2
Diabetes impairs thedevelopment of early strength, but not the accumulation of 
collagen, during intestinal anastomotic 
healing in the rat
Mi chi e l  H.J.  Verhofstad and Th i j s  Hendr iks
Br J  Surg 1994; 81: 1040-5
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S U M M A R Y
The evidence that diabetes mellitus 
adversely affects healing is derived from data on skin, where 
diminished wound strength is accompanied by a reduced 
collagen content. As no such data are available on intestinal 
anastomotic repair, and it has been reported that collagen 
metabolism in skin and intestine is affected differently by 
the diabetic state, anastomotic healing in the rat intestine 
during uncontrolled diabetes was examined. W istar rats 
underwent resection and anastomosis of both ileum and 
colon i  week after a single injection of streptozotocin 
(diabetic group) or citrate (control group). After 3 days the 
mean bursting pressure of ileal anastomoses was 4 .1  kpa in 
controls and i .o  kpa in diabetic animals (p<0.05). For colon, 
these values were 12 .0  and 4.9 kpa respectively (p<0.05). 
This negative effect of diabetes persisted after 7 days in 
ileum but not in colon. Diabetic animals had more 
anastomotic abscesses, especially in the ileum: nine of 
sixteen animals at 3 days after operation versus one of fifteen 
in the control group (P<o.oi). Anastomotic hydroxyproline 
concentration and content in diabetic animals were not 
reduced. The postoperative collagen synthetic capacity, 
as measured in tissue explants, was strongly stimulated in 
the wound area and appeared essentially unchanged in the 
diabetic animals. Uncontrolled streptozotocin-induced 
diabetes severely impairs the development of anastomotic 
strength in the rat intestine but, unlike impaired wound 
healing in skin, this phenomenon is not caused by deficient 
accumulation of collagen.
I N T R O D U C T I O N
Anastomotic leakage is a most serious complication in 
gastrointestinal surgery, with concomitant high morbidity and mortality rates. 
Failure of colonic anastomoses depends on many factors and, as a consequence, 
reported leakage rates vary widely. In a much-cited multicenter study1 of 
patients who underwent elective surgery for adenocarcinoma of the large bowel 
the overall incidence of leakage was 13  per cent, but values varied from 0.5 to 
30 per cent between clinics. Dehiscence of anastomoses of the small bowel 
occurs less frequently2. Numerous technical, local and systemic factors interact 
to determine the success of anastomotic healing. The combined presence of 
negative determinants may increase the risk of leakage to such an extent that 
the surgeon may forgo primary anastomosis. It is generally accepted that 
diabetes is one such determinant3 and should be considered a detrimental 
factor for anastomotic repair. Surprisingly, clinical or experimental data on the 
effects of diabetic control in the perioperative period on the outcome of 
anastomotic healing in the intestine are virtually absent.
Although it is accepted that diabetes adversely affects 
wound repair4, the clinical and experimental evidence for poor healing is 
derived from skin wounds or granulation tissue in wound chambers. Studies 
in animals with (streptozotocin-)induced5,6 or genetic7,8 diabetes have clearly 
shown impaired healing. Reduced development of strength is accompanied by 
decreased formation of wound collagen. These results are then extrapolated to 
other tissues such as intestine. However, it has been stated repeatedly that 
the general applicability of data from skin wound experiments remains to be 
established9-11. As yet, no data are available on healing of intestinal anasto­
moses under diabetic conditions. The collection of such data is required 
because the intestine may react differently to the diabetic state than do other 
tissues, particularly with respect to collagen metabolism. Both net collagen 
synthesis and mass are increased in the intestine but decreased in the skin of 
streptozotocin-treated diabetic rats12. Also, collagen metabolism is unchanged 
in the intestine of spontaneously diabetic mice whereas collagen synthesis is 
reduced in skin13. Therefore, assuming that collagen metabolism is crucial to
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wound strength, it is conceivable that wound healing in the intestine will 
prove to be less affected by the diabetic state than the repair process in skin.
This study was performed to investigate this possibility. 
The effect of insulin-deficient diabetes, induced by streptozotocin i  week 
before operation, on the healing of ileal and colonic anastomoses was assessed 
in rats by measurements of strength, abscess formation, hydroxyproline 
content and collagen synthesis.
M A T E R I A L S  A N D  M E T H O D S
A n im als
A  total of 7 2  male W istar rats were used for two 
experiments: 48  animals to examine the effect of uncontrolled diabetes on 
anastomotic strength (experiment i)  and 24 animals to assess the effect of 
uncontrolled diabetes on collagen synthesis in uninjured and anastomosed 
intestine (experiment 2). A ll animals had free access to water and were fed 
a standard diet. The animal cages were illuminated from 06.00 until 18 .00  
hours.
In experiment i ,  48 rats (mean ± s d  body weight: 2 7 1  ± 22 g) were divided 
into two groups: a control group (»=18) and a diabetic group (» = 30). The 
animals in the latter group were rendered diabetic by a single intravenous 
injection of streptozotocin, dissolved in citrate buffer (10  mmol/l, pH 4.5) in 
a dose of 50 mg/kg body weight ( 12 .5  mg/ml). Control animals received 
buffer only. A ll animals were observed clinically and weighed daily. A ll rats 
underwent operation under general anesthesia 7 days after injection. H alf of 
the rats in each group were scheduled to be killed either 3 or 7 days after 
operation for determination of anastomotic strength and hydroxyproline 
content. Non-fasting blood glucose levels were determined in the tail vein of 
each rat immediately before operation and on the day of killing.
In experiment 2, 24 rats (mean ± s d  body weight: 268 ± 9 g) were divided 
into a control and a diabetic group of i2  animals each. They were treated in a 
similar fashion as the corresponding groups in experiment i  and were killed
for assay of collagen synthesis in uninjured intestine and anastomoses,
3 or 7 days after operation. A ll experiments were approved by the Animal 
Experiments Ethics Review Committee of the Medical Faculty, University of 
Nijm egen.
O perative procedure
An anastomosis was fashioned in both the ileum and colon 
of all animals. Diabetic and control animals were operated on alternately. 
Surgery was performed under semisterile conditions using a Zeiss operating 
microscope. Rats were anesthetized by intraperitoneal injection of sodium 
pentobarbital (50 mg/kg). The abdomen was opened by median laparotomy 
of approximately 4 cm. After resection of a 10-m m  control segment, 
approximately 15  cm proximal to the ileocecal junction, an ileoileal 
anastomosis was constructed using eight single-layer inverting interrupted 
8/0 nylon sutures (Ethilon; Ethicon, Norderstedt, Germany). For the colonic 
anastomosis a similar procedure was performed, approximately 3 cm proximal 
to the peritoneal reflection. The abdomen was closed using a continuous silk 
suture for the musculofascial layer and staples for the skin.
Investigations in  experim ent 1
Each animal was anesthetized by intraperitoneal injection 
of sodium pentobarbital, and blood for albumin-protein measurement was 
collected by intracardiac puncture. A  lethal dose of sodium pentobarbital was 
injected intracardially. The abdomen was opened and inspected for signs of 
infectious complications. The anastomotic segments were resected, leaving 
surrounding tissue in place, and washed in 0.9 per cent saline. Feces were 
removed carefully. Subsequently the anastomotic segment was connected to 
an infusion pump on one side and to a manometer on the other. Pressure was 
then raised by infusion of methylene blue, dissolved in a 0.9 per cent saline, 
at a rate of 2 ml/min. Bursting pressure was defined as the maximum 
intraluminal pressure the segment resisted, expressed in kilopascals. The 
bursting site was also noted. Thereafter, the segment was cleaned from 
adhesions and surrounding tissue (including abscesses) and a 5 -mm sample, 
containing the suture line in the middle, was collected and stored in liquid 
nitrogen for hydroxyproline assay.
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Investigations in  experim ent 2 
Collagen synthesis was measured in 10-m m  control 
segments resected during operation and 5-mm anastomotic segments obtained 
after killing, according to a procedure validated previously for rat intestinal 
tissue14. A ll samples were washed immediately in ice-cold 0.9 per cent saline 
and cut into pieces of 1-2  mm2. Samples of equal size (approximately 50 mg 
wet weight; duplicates for anastomoses and triplicates for control tissue) were 
divided in Petri dishes of diameter 35 mm. The pieces were washed once with 
0.9 per cent saline and once with incubation medium (Dulbecco’s modified 
Eagles medium containing 50 |J.g/ml ascorbate and 250  |J.g/ml kanamycin). 
Subsequently 1.5  ml incubation medium was added and samples were 
incubated for 30 min at 37 ° c  (95 per cent air, 5 per cent carbon dioxide).
The medium was then removed by suction and replaced with 1 .5  ml 
incubation medium containing 4.5 |jci [2 ,3 -3H]proline (300 mci/mg, 
Amersham International, Amersham, u k ). Incubation proceeded for 3 h.
A ll subsequent steps were carried out at 4 oc. Both tissue and medium were 
transferred to a centrifugation tube and spun for 5 min at 2500^. The pellet 
was homogenized in 3.0 ml tris(hydroxymethyl)methylamine (Tris)-HCl 
50 mmol/l, pH 7.6, containing ethylenediamine tetra-acetic acid 25 mmol/l, 
N-ethylmaleimide 10  mmol/l, phenylmethylsulphonylfluoride 1 mmol/l and 
proline 1 mmol/l. Trichloroacetic acid (t c a ) was added (final concentration 
0.6 mol/l) to the homogenate, which was then centrifuged for 5 min at 2500^. 
The precipitate was washed three times with t c a  0.3 mol/l containing proline
i mmol/l. The final pellet was dissolved in 0.75 ml NaOH 0.2 mol/l and 
neutralized by the addition of 0.3 ml N-(2-hydroxyethyl)piperazine-N-(2- 
ethanesulphonic acid) (h e p e s ) i  mol/l and 0.3 ml h c I 0 .15  mol/l. Aliquots 
from this solution (0.1 ml) were counted to determine the incorporation in 
total protein. To determine proline incorporation into collagen 0.2 ml Tris-Hcl
20 mmol/l, pH 7.6, containing cac l2 50 mmol/l and 0 .1 ml collagenase (type 
7; Sigma Chemicals, St Louis, Missouri, u s a ) ,  chromatographically purified on 
a G200 gel filtration column, was added to a 0.5-m l aliquot of the solubilized 
sample and the mixture was incubated for 5 h at 37 °c . The digestion was 
terminated by addition of t c a  and tannic acid up to final concentrations of 
0.6 mol/l and 3 mmol/l respectively. After centrifugation (10  min at 14  500g) 
a i  .0-ml aliquot of the supernatant was counted in a liquid scintillation 
analyzer. The same procedure was followed without the addition of 
collagenase. Subtraction of the counts released in this blank incubation from
those released in the presence of collagenase yielded the collagen-specific 
incorporation, which w ill be referred to as collagenase-digestible protein (c d p ). 
Subtraction of the radioactivity in the c d p  fraction from that in total protein 
yields the incorporation into non-collagenous protein (n c p ).
The relative collagen synthesis was calculated using a formula15 that takes into 
account the enrichment of proline in collagen compared to other proteins. 
where d.p.m. is disintegrations per minute:
Relative collagen synthesis (%) =
d.p.m. in cdp
--------------------------------------------------------  x 100%
(d.p.m. in n c p  x 5.4) + (d.p.m. in c d p )
A n a lytica l procedures
Tail-vein blood glucose was measured using glucose reagent 
strips (Haemoglukotest 1-4 4  r ; Boehringer, Mannheim, Germany) and 
a reflectance meter (Reflolux s ; Boehringer). Serum albumin and protein 
concentrations were determined with a Hitachi system 747 (Boehringer, 
Almere, The Netherlands), using the bromine-cresol green and the Biuret 
methods respectively. The tissue hydroxyproline content was measured as 
described previously16, essentially using the method of Prockop and 
Udenfriend17. d n a  content was measured in the NaOH-solubilized t c a  
sediment by the method of Burton18, using calf thymus d n a  as a standard. 
Statistical methods are given with the results. Differences between groups 
were considered significant when P<0.05.
RESULTS
E x p erim en t 1
During the experimental period ten diabetic rats died 
prematurely; two died before operation, three during operation and two on the 
first day after surgery, showing necrotic intestine due to volvulus. Three rats 
died from a ruptured ileal anastomosis, two on day 2 and one on day 6  after
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Table 1 B l oo d  g lu c o s e  and  s e r u m  a l b u m i n - p r o t e i n  c o n c e n t r a t i o n s
No. of animals glucose (mmol/l) albumin (g/l) protein (g/l)
[60]
At operation 
Controls 
Diabetic rats
i 8
20
5.0 ± 0.7 
i 9-4 ± 2 .5
Day 3
Controls 
Diabetic rats
9
i i
4.9 ± 0.3
17.0 ± 8.i f
23 ± i 
20 ± 3 $
50 ± 4 
46 ± 4 $
Day 7
Controls 
Diabetic rats
4.7 ± 0.8 25 ± 4 
24 ± 3
52 ± 7 
48 ± 39 15.2 ± 3.3 *
Values are mean ± sd; *p<0.00i, fP<0.0i, $P<0.05 versus controls (Kruskal-Wallis test).
operation. A ll were excluded from the study. There were no deaths in the 
control group. Blood glucose levels in the various groups are summarized 
in Table 1 .  The rats became hyperglycemic soon after administration of 
streptozotocin and developed clinical signs like polyphagia, polydipsia, 
diarrhoea, polyuria and glucosuria, but no ketoacidosis, within the 
experimental period. A t operation, 7 days later, mean glucose levels had 
increased approximately fourfold. Significant hyperglycemia persisted after 
operation until death. Steptozotocin-treated animals lost weight compared 
with non-diabetic controls. Mean ± s d  body weight at operation as a 
proportion of initial weight was 10 7  ± 3 per cent in the control group (»  = i 8 )  
and 94 ± 4 per cent in the diabetic group (»=20). Values were 99 ± 2 per cent 
(n=9) and 87 ± 5 per cent ( » = i i ) on day 3, and 10 2  ± 4 per cent (»=9) and 
89 ± 6 per cent (»=9) on day 7 for control and diabetic groups respectively.
A ll differences between the groups were significant (p < 0.0005, Kruskal-W allis 
test). Loss of body weight due to surgery was similar in both groups. Mean 
± s d  weight loss with respect to weight at operation was maximal after 2 days 
and was 8 ± 4 per cent in diabetic animals (»=20) and 8 ± 3 per cent in 
controls ( » = i 8 ). A  slight but significant decrease in albumin and protein 
levels was observed in diabetic animals 3 days after surgery (Table 1). This 
effect did not persist at 7 days.
Figure 1 B u r s t i n g  p r e s s u r e ,  b u r s t i n g  s i t e  a nd  a b s c e s s  f o r m a t i o n
25
20
i 5
10
5
Bursting 
pressure 0 
(kPa)
40
30
20
10
0
Ileum Colon
D ay 3
o
°SP
- A A A ^ A A -
oo
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_I_
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o
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A
- aW -
• •  •
•o  •  Day 7
• 0
• •  * A  •
O»
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•
0
0
— 1-------------daIaa ------------------------- ----------------1--------------- A---------------
Control Diabetes Control Diabetes
Bursting pressure, bursting site and anastomotic abscesses on day 3 and 
day 7. Circles, No abscess present; triangles, abscess present; open 
symbols, rupture within the suture line; closed symbols, rupture outside 
the suture line
The number of animals with anastomotic abscesses in the 
various groups is given in Table 2 . The frequency of abscess formation was 
greater in uncontrolled diabetic animals, particularly in the ileum 3  days after 
operation.
Individual measurements of anastomotic strength are shown 
in Figure 1 . A  total of five anastomoses were damaged during the assay 
procedure and excluded from the results. At the first visual inspection after
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Table 2 A n a s t o m o t i c  a b s c e s s  f o r m a t i o n  a n d  b u r s t i n g  p r e s s u r e
n
Abscesses_______
Ileum Colon
Bursting pressure (kPa)
Ileum Colon
Day 3
[62]
Controls 
Diabetic rats
9 1 
i i  7 *
0
4
4.1 ± 4.1 (n=7) 12.0 ± 6.9 
1.0 ± 1.4 f  (n= 10) 4.9 ± 4.8 f
Day 7
Controls 9 0
Diabetic rats 9 3
0
1
33.9 ± 4.1 (n = 8) 25.5 ± 3.6 
13.7 ± 16.5 f  20.8 ± 8.7 (n = 8)
The number of abscesses is given. *: P<0.05 versus controls (two-tailed Fisher’s exact test); 
Mean ± sd bursting pressures are given in kilopascals. The number of observations is given (n) 
unless stated otherwise in parentheses. f?<0.05 versus controls (Kruskal-Wallis test).
opening the abdomen, a number of anastomoses, particularly in the ileum of 
diabetic rats, appeared to have ruptured spontaneously during the course of the 
experiment; they are included in the results with a bursting pressure of zero.
In these cases, anastomotic abscesses were almost invariably present. On day 3 
after operation, the mean bursting pressure was strongly and significantly 
reduced in the diabetic animals (Table 2), by 76 per cent in ileum and by 59 
per cent in colon respectively. At this time point, disruption always occurred 
within the anastomosis. On day 7 after operation, the mean strength of the 
anastomotic segment was still lower in the diabetic group than in the controls, 
although significantly so only in the ileum. However, in most 7-day segments 
from the control group rupture occurred away from the suture line. In the 
diabetic group six of nine ileal segments ruptured in the suture line versus two 
of eight in the control group, again indicating impaired anastomotic strength 
caused by the induced diabetes.
indicative for the relative and absolute amount of collagen present, for the 
various groups are given in Figure 2. N o indication was found for a reduced 
level of collagen in the streptozotocin-treated animals. On the contrary, the 
only significant difference between diabetic and control groups was observed 
in the colon after 3  days, when anastomotic collagen content was actually 
higher in the diabetic group. In the ileum, both hydroxyproline concentration
The mean hydroxyproline concentration and content,
Figure 2 H y d r o x y p r o l i n e  c o n c e n t r a t i o n  a nd  c o n t e n t
Hydroxyproline concentration (a) and content (b) in anastomoses. 
Values are mean ± sd. White bars, control group (»=9); black bars, 
diabetic animals (» = 1 1  at day 3, » = 9 at day 7). *P<0.05 (Kruskal- 
Wallis test)
and content strongly increased between 3 and 7 days after operation, a clear 
indication of massive postoperative collagen synthesis. This effect was less 
pronounced in the colon. In diabetic animals, no indication was found of any 
difference in anastomotic hydroxyproline concentration or content between 
animals with or without anastomotic abscesses.
[63]
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E x p erim en t 2
A ll 12  control animals survived the experimental period and 
were killed as scheduled. One diabetic rat died 1  day after operation, showing 
necrotic small bowel after a massive volvulus. Another diabetic rat died 4 days
D i a b e t e s  a nd  a n a s t o m o t i c  h e a l i n g  in t h e  i n t e s t i n e
[64]
Figure 3 A b s o l u t e  c o l l a g e n  s y n t h e s i s
800
600
d.p.m.
per mg 400 
»et weight
200
0
200
15°
d.p.m.
Per Rg
100 
50 
0
Control Day 3 Day 7 Control Day 3 Day 7
Absolute collagen synthesis in uninjured and anastomotic tissue. Values 
represent mean ± sd. (a) Synthesis expressed on the basis of wet weight; 
(b) synthesis related to dna content. d.p.m., disintegrations per minute. 
White bars: control group (»=12 for control segment, »=6 for 
anastomosis at days 3 and 7); black bars: diabetic group (»=10 for 
control segment, »=5 for anastomosis at days 3 and 7). *P<0.0i, 
fp<0.05 (Kruskal-Wallis test)
after operation from the effects of a leaking ileal anastomosis. Blood glucose 
levels and body weight were similar to those reported for animals in 
experiment i .  Anastomotic abscess formation was also similar to that observed 
in experiment i .  N o abscesses were found in the control group. In the diabetic 
group two of five animals showed abscesses in the ileum and one of five in the 
colon 3 days after operation. At 7 days the frequency was one out of five in 
both ileum and colon. The differences between control and diabetic groups 
were not significant. However, if  the results of experiment i  and 2 are taken
Figure 4 R e l a t i v e  c o l l a g e n  s y n t h e s i s
2.0
i -5
1.0
0 -5
% 0 
2-5 
2.0
1-5
I .0
0.5
0
Control Day 3 Day 7
Relative collagen synthesis in uninjured and anastomotic tissue for 
ileum (a) and colon (b). Values represent mean ± sd. Collagen synthesis 
is expressed as the percentage of total protein synthesis. White bars: 
control group (» = 12 for control segment, »=6 for anastomosis at days 
3 and 7); black bars: diabetic group (»=i0 for control segment, »=5 for 
anastomosis at days 3 and 7). *P<0.00i, fp<0.0i, $P<0.05 (Kruskal- 
Wallis test).
together, significant differences are obtained (two-tailed Fischer’s exact test). 
Diabetic animals had significantly more anastomotic abscesses in the ileum at 
3 days (P< 0 .0 i ) and 7 days (P<0.05), and in the colon at 3 days (P<0.05).
Collagen synthesis was measured at operation and, in the 
same animal, after killing. Administration of streptozotocin and the resulting 
hyperglycemia led, within i  week, to reduced collagen synthesis in uninjured 
ileum. The reduction was significant, both for the absolute collagen synthesis
[
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related to d n a  content (Figure 3) and for relative collagen synthesis (Figure 4). 
Surgery strongly, and specifically, stimulated collagen synthesis. After 
operation no difference was found between control and diabetic groups, 
with the exception of relative collagen synthesis at 7 days. This value was 
higher in the diabetic animals than in controls. Thus, the diabetic animals 
fully retained the capacity for increased collagen synthesis in ileal wounds.
In the colon the effect of streptozotocin on collagen synthetic capacity in the 
uninjured tissue was less prominent; although the mean absolute production 
rates (Figure 3) were lower in the diabetic than the control group, the 
differences remained non-significant. In the colon, collagen synthesis was also 
increased during healing, although the response was less than that in the 
ileum. In contrast to ileum, both absolute and relative collagen synthesis after 
3 days was significantly lower in the diabetic group. However, this difference 
was only transient: it had disappeared completely 7 days after operation.
D I S C U S S I O N
The present results leave little doubt that uncontrolled 
streptozotocin-induced diabetes impedes the development of postoperative 
strength and impairs anastomotic healing in the intestine. The measurements 
of bursting pressure 3 days after operation revealed a significant and massive 
loss of strength in the diabetic animals. This effect was particularly noticeable 
in the ileum, where six of ten anastomoses were completely insufficient at this 
time. In addition, four rats that died prematurely showed dehiscence of the 
ileal anastomosis at autopsy. The negative effect persisted in the small bowel, 
while in the colon there was no difference from the control group 7 days after 
operation. A t present there is no ready explanation for the observation that 
effects in the ileum were more severe than those in the colon. The present 
results essentially agree with those reported by Gottrup and Andreassen19, 
who studied repair of linear incisions in the stomach and duodenum of rats 
i0  days after a single injection of streptozotocin. Breaking strength in the 
duodenum was reduced by 26  and 33 per cent at 7 and 20 days respectively 
after operation. In the present study the first week after operation was
investigated as clinical anastomotic leakage almost invariably occurs within 
this period. Clearly, the absence of diabetic control endangers anastomotic 
integrity and enhances the possibility of leakage and its subsequent severe 
complications.
It therefore appears that the intestine and skin behave 
similarly with respect to wound repair under diabetic conditions, at least as 
far as the development of postoperative strength is concerned. Although the 
experimental conditions vary considerably and the first measurement is usually 
delayed until 2 weeks after wounding, reports on healing of skin incisions in 
animals with uncontrolled diabetes consistently show reduced strength5,6,20’21. 
However, fundamental differences may exist between intestinal and cutaneous 
repair with regard to the mechanisms which cause reduced wound strength. 
Assuming that wound strength is derived from collagen fibrils, it seems 
reasonable that altered collagen metabolism is the underlying cause for 
impaired healing during diabetes. Indeed, experiments with subcutaneous 
wound cylinders have shown that accumulation of hydroxyproline is strongly 
reduced when the formation of granulation tissue is assessed in streptozotocin- 
induced diabetic animals5,7,20,22,23. Thus, impaired cutaneous wound strength 
is thought to be caused by a reduced amount of collagen.
In the present experiments no evidence was found for a 
reduced level of wound collagen in intestinal anastomoses. Despite the fact 
that measurement of anastomotic hydroxyproline levels displayed a relatively 
high variation, a reduction of the degree reported for wound chamber studies 
(and, by inference, for skin) should have been found if it existed. The absence 
of such an effect does not exclude the possibility that a quantitatively minor 
loss of collagen, that is undetected using the present procedure, may have 
caused the early loss of strength as measured 3  days after operation. Although 
collagen synthesis in intestinal anastomoses is increased very shortly after 
operation24, it is unlikely that newly-formed collagen contributes significantly 
to wound strength during the immediate postoperative period. Early strength 
is determined by the suture-holding capacity of the existing connective 
tissue25. Sutures have to be anchored primarily in the submucosal collagenous 
network. A  certain degree of resorption of the extracellular matrix is an 
integral part of tissue repair in general9,11. Increased collagenolytic activity has 
been found in intestinal anastomoses during the early healing period26. Since
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it has been reported23 that collagenase activity is enhanced in wounds from 
diabetic animals, it seems conceivable that a limited and localized degradation 
of collagen fibrils may loosen the structure of the matrix, thereby diminishing 
its capacity to retain the sutures and leading to loss of strength and eventually 
anastomotic leakage.
[68]
After this period where old collagen determines early wound 
strength, newly synthesized collagen fibrils should restore the initial strength 
to the healing bowel wall. The postoperative synthetic response was essentially 
unaltered in the diabetic animals. Although the stimulation of collagen 
synthesis appeared to be somewhat delayed in colonic anastomoses, it was 
unchanged in the ileum where the effects of diabetes on the strength of 7 -day- 
old anastomoses were most pronounced. It thus seems that, unlike in the skin, 
impaired healing in the intestine is not caused by a reduction in the amount 
of collagen present in the wound area. Loss of strength in the intestine could 
be caused by a change in the quality of the collagen fibrils. Increased collagen 
glycation27 and abnormal collagen crosslinking28 have been reported in young 
granulation tissue from streptozotocin-induced diabetic rats. Thus, hyper­
glycemia-induced structural changes may result in the formation of looser 
fibrils which endow reduced strength to the healing bowel wall.
It seems unlikely that toxic effects of streptozotocin could 
account for the impaired healing (and the reduced basal collagen synthetic 
capacity observed in the uninjured bowel wall). Normalization of blood 
glucose levels has been shown to lead to normal healing in skin wounds5,6,23. 
Additional experiments in the authors’ laboratory have shown that this also 
occurs if  normoglycemia is restored before operation (see chapter 3).
A  sufficient supply of nutrients is a prerequisite for optimal 
healing, and adequate neovascularization is required for this purpose. Micro­
angiopathy is a complication of chronic diabetes but is unlikely to contribute 
to the adverse effects found in the present, relatively short-term, experiments. 
Moreover, it has been reported29 that streptozotocin-induced diabetes increases 
angiogenesis in wounded rat mesentery. Malnutrition has adverse effects on 
repair, although less so in colonic wounds than in skin wounds30. In the 
present study, diabetic rats lost weight in comparison with non-diabetic 
controls. However, the limited degree of weight loss and the minor, albeit
significant, reduction in serum albumin and protein levels do not seem 
sufficient to explain the impaired healing30,31.
In almost all cases where anastomotic bursting pressure 
could not be measured in surviving animals, anastomotic abscesses were found. 
This raises the question of whether abscess formation is a cause or a conse­
quence of deficient repair. Patients with poorly controlled diabetes show an 
increased susceptibility to infection, possibly caused by suppression of certain 
immunological functions32. The presence of peritonitis or abscesses has been 
known to result in reduced strength of experimental intestinal anastomoses33. 
However, if  diabetes impairs healing primarily because of induction of 
intraperitoneal infection, abscesses should have been present in all anastomoses 
that showed reduced strength. But at 7 days after operation three ileal 
anastomoses in the diabetic group had become very weak with no abscess 
formation.
In conclusion, uncontrolled streptozotocin-induced diabetes 
strongly impairs the early healing of intestinal anastomoses and increases the 
incidence of leakage. Deficient healing is not accompanied by a significant 
reduction in the accumulation of collagen in the wound area and the 
stimulation of postoperative collagen synthesis appears to be unaffected.
In this respect, the repair of intestinal anastomoses is different from that 
in skin wounds under similar conditions.
D
ia
be
te
s 
an
d 
an
as
to
m
ot
ic
 
he
al
in
g 
in 
ra
t 
in
te
st
in
e 
9
 
Ch
ap
te
r 
2
Diabetes and anas tom o t i c  hea l ing in the in test ine
[70]
a c k n o w l e d g e m e n t s
The authors are grateful to C.M.L.C. Huyben and B.M. de Man for expert technical 
assistance, to Dr T.M. de Boo, Department of Medical Statistics, for statistical 
evaluation of the data and to Dr J.A. Lutterman, Department of Internal Medicine, 
for helpful discussion.
r e f e r e n c e s
1. Fielding LP, Stewart-Brown S, Blesovsky L, Kearney G. Anastomotic integrity after 
operations for large bowel cancer; a multicentre study. Br Med J  1980; 281: 411-4
2. Hesp WLEM, Lubbers EJC, de Boer HHM, Hendriks T. Anastomotic insufficiency 
in small bowel anastomosis - incidence and treatment. Langenbecks Arch Chir 1986; 
368: 105-11
3. Hunt TK. Comment. In: Hunt TK, ed. Wound healing and wound infection: theory 
and surgical practice. New York: Appleton-Century-Crofts, 1980: 192-3.
4. Goodson WH, Hunt TK. Wound healing and the diabetic patient. Surg Gynecol 
Obstet 1979; 149: 600-8
5. Goodson WH, Hunt TK. Studies of wound healing in experimental diabetes 
mellitus. J  Surg Res 1977; 22: 221-7
6. Andreassen TT, Oxlund H. The influence of experimental diabetes and insulin 
treatments on the biomechanical properties of rat skin incisional wounds. Acta 
Chirurgica Scandinavica 1987; 153: 405-9
7. Goodson WH, Hunt TK. Wound collagen accumulation in obese hyperglycemic 
mice. Diabetes 1986; 35: 491-5
8. Greenhalgh DG, Sprugel KH, Murray MJ, Ross R. pdgf and fg f stimulate wound 
healing in the genetically diabetic mouse. Am J  Pathol 1990; 136: 1235-46
9. Forrest L. Current concepts in soft connective tissue wound healing. Br J  Surg 
1983; 70: 133-40
10. Smith R. Recovery and tissue repair. Br Med Bull 1983; 41: 295-301
11. Hendriks T, Mastboom WJB. Healing of experimental intestinal anastomoses: 
parameters for repair. Dis Colon Rectum 1990; 33: 891-901
12. Schneir M, Bowersox J, Ramamurthy N, Yavelow J, Murray J, Edlin-Folz E, Golub 
L. Response of rat connective tissues to streptozotocin-diabetes. Tissue-specific 
effects on collagen metabolism. Biochim Biophys Acta 1979; 583: 95-102
13. Bowersox JC. In vivo collagen metabolism in spontaneously diabetic (db/db) mice. 
Exp Mol Path 1986; 45: 221 -6
14. Martens MFWC, Hendriks T. Collagen synthesis in explants from rat intestine. 
Biochim Biophys Acta 1989; 993: 252-8
15. Peterkofsky B, Chojkier M, Bateman J. Determination of collagen synthesis in 
tissue and cell culture systems. In: Furthmayr H, ed. Immunochemistry of the 
Extracellular Matrix. Boca Raton: CRC Press, 1982: Vol 2, 19-47
16. Hesp WLEM, Hendriks T, Lubbers EJC, de Boer HHM. Wound healing in the 
intestinal wall. A comparison between experimental ileal and colonic anastomoses. 
Dis Colon Rectum 1984; 27: 99-104
17. Prockop DJ, Udenfriend SA. A specific method for analysis of hydroxyproline in 
tissues and urine. Anal Biochem i960; 1: 228-39
18. Burton K. A study of the conditions and mechanisms of the diphenylalanine 
reaction for the colorimetric estimation of deoxy-ribonucleic acid. Biochem J  1956; 
62: 15-23
19. Gottrup F, Andreassen TT. Healing of incisional wounds in stomach and 
duodenum: the influence of experimental diabetes. J  Surg Res 1981; 31: 6i-8
20. Seifter E, Rettura G, Padawer J, Stratford F, Kambosos D, Levenson SM. Impaired 
wound healing in streptozotocin diabetes. Prevention by supplemental vitamin a. 
Ann Surg 1981; 194: 42-50
21. Yue DK, McLennan S, Marsh M, May YW, Spaliviero J, Delbridge L, Reeve T, 
Turtle JR. Effects of experimental diabetes, uremia and malnutrition on wound 
healing. Diabetes 1987; 36: 295-9
22. Grotendorst GR, Martin GR, Pencev D, Sodek J, Harvey AK. Stimulation of 
granulation tissue formation by platelet-derived growth factor in normal and 
diabetic rats. J  Clin Invest 1985; 76: 2323-9
23. Hennessey PJ, Black T, Andrassy RJ. Epidermal growth factor and insulin act 
synergistically during diabetic healing. Arch Surg 1990; 125: 926-9
24. Martens MFWC, Hendriks T. Postoperative changes in collagen synthesis in rat 
intestinal anastomoses: differences between small and large bowel. Gut 1991; 32:
i482-7
25. Högström H, Haglund U, Zederfeldt B. Beneficial effect of proteinase inhibitors 
on early breaking strength of intestinal anastomoses. Acta Chirurgica Scandinavica 
1985; 151: 529-32
26. van der Stappen JWJ, Hendriks T, de Boer HHM. Collagenolytic activity extracted 
from intestinal anastomoses of the rat. Matrix 1989; 9: 238-43
27. Black CT, Hennessey PJ, Ford EG, Andrassy RJ. Protein glycosylation and collagen 
metabolism in normal and diabetic rats. J  Surg Res 1989; 47: 200-2
28. Reiser KM, Crouch EC, Chang K, Williamson JR. Lysyl oxidase-mediated 
crosslinking in granulation tissue collagen in two models of hyperglycemia. Biochim 
Biophys Acta 1991; 1097: 55-61
29. Franzen L, Adamson P, Norrby K. Increased angiogenesis during wound healing in 
rats with streptozotocin-diabetes. Int J  Microcirc Clin Exp 1990; 9: 401-10
30. Irvin TT. Effects of malnutrition and hyperalimentation on wound healing. Surg 
Gynecol Obstet 1978; 146: 33-7
31. Law NW, Ellis H. The effect of parenteral nutrition on the healing of abdominal 
wall wounds and colonic anastomoses in protein-malnourished rats. Surgery 1990; 
io7: 449-54
32. Casey JI. Host defense and infections in diabetes mellitus. In: Rifkin H, Porte D jr, 
eds. Diabetes mellitus, theory and practice. New York Amsterdam London: Elsevier, 
1990: 617-24
33. Hesp WLEM, Hendriks T, Lubbers EJC, de Boer HHM. Wound healing in the 
intestinal wall. Effects of infection on experimental ileal and colonic anastomoses. 
Dis Colon Rectum 1984; 27: 462-7
D
ia
be
te
s 
an
d 
an
as
to
m
ot
ic
 
he
al
in
g 
in 
ra
t 
in
te
st
in
e 
1 
Ch
ap
te
r 
2

Chapter 3
m  omplete prevention o f
impaired anastomotic 
healing in diabetic rats requires preoperative 
blood glucose control
Mi chi e l  H.J.  Verhofstad  
and Thi j s  Hendr iks
Br J  Surg 1996; 83: 1717-21
Diabetes and anas tom o t i c  hea l ing in the in test ine
[74]
S U M M A R Y
Uncontrolled diabetes severely impairs 
early healing of experimental intestinal anastomosis. This 
study aimed to compare the potential beneficial effect of 
insulin treatment, started before or immediately after 
surgery. A  normal blood glucose level was attained in 
diabetic rats by twice-daily administration of insulin, 
commenced either 4 days before operation (insulin-1 group) 
or on the day of operation (insulin-2 group). A  non-diabetic 
control group and an uncontrolled diabetic group were also 
studied. Three days after operation, mean ± sd bursting 
pressures in the diabetic group were severely reduced 
compared with those in controls: 1.0 ± 1.4 versus 8.1 ± 2.9 
kpa in the ileum and 4.9 ± 4.7 versus 18.1 ± 5.8 kpa in 
the colon. For ileal anastomosis, values in both groups of 
animals receiving insulin were similar to those in controls, 
but for colonic anastomosis the mean bursting pressure in 
the insulin-2 group remained significantly (p<o.oi7) below 
that in the insulin-i group (10.2 ± 6.4 versus 20.7 ± 7.9 
kpa, respectively). After 7 days mean bursting pressures in 
both ileum and colon were restored to control levels in 
the insulin-i group but not in the insulin-2 group. 
Anastomotic abscess formation after 3  days was also 
significantly (p<o.oi7 more common in the diabetic and 
insulin-2 groups, but not in the insulin-i group than in the 
control group. Postoperative blood glucose control alone 
does not completely prevent the detrimental effects of 
uncontrolled diabetes on healing intestinal anastomoses.
I N T R O D U C T I O N
Wound repair in diabetic patients is frequently beset by 
complicationsi . This clinical observation has been confirmed in rodents with 
toxin (streptozotocin-induced2-5 and endogenous6-8 diabetes. The development 
of cutaneous wound strength is strongly inhibited and associated with reduced 
accumulation of collagen. It remains to be established whether administration 
of insulin can return all parameters of wound healing to normal. Model studies 
in skin indicate that even when the blood sugar level is controlled with 
insulin, diabetes leads to structurally deficient healing9, particularly in the 
early phase after wounding4.
Impaired healing of intestinal anastomosis will increase 
the chances of leakage. The assumption that diabetes mellitus should be 
considered as a factor detrimental to the repair of colonic anastomosis appears 
well accepted10’11. Consequently the presence of diabetes may predispose the 
surgeon toward a staged procedure rather than construction of a primary ana­
stomosis. In view of these potentially important consequences, there should be 
reticence in extrapolating results obtained on skin to other soft tissues, such 
as the gastrointestinal tract12. In streptozotocin-induced diabetic rats, anasto­
motic abscess formation increases and the development of wound strength is 
severely reduced but, contrary to the situation in skin, this phenomenon is not 
accompanied by deficient accumulation of collagen13.
This study reports on attempts to prevent loss of early 
anastomotic strength by insulin administration. Normoglycemia was restored 
either 4 days before operation of from the day of operation onwards.
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M A T E R I A L S  A N D  M E T H O D S
Animals
Ninety male Wistar rats (mean ± sd body weight:
258 ± 15 g) were used in these studies. Rats were randomly divided into four 
groups: one non-diabetic control group (n=2o), one uncontrolled diabetic 
group (»=30), one diabetic group treated with insulin before and after 
operation (»=20) and one diabetic group treated with exogenous insulin after 
operation only (»=20). These groups will be referred to as control, diabetic, 
insulin-i and insulin-2 groups respectively. A ll animals were housed two per 
cage. They were fed a d libitum with standard chow and had free access to 
water. The animal residence was illuminated from 06.00 to 18.00 hours.
A ll experiments were approved by the Animal Experiments Ethics Review 
Committee of the Medical Faculty, University of Nijmegen.
Diabetes and insulin
The rats in the experimental groups were rendered diabetic 
by intravenous injection of streptozotocin (Sigma, St Louis, Missouri, usa) in 
a dose of 50 mg per kg body weight, freshly dissolved in citrate buffer (o.o i 
mmol/l, pH 4.5) at a concentration of 12.5 mg/ml. The non-diabetic control 
group received citrate only. Three days after injection of streptozotocin, at
18.00 hours, the tail vein blood glucose levels of the rats in the insulin-i 
group were measured (Haemoglukotest strips and a Reflolux s reflectance 
meter; Boehringer Mannheim, Mannheim, Germany). Thereafter, the animals 
were injected subcutaneously with insulin (heat-treated insulin ultralente 
bovine 40 units/ml, pH 5.5 (n o v o , Copenhagen, Denmark), dissolved in saline 
up to a final concentration of 10 units/ml just before use) in a standard dose of
10 units per kg body weight. On subsequent days insulin was administered 
twice daily at 09.00 and 18.00 hours, immediately after measurement of tail 
vein blood glucose concentration. Dosages of insulin were adapted individually 
for each rat, depending on the actual blood glucose level measured and its 
body weight. This regimen was chosen after pilot experiments in which 
several insulin types, dosages and time schedules were studied (results not 
shown). Blood glucose levels between 4.0 and 10.0 mmol/l were considered to
be normal. The insulin-2 group first received exogenous insulin on the day of 
surgery at 18.00 hours and animals were subsequently treated in the same way 
as those in the insulin-i  group. The control group was treated with subcuta­
neous saline at the same time points that the insulin-i group received insulin. 
Tail vein blood from the control group animals was also collected twice daily 
throughout the experiment. The diabetic group was not treated with insulin 
or saline. Tail vein blood glucose concentration in the diabetic group was 
measured only at operation and killing.
Operative procedure
One week after the streptozotocin (or buffer) injection 
all rats were operated by the same surgeon (m .j .h .v .). Animals received an 
anastomosis in both ileum and colon. Animals from the various groups were 
operated on alternately. Operations were performed under semisterile 
conditions using a Zeiss operating microscope. Rats were anesthetized by 
intraperitoneal injection of sodium pentobarbital 50 mg/kg. A  median 
laparotomy of approximately 4 cm was performed. After resection of a 
i-cm  control segment, approximately 15 cm oral to the ileocecal junction, 
an ileoileal anastomosis was constructed, using eight single-layer inverting 
interrupted 8/0 Ethilon (Ethicon, Norderstedt, Germany) sutures. For the 
colonic anastomosis a similar procedure was performed, approximately 3 cm 
oral to the peritoneal reflection. The abdomen was closed with a running 
3/0 silk suture for the musculofascial layer and staples for the skin.
Anastomic strength
One-half of the animals in each group were killed 3 days 
after surgery and the remaining half after 7 days. The abdomen was opened 
and inspected for signs of infectious complications. The anastomotic segments 
were resected, leaving surrounding tissue in place, and washed in saline. Feces 
were removed carefully. Subsequently, the anastomotic segment was connected 
to an infusion pump on one side and to a manometer on the other. Intra­
luminal pressure was then raised by infusion of methylene blue, dissolved in 
saline, at a rate of 2 ml/min. Bursting pressure was defined as the maximum 
intraluminal pressure the segment resisted, expressed in kilopascals. The 
bursting site was also noted.
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Statistical analysis
Differences between groups were analyzed for statistical 
significance with a Wilcoxon rank sum test or a two-tailed Fisher’s exact test 
when appropriate. To correct for the fact that multiple comparisons were 
made, pairwise comparisons were performed with a level of significance of 
a*=2a/k, where k is the number of pairwise comparisons. Thus, differences 
between groups (six possible comparisons) were considered significant 
(a=o.o5) at P<a*=o.oi7.
RESULTS
Mortality
During the study ten rats from the diabetic group died 
prematurely: two animals died before operation, three during operation and 
two on the first postoperative day from intestinal volvulus. Three rats died 
from a ruptured ileal anastomosis, two on day 2 and one on day 6 after 
operation. Four animals from the insulin-2 group died: three suffered from 
anastomotic failure in the ileum and subsequent peritonitis within 24 h after 
operation, while one rat died after the first insulin injection, presumably from 
hypoglycemia as the anastomosis was intact. A ll these animals were excluded 
from the study. There were no deaths in the control and insulin-1 groups. 
Mortality in the diabetic group was significantly increased compared with 
that in control and insulin-i groups (p <0.003, two-tailed Fisher’s exact test).
Blood glucose and insulin
Non-fasting blood glucose concentrations in the various 7- 
day groups are summarized in Figure 1. Measurements in the 3-day groups 
were similar. The rats became hyperglycemic soon after administration of 
streptozotocin and developed polyphagia, polydipsia, diarrhoea and polyuria, 
but no ketoacidosis within the experimental period. Blood glucose levels 
during uncontrolled diabetes were increased approximately fourfold and 
remained strongly raised throughout the experiment. Twice-daily admini­
stration of insulin resulted in normal blood glucose levels within 2 days of
Figure 1 N o n - f a s t i n g  b l o o d  g l u c o s e  l e v e l s
Values are the mean ± sd of measurements performed at 09.00 hours in 
the 7-day groups. Light grey bars: control group (»=10); dark grey bars: 
diabetic group (»=9); black bars: insulin-i group (» = 10); white bars: 
insulin-2 group (» = 9). *P<0.0i7 versus control group; fP<0.0i7 versus 
control and insulin-i groups; $P<0.0i7 versus all other groups 
(Wilcoxon rank-sum test)
[
starting treatment. Preoperative dosages of insulin varied between 0.5 and 1.0 
units/kg at 09.00 hours and between 7.0 and 10.0 units per kg body weight at
18.00 hours. Figure 2a shows that, in unoperated animals, this procedure 
effectively produced normal blood glucose levels over the entire 24-h period. 
The insulin requirement was strongly reduced after operation. For instance, 
the total amount of insulin needed by rats in the insulin-i group on the first 
postoperative day varied between 0 and i  units/kg, resulting in a mean blood 
glucose level of 5.3 ± 2.4 mmol/l (»=20) at 09.00 hours on day 2. Although 
strict control of blood glucose concentration within the normal range became 
more difficult (Figure 2b), mean non-fasting blood glucose values in both 
insulin-treated groups were within the normal range (Figure 1 for 7 -day 
groups).
Body weight
Changes in body weight during the experiment are depicted 
in Figure 3 . After 3 days body weight in the experimental groups was 
significantly (p< 0.005) lower than that in the control group. Preoperative 
administration of insulin restored weight gain. On the day of operation body C
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Table 1 A n a s t o m o t i c  a b s c e s s  f o r m a t i o n
Day 3 _____________  Day 7
Group anastomoses abscess anastomoses abscess
Control 20 I 20 0
Diabetic 22 II  * f i 8 4
Insulin-i 20 2 20 0
Insulin-2 14 6 $ i 8 3
Values pertain to ileal and colonic anastomoses. *P=o.ooi7 (diabetic versus control group); 
fP=o.oo7 (diabetic versus insulin-1 group); $P=o.oi2 (insulin-2 versus control group) (two­
tailed Fisher’s exact test).
weight of animals in the diabetic and insulin-2 groups was significantly 
(p <o .o o o i) lower than that of those in the control and insulin-i groups.
Anastomotic abscess formation
The total number of anastomotic abscesses, observed in the 
ileum and colon within each group, is shown in Table 1. In the control group 
only one abscess was found. Uncontrolled diabetes significantly increased the 
frequency of abscess formation. The insulin-i regimen almost completely 
prevented the development of this infectious complication, whereas 
postoperative administration showed only a limited beneficial effect.
Bursting pressure
The individual measurements of bursting pressure, in 
relation to bursting site and abscess formation, are shown in Figure 4. Three 
anastomoses were damaged by the investigator during the assay procedure and 
were excluded from analysis. Several anastomoses in the diabetic and insulin-2 
groups had ruptured spontaneously during the course of the experiment.
These bursting pressures were zero. Mean bursting pressures (Table 2) in the 
diabetic group were strongly (p<o.oi7) reduced in both ileum and colon 
when compared with the control group. The insulin-i regimen completely 
prevented this reduction of anastomotic strength. A t day 3 the insulin-2 group 
showed normal anastomotic strength in the ileum. However, although the 
mean bursting pressure in colonic anastomoses was higher than in the diabetic 
group, it was still reduced by 44 per cent compared with that in the control
Figure 2 B l o o d  g l u c o s e  c o n t r o l
hours
Blood glucose control over a 24-h period showing typical examples for 
blood glucose values in streptozotocin-treated rats before (a) and 2 days 
after (b) operation. The doses of insulin are also given. Grey lines show 
the normal range for blood glucose concentration
group. A ll 3-day segments ruptured within the suture line. A t 7 days, 
anastomoses in the control group had invariably grown stronger than the 
adjacent tissue: the bursting site was always outside the anastomotic area.
This gain in strength was severely inhibited in animals with uncontrolled 
diabetes, particularly so in the ileum where six of nine anastomotic segments 
ruptured within the actual wound area. Again, the insulin-2 regimen seemed 
insufficient to restore healing completely as rupture occured within the suture 
line in a total of five cases.
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Figure 3 Bo d y  w e ig h t
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D I S C U S S I O N
Impaired wound healing is a postoperative complication 
commonly encountered in patients with diabetes mellitus. Clinical1’14 and 
experimental2,3,5’9 evidence for poor healing is mainly derived from skin 
wounds. Despite the absence of clinical evidence15 diabetes is generally 
presumed to also impair intestinal healing and this assumption was recently 
confirmed by Gottrup and Andreassen16, who studied repair of linear incisions 
in the stomach and duodenum of streptozotocin-induced diabetic rats; 
breaking strength in the duodenum was reduced by 26 and 33 per cent at 
7 and 20 days after operation, respectively16. The present data show that 
untreated streptozotocin-induced diabetes severely lowers anastomotic 
strength: 3 days after operation anastomotic bursting pressure was reduced by 
88 per cent in the ileum and by 73 per cent in the colon. Moreover, complete 
anastomotic failure was evident in many untreated diabetic rats. It seems that 
the loss of strength of intestinal anastomosis constructed in a diabetic animal
Figure 4 B u r s t i n g  p r e s s u r e ,  b u r s t i n g  s i t e  a nd  a b s c e s s  f o r m a t i o n
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is far greater than that reported for linear incisions in the upper gastrointes­
tinal tract16 or skin2-5. Thus, the presence of uncontrolled diabetes must be 
considered a primary risk factor for anastomotic repair.
Although it is generally believed that good control of 
diabetes in the perioperative period promotes healing17, this strategy is often 
not vigorously practiced, possibly because the absence of clear evidence for 
such a strategy results in a lack of enthusiasm by clinicians. Data on the
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Table 2 A n a s t o m o t i c  b u r s t i n g  p r e s s u r e
Bursting pressure (kpa) ____________
Day 3
Control 
Diabetic 
Insulin-1 
Insulin-2
10
10
10
7
Ileum
8.i ± 2.9 
1.0 ± 1.4 *
9.9 ± 4.5
10.9 ± 7.5
10
11 
10
7
Colon
18.1 ± 5.8 
4.9 ± 4.7 f t  
20.7 ± 7.9
10.2 ± 6.4 t
Day 7
Control 
Diabetic 
Insulin-1 
Insulin-2
9
9
10
9
44.9 ± 8.7
13.6 ± 16.3 f t  
43.8 ± 7.6
30.1 ± i 3.3 f t
10
8
10
9
30.7 ± 3.0 
20.5 ± 8.6 f t
34.2 ± 4.2
24.7 ± 3.4 f t
Bursting pressure values are mean ± sd; *P<o.oi7 versus all other groups; fP < o.o i7  versus 
control group; $P<o.oi7 versus insulin-1 group (Wilcoxon rank-sum test)
n n
efficacy of insulin treatment in restoring normal wound strength in experi­
mental diabetes are equivocal. I f  insulin treatment is started immediately after 
induction of diabetes, the strength of incisional wounds in skin or duodenum 
equals that of controls4,16, and Yue et a l.5 suggest, without showing actual 
data, that insulin improved wound strength in a dose-dependent manner. 
However, more recent data on skin wounds indicate that insulin cannot fully 
prevent the inhibitory effects of diabetes in either streptozotocin-induced or 
genetically-diabetic rats and it was concluded that diabetes causes structurally 
deficient wound healing even when the blood sugar level is returned to normal 
with insulin9. This conclusion is perhaps supported by the findings of 
Andreassen and Oxlund4, who reported that insulin treatment from the fifth 
preoperative day was not sufficient to prevent the inhibitory effects of diabetes 
in the early phase of cutaneous wound repair.
The present results indicate that anastomotic healing in 
both the ileum and colon of diabetic animals proceeds undisturbed if hyper­
glycemia is tightly controlled from 4 days before operation onwards. It must 
be emphasized that, in contrast to most experimental studies, particular care 
was taken to establish optimal control of blood sugar levels in each animal
with a very long acting insulin, as required in the rat18. This is especially 
important on the first days after surgery when the insulin need is low and may 
vary widely between animals. It remains to be established whether less careful 
diabetic control, for example by administration of a fixed dose of insulin over 
the entire experimental period (a procedure regularly adopted in other 
reported experiments2,3,5), will result in less complete restoration of anasto­
motic repair.
Insulin treatment from the day of operation onwards does 
not seem sufficient to result in normal anastomotic healing. Although ileal 
wound strength in the insulin-2 group equalled control values at day 3, this 
was not the case for the colon. Furthermore, the incidence of abscess formation 
remained high, particularly in the ileum. After 7 days, the mean bursting 
pressures in the insulin-2 group remained significantly below those in the 
control and insulin-1 groups. A t this time the bursting site is mostly outside 
the suture line, so these values represent the strength of the uninjured adjacent 
bowel wall rather than that of the anastomotic area. Apparently a period of 
uncontrolled hyperglycemia reduces the strength of the intestinal wall. It 
could be that hyperglycemia enhances non-enzymatic glycation of proteins 
including collagen19,20, a process that is poorly reversible and results in 
disturbed intermolecular crosslinking21 and subsequent loss of submucosal 
strength.
The reduced strength of wounds in diabetic animals is 
attributed to impaired accumulation of collagen2,22,23. Contrary to these 
findings, it was established that this was not the case for intestinal anasto­
moses: loss of strength was not accompanied by a lowered anastomotic 
collagen content13,24. Presumably, a qualitative change in newly formed 
collagen causes the reduction in wound strength. The results from an earlier 
series of experiments13 suggested that anastomotic abscesses were a 
consequence rather than the cause of diminished anastomotic strength in 
diabetic animals. This hypothesis appears to be strengthened by the present 
results. Although Figure 4 indicates that in the individual anastomoses the 
presence of an abscess was often attended by a low bursting pressure, this was 
not invariably the case: 3  days after operation the mean anastomotic strength 
was normal in the ileum of the insulin-2 group, while five out of seven 
anastomoses showed abscesses. Also, in the colon the insulin-2 regimen led to C
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a reduction in the number of abscesses without fully restoring anastomotic 
strength.
Hypovolemia as a cause for weight loss is unlikely to 
contribute significantly to poor healing: Foster et a l.25 reported that a 10 per 
cent loss of circulating volume did not reduce strength of colocolic or ileocolic 
anastomoses in rats. Yue et a l.5 concluded that a comparable diabetes-induced 
loss of weight had no independent effect on cutaneous wound strength: 
malnutrition over 8 weeks was more important than actual weight loss. 
Moreover, malnutrition impairs wound healing but to a much lesser degree in 
colonic anastomoses than in skin wounds26. Because rats in the present 
experiment were fed ad libitum  and the experimental period was only 2 weeks, 
neither malnutrition nor weight loss appears sufficient to explain the observed 
differences in wound strength. Also, local administration of insulin to skin 
wounds restores the normal healing response in rats with uncontrolled diabetes 
and concomitant weight loss23. Thus, although changes in body weight 
apparently parallel the degree of intestinal healing, a causal relationship seems 
unlikely.
These studies show that uncontrolled diabetes severely 
reduces early anastomotic strength. Optimal control of blood sugar 
concentration by administration of insulin from 4 days before operation 
onwards may prevent this effect, but postoperative diabetic control alone is 
insufficient to restore adequate healing fully. It remains to be established to 
what extent less strict control of blood sugar levels in the perioperative period 
or preoperative insulin therapy alone may affect normal anastomotic repair.
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S U M M A R Y
Pancreatic islet transplantation may prevent 
secondary complications of diabetes mellitus, but its potential 
benefits on early complications have been incompletely 
examined. The objective of this study was to investigate whether 
preoperative islet transplantation would normalize impaired 
healing of intestinal anastomoses in diabetic rats. Male Lewis 
rats were divided into a control group ( i), an uncontrolled 
diabetic group (i i ), and a transplant group ( i i i). Nine days before 
surgery, groups ii  and ii i  were rendered diabetic by injection of 
streptozotocin. Two days before surgery, group iii  received an 
intrahepatic isogenic two-donor islet graft, whereas groups i and
ii  underwent sham transplantation. On day o, all animals 
underwent resection and anastomosis of both ileum and colon. 
Half of the animals in each group were killed on day 3 and the 
other half were killed on day 7. Blood glucose levels in group ii 
rats remained over 20 mmol/l throughout the experiment, 
whereas in group ii i  rats they were normalized within 24 hours 
after transplantation. At death, group i i  rats, but not groups i 
and iii  rats, showed a high incidence of anastomotic abscesses. 
Uncontrolled diabetes lowered anastomotic strength, and 
transplantation prevented this reduction. For instance, anasto­
motic bursting pressure in the ileum on day 3 was 11.9 ± 4.8 
kpa in group i rats, 3.3 ± 3.0 kpa in group i i  rats, and 11.1 
± 4.3 kpa in group i i i  rats. Rupture on day 3 always occurred 
within the anastomosis, whereas on day 7 intraanastomotic 
ruptures were only observed in group ii  rats. No differences 
between the groups were found for either anastomotic 
hydroxyproline concentration or content. However, the acid 
solubility of anastomotic collagen was significantly higher in 
group ii  rats than in groups i and iii  rats. Thus, uncontrolled 
diabetes lowers anastomotic strength without affecting 
anastomotic collagen content. Defective repair is prevented by 
pancreatic islet transplantation before surgery.
I N T R O D U C T I O N
The aim of pancreatic islet transplantation is to prevent 
secondary complications of diabetes mellitus by restoring a physiologic glucose 
metabolism. In laboratory animals, this treatment has been reported to stabi­
lize or even reverse the development of long-term complications of diabetes, 
such as retinopathy1, angiopathy2, nephropathy3 and neuropathy4.
In addition to these secondary complications of diabetes, early sequelae of the 
disease are also recognized. Among the early sequelae, impaired wound 
healing5 and wound infections account for a significant surgical morbidity. 
Thus far, the potential beneficial effects of islet transplantation on such early 
complications have not been completely investigated.
Various experimental studies, mostly performed in the 
skin or wound chambers of rodents with chemically induced diabetes, have 
confirmed the clinical observation of inferior healing6,7. Wound strength is 
severely decreased in hyperglycemic diabetics, and this effect has customarily 
been attributed to diminished capacity to accumulate collagen in the wound 
area. Other reported changes related to collagen metabolism in diabetes- 
impaired healing include increased collagen crosslinking8 and increased 
collagenase activity9. Under certain conditions, insulin treatment can negate 
these phenomena6,9,10. Recently, it has been shown that exogenous growth 
factors stimulate cutaneous wound repair in genetically diabetic mice which 
generally exhibit a suppressed healing response11.
Although all wounds probably heal by the same basic 
mechanisms, repair in various tissues may well be affected differently by the 
diabetic state. In this respect, healing of intestinal anastomoses has not been 
investigated, although complications in anastomotic repair may lead to serious 
clinical morbidity and mortality. Very recently, we examined the effect of 
streptozotocin-induced uncontrolled diabetes on anastomotic healing in the 
rat intestine. The development of early wound strength was indeed seriously 
compromised, but a concomitant decrease in collagen synthetic capacity could 
not be shown12. The present study was performed to extend these findings and
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investigate the effect of preoperative pancreatic islet transplantation on 
impaired healing of experimental anastomoses.
M A T E R I A L S  A N D  M E T H O D S
[92]
Animals
One-hundred inbred male Lewis-Hannover rats were housed 
two per cage and observed for i  week before the study. They were allowed 
free access to water and were fed a standard diet (Hope Farms, Woerden,
The Netherlands). Rats were weighed at the onset of the experiment and daily 
after pancreatic transplantation or the sham procedure. Sixty rats with a mean 
weight of 288 ± 12 g (standard deviation; s d ) were divided into three groups. 
These groups of 20  animals each were as follows: control, diabetic, and 
transplant groups. The animals in the latter two groups were rendered diabetic 
(mean blood glucose over 20 mmol/l) 9 days before surgery by a single 
intravenous injection of streptozotocin (Sigma Chemical Co., St. Louis, m o , 
u s a ) at a dose of 50 mg/kg body weight. Streptozotocin was dissolved in 
citrate buffer (10 mmol/l, pH 4.5) at a concentration of 12.5 mg/ml. Control 
animals received only citrate buffer. Forty rats were used as pancreas donors for 
pancreatic islet isolation. A ll animals received humane care, and the study was 
carried out after approval by the Animal Ethical Review Committee of the 
Faculty of Medicine, University of Nijmegen.
Pancreatic islet transplantation
Seven days after streptozotocin injection (i.e., 2 days before 
surgery), the animals of the transplant group each received an intraportal 
pancreatic islet graft, obtained from two donor rats, according to a previously 
described methodi3 with minor modifications. Donor animals underwent 
a laparotomy under ether anesthesia. The common bile duct was identified, 
and its distal end was occluded with a hemostatic clip (LS100; Ethicon, 
Norderstedt, Germany). Cardiorespiratory arrest was then induced by 
inflicting a pneumothorax. The proximal common duct was then incised, 
cannulated with a 18-gauge polyethylene catheter, and injected with 15 ml
ice-cold Hank’s balanced salt solution (h b s s ; Gibco, Breda, The Netherlands) 
containing i  mg/ml collagenase (Boehringer, Mannheim, Germany; intrinsic 
activity 1.58 Wünsch u/mg), distending the pancreas. A  total pancreatectomy ^
was performed, carefully maintaining the integrity of the pancreatic capsule. ^
The pancreas was incubated in a 50 ml tube for 23 minutes at 37 ° c  in a 
stationary water bath. Digestion was halted by adding 35 ml of h b s s  at 4 ° c .  [93]
Dissociation of the tissue was achieved mechanically by shaking and passing -S
through a 800 |j.m pore size nylon mesh screen. The suspension was centri- , t
fuged for i  minute at 200g, and the supernatant was discarded. The pellet Js
* ^
was dispersed in 14 ml of a 27%  dextran solution (Sigma; molecular weight 
70,000, industrial grade) prepared with h b s s , final density 1.094 g/ml.
A  discontinuous density gradient was established by adding a 6 ml layer of 
23% (density 1.081 g/ml) and on top a 4 ml layer of i i %  (density 1.041 
g/ml) dextran solution. The gradient was centrifuged at 40g for 4 minutes and §
subsequently at 500g for 12 minutes. Pancreatic islets were harvested from the §
upper interface with a Pasteur pipet. After two washes in 50 ml h b s s  followed $
by centrifugation at 40g for 2 minutes, the islets from two donor animals were 
dispersed in 2.5 ml h b s s . Diabetic animals from the transplant group were 
anesthetized with ether and underwent a median laparotomy. A  23-gauge 
butterfly needle was used to inject the islets in a mesenteric vein. Metal clips 
(LS100; Ethicon) were used for hemostasis. The abdomen was closed using a 
running 4-0 silk suture for the musculofascial layer and staples for the skin. §
Animals in the control and diabetic groups were subjected to a sham operation 
and were injected with 2.5 ml h b s s  without pancreatic islets. • *
ssAnastomotic construction §
Two days after the sham transplantation or day 0, all ^
animals received an anastomosis in both ileum and colon. Diabetic, trans­
plant recipients and control animals were operated alternately. Surgery was 
performed under semisterile conditions with the use of a Zeiss operating 
microscope. Rats were anesthetized with an intraperitoneal injection of sodium 
pentobarbital (50 mg/kg). Access to the peritoneal cavity was obtained by a 
relaparotomy. After resection of a i  cm ileal segment approximately i5  cm 
proximal to the ileo-cecal junction, an ileo-ileal end-to-end anastomosis was 
constructed with the use of eight interrupted single-layer inverting 8-0 
Ethilon (Ethicon) sutures. For the colonic anastomoses a similar procedure was 
performed at approximately 3 cm proximal to the peritoneal reflection. The
8'S
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abdomen was closed with a running 4-0 silk suture for the musculofascial 
layer and staples for the skin.
Anastomotic strength
H alf of the rats in each group were killed 3 days after their 
anastomotic operation by a lethal intraperitoneal dose of sodium pentobarbital 
(>200 mg/kg). The remaining half were killed 7 days after their operation.
The abdomen was opened and inspected macroscopically for signs of infectious 
complications. Intestinal segments of approximately 3 cm, containing the 
anastomosis in the middle, were resected, leaving surrounding tissue in place 
and washed in 0.9% (weight/volume) Nacl. Feces were removed carefully. 
Subsequently, the anastomotic segment was connected to an infusion pump on 
one side and to a manometer on the other side. Pressure was raised by infusion 
of methylene blue, dissolved in 0. 9% (w/v) Nacl at a rate of 2 ml/min, and was 
recorded graphically. Bursting pressure was defined as the maximum intra­
luminal pressure which the segment resisted and expressed in kilopascals.
The bursting site was also recorded. Thereafter, the segment was cleaned from 
adhesions and surrounding tissue (including abscesses), and a 5 mm strip 
biopsy section, containing the entire anastomosis in the middle, was collected 
and stored in liquid nitrogen for hydroxyproline assay.
Biochemical determinations
Non-fasting glucose levels in blood collected from the 
tail vein of rats were measured with the use of glucose reagent sticks 
(Haemoglukotest 1-44 r ; Boehringer) and a reflectance meter (Reflolux s ; 
Boehringer). Blood glucose levels of the rats in the transplant group were 
measured on the day of transplantation and on all subsequent days until death, 
whereas measurements in the control and diabetic groups were performed only 
at the days of the sham transplantation, anastomotic construction, and death.
Tissue hydroxyproline, as a measure for collagen, was 
analyzed as described before14, essentially according to Prockop and 
Udenfriend15. To measure the solubility of collagen, approximately 8 mg 
lyophilized tissue was suspended in 1.1 ml 0.5 mol/l acetic acid and left 
overnight at 4oc  under continuous rotation. After centrifugation for 1 hour at 
40,000^, both pellet and supernatant were lyophilized and measured for their 
hydroxyproline content.
Table 1 N o n - f a s t i n g  b l o o d  g l u c o s e  l e v e l s
Day 3
Control group 10 
Diabetic group 9 
Transplant group 10
Glucose concentration (mmol/l) __
At transplantation A t operation
6.0 ± 0.9 
21.5 ± 2.2 * f  
25.3 ± 3.2 *
5.4 ± 0.6 
24.0 ± 4.8 *$ 
8.9 ± 2.9B
At death
4.9 ± 1.0
17 .i ± 5.5 § 1
5.9 ± 2.0
[
Day 7
Control group 10 6.5 ± 0.8
Diabetic group 10 21.5 ± 3.2
Transplant group 10 21.9 ± 3.5
5.3 ± °.9 
22.7 ± 4.9 *$
7.0 ± 2.3
5.3 ± 0.8 
24.7 ± 3.3 *1 
4.9 ± 0.7
Data are expressed as mean ± sd. Differences between groups were tested for significance with 
a Kruskal-Wallis K-sample test. *P<0.00i versus control, fP<0.05 versus transplant group, 
$P<0.00i versus transplant group, §P<0.0i versus control, ^P<0.0i versus transplant group.
n
*
*
For statistical analysis of differences between groups, 
a Kruskal-Wallis K-sample test and a two-tailed Fischer’s exact test were 
used when appropriate.
RESULTS
During the course of the study, one diabetic rat died during 
an operation. This animal was excluded from the study. The mean blood 
glucose levels, as measured at the days of transplantation, intestinal operation, 
and death are shown in Table 1 . Figure 1 shows the temporal course of blood 
glucose values in the various groups of rats killed 7 days after the anastomotic 
operative procedure. The rats became hyperglycemic within 24 hours after 
administration of streptozotocin (not shown), and signs of polydipsia, poly­
phagia, polyuria and diarrhea developed. N o clinical signs of ketoacidosis were 
observed during the experimental period. Before islet transplantation, the 
blood glucose levels in the diabetic and transplant groups were increased
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Figure 1 N o n - f a s t i n g  b l o o d  g l u c o s e  l e v e l s
30
- 2 - 1 0 1  2 3 4 5  6 7
Day
Temporal levels of non-fasting blood glucose. Data are given (mean ± 
sd , ® = io ) for groups killed 7 days after the intestinal operation.
The transplant group (grey bars) was measured daily after islet 
transplantation (day -2). Diabetic (black bars) and control groups 
(white bars) were measured only on the days of sham transplantation, 
operation (day o) and death.
approximately fourfold when compared with the control group. Pancreatic 
islet transplantation resulted in normoglycemia after 24 hours in all cases, 
and blood glucose levels remained normal throughout the study. Significant 
hyperglycemia persisted in the diabetic group until death.
Figure 2 shows the temporal course of the animals’ weight in 
the three groups during the study. Here, only the data from the animals killed 
at 7 days after the intestinal procedure were used. Clearly, diabetic rats lost 
body weight in relation to healthy controls. However, after islet transplan­
tation, the course of body weight was similar to that of control animals. The 
body weights in the control group were significantly (p < o .o o i ) higher than 
those in both the diabetic and the transplant groups at the time of transplan­
tation, operation, and death. The transplant group differed from the diabetic 
group at operation (p < 0 .0 5 )  and at death 7 days after operation (p < o .o o i ).
The number of anastomotic abscesses in the diabetic groups was increased 
(Table 2) when compared with the control and transplant groups, particularly 
in the ileum 3 days after the operation.
Figure 2 Body weigh t
IIO
IOO
% 90 
8o
[
-9 -8 -7 -6 -5 -4 -3 -2- - i 0 i 2 3 4  5 6  7
Day
Temporal changes in body weight. Animals were treated with 
streptozotocin (diabetic group, dashed line, and transplant group, 
dotted line) or citrate buffer (control group, solid line) at day -9, 
underwent transplantation with pancreatic islets at day -2, operated at 
day o, and killed at day 7. Data are expressed relative to initial weight 
and given as mean ± sd (n=io).
The individual measurements of anastomotic strength, in 
relation to bursting site and abscess formation, are shown in Figure 3 . One 
anastomosis was damaged by the investigator during the assay procedure and 
was excluded from the results. Three ileal anastomoses from diabetic rats 
ruptured spontaneously during the course of the experiment. They were 
included in the results with a bursting pressure of zero. In these cases anasto­
motic abscesses were invariably present. Three days after operation the mean 
anastomotic bursting pressure was significantly reduced in the diabetic 
animals by 73 per cent (p<o.ooi) in ileum and by 26 per cent (p<o.oi) in 
colon when compared with control animals (Table 3). Transplantation with 
pancreatic islets prevented this reduction of anastomotic strength. A t 3 days, 
the forced disruption almost invariably occurred within the anastomosis. Only 
two colonic segments of control rats and one colonic segment of a rat that 
underwent transplantation ruptured outside the suture line. Seven days after 
operation the mean strength of both ileal (p<o.oi) and colonic (p<o.ooi) 
anastomotic segments was still significantly lower in the diabetic group than 
in the control group. N o differences were observed between control and 
transplant groups in the ileum. However, transplantation of pancreatic islets
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Table 2 A n a s t o m o t i c  a b s c e s s  f o r m a t i o n
Day 3
Control group 
Diabetic group 
Transplant group
10
9
10
Number of abscesses_
Ileum Colon
0
5*
I
Day 7
Control group 
Diabetic group 
Transplant group
I0
I0
I0
Overall statistical analysis with a two-tailed Fischer’s exact test yielded significant differences 
in the ileum at day 3 (p<o.oi) and at day 7 (p<0.05). Comparison of numbers in the separate 
groups yielded one difference: *P<0.05 versus control.
n
0
did not completely restore the decreased bursting pressure in the colon. 
Rupture in all 7-day-old segments from the control group occurred outside 
the suture line. In the diabetic group, six of ten ruptures in both ileum and 
colon occured within the anastomotic area, indicating a significant (p < o .o i , 
Fischer’s exact test) loss of wound strength. Islet transplantation completely 
prevented this phenomenon.
Diabetes-induced reduction of anastomotic strength was not 
accompanied by reduced levels of wound collagen. Table 4 gives the mean 
values for both anastomotic hydroxyproline content, expressed on the basis of 
tissue dry weight and tissue sample size. N o indications of decreased anasto­
motic hydroxyproline levels were found in the diabetic group, as compared 
with the control group. Also, both hydroxyproline content normalized per 
tissue dry weight and sample size were similar in both control and transplant 
groups. In 7-day-old anastomotic tissue in the ileum, acetic acid solubility 
was 8.6 ± 1.7%  (»=9) in the control group, 14.5 ± 5.9% (»=7) in the diabetic 
group and 7.8 ± 1.5%  ( » = i o ) in the transplant group. The values for colon 
were 5.7 ± 1.7%  (»=9), 7.6 ± 2.5% ( » = i o ) and 4.9 ± 0.4% ( » = i o ), respec­
tively. Both in the ileum and colon, solubility in the diabetic group was thus 
significantly increased if compared with the control group (p < 0 .0 5 ) .
Table 3 Anas tomo t i c  burst ing  pressures
Bursting pressures (kpa) 
n Ileum
Day 3
Control group 
Diabetic group 
Transplant group
10
9
9
11.9 ± 4.8 
3.3 ± 3.0 * f  
I I .I  ± 4.3
I0
9
I0
Colon
i 9.7 ± 4.4
14.5 ± 3.9 $
16.6 ± 3.8
[
Day 7
Control group 
Diabetic group 
Transplant group
I0
I0
4^2 ± 5.5 
2 5 .I ± 14.2 $§ 
37.9 ± 7.5
I0
I0
I0
33.1 ± 2.4
23.5 ± 4.3 *§
28.3 ± 5.3 %
Data are expressed as mean ± sd. Differences between groups were tested for significance with 
a Kruskal-Wallis K-sample test. *P<o.ooi versus control, fP < o.oi versus transplant group, 
$P<o.oi versus control, §P<0.05 versus transplant group, ^[P<0.05 versus control.
n
Transplantation significantly (p<0.0i versus diabetic group) reduced solubility 
of anastomotic hydroxyproline, resulting in values which were similar to those 
observed in the control group.
D I S C U S S I O N
It has been shown both clinically5 and experimentally6,7 
that cutaneous wound healing is impaired in diabetics in whom blood glucose 
is not carefully controlled. The present study indicates that healing of intes­
tinal anastomoses is similarly disturbed. In both the ileum and colon, early 
anastomotic strength is significantly reduced. In addition, the incidence of 
anastomotic abscess formation is increased, especially in the ileum. Such 
deficient healing is an early complication of uncontrolled diabetes, as the 
animals were operated 9 days after induction of diabetes.
Pa
nc
re
at
ic
 
isl
et
 
tr
an
sp
la
nt
at
io
n 
an
d 
in
te
st
in
al
 a
na
st
om
os
es
 
in 
di
ab
et
ic
 
ra
ts 
9
 
Ch
ap
te
r 
4
Diabetes and anas tom o t i c  hea l ing in the in test ine
[100]
Figure 3 Burs t ing pr es s u re ,  burs t ing  s i te  and a n a s t o m o t i c  a b s c e s s e s
pressure
c d c dt t
Relationship between bursting pressure, bursting site and anastomotic 
abscesses in individual animals from the control group (C), pancreatic 
islet transplant group (T) and diabetic group (D). Circles show no 
abscess present; triangles show abscess present; open symbols show 
rupture within the suture line; closed symbols show rupture outside the 
suture line.
Intensive exogenous insulin supplementation improves 
healing of incisional wounds in the skin of streptozotocin-induced diabetic 
animals6,9,I0. This effect has also been described for incisional wounds in 
stomach and duodenumI6. Additional observations in our laboratory indicate 
that exogenous insulin increases anastomotic strength in the intestine of 
streptozotocin-treated rats (see chapter 3). Am ple proof exists that trans­
plantation of pancreatic islets is superior to exogenous insulin regimens in 
stabilizing or preventing secondary diabetic complications. In particular, 
correction of early diabetic glomerulopathy and early peripheral motor
Table 4 A n a s t o m o t i c  h y d r o x y p r o l i n e
Hydroxyproline ____________
Concentration (|ig/mg dry weight) _ Content ( g^/5mm intestine) -
Day 3 Day 7 Day 3 Day 7
Ileum
Control group 7.1 ± 1.0 I0.2 ± 1.9 I I 2 ± I 9 I88 ± 72
Diabetic group 7.0 ± 0.9 (8) 10.3 ± 2.0 (8) 132 ± 26 (8) 282 ± 74 (8)
Transplant group 7.1 ± I .0 (9) I0.7 ± I.I I 37 ± 25 (9) I 77 ± 44
[1
Colon
Control group II  . 2 ± 0 . 9 14.0 ± 2.8 210 ± 47 260 ± 60
Diabetic group 9.9 ± 0.8 (7) I I .7 ± 2.5 2 i 6 ± 32 (7) 275
VAVA±
Transplant group I0 . 4 ± I . 0 13.9 ± i . 6 223 ± 30 273 ± 46
Data represent mean values ± sd; »= i o , unless stated otherwise (in parentheses). Statistical 
analysis with a Kruskal-Wallis K-sample test yielded no significant differences between groups.
neuropathy has been obtained with islet transplantation3,4. In our study, islet 
transplantation normalizes blood glucose levels within 24 hours and preserves 
normoglycemia in the perioperative period and during the early repair phase. 
Defective healing of anastomoses constructed 2 days after islet transplantation 
- as present in diabetic animals which receive a sham transplantation - is 
prevented almost completely. Three days after operation, the mean bursting 
pressure is similar in control and transplant groups. After 7 days the mecha­
nical strength of the anastomoses is greater than that of the surrounding tissue 
in both control and transplant group animals. Here, all provoked ruptures 
occur outside the suture line, in contrast to the diabetic animals where rupture 
frequently occurs within the wound area. The minor, but significant, diffe­
rence in mean colonic bursting pressure observed 7 days after the operation 
between the control and transplant groups is therefore a result of reduced 
strength of the uninjured intestinal wall and not of the anastomosis. In 
addition to normalizing wound strength, islet transplantation also reduces 
anastomotic abscess formation.
The fact that cutaneous wound repair may be delayed and 
incomplete as a consequence of poorly controlled diabetes is well recognized. 
Experimental studies on skin wounds and wound chambers indicate that
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changes in the metabolism of collagen may be the underlying cause for the 
diminished wound strength observed because the hydroxyproline content of 
granulation tissue appears to be significantly reduced in streptozotocin- 
induced diabetic animals6,7,9. Therefore, impaired cutaneous wound strength is 
thought to be the result of lowered accumulation of collagen. In a prior study, 
we did not find such reduced collagen content in intestinal anastomoses in 
streptozotocin-induced diabetic Wistar rats12. The present data, obtained with 
Lewis rats, confirm this finding and strengthen our concept that intestine and 
skin react differently to the hyperglycemic state. It has been emphasized before 
that, although all wounds may heal by an essentially common mechanism, one 
should exert caution in extrapolating the results from research on skin repair 
to the healing of other soft tissues17,18.
The strength of the healing intestinal wall essentially 
depends on the presence of collagen17. Although the capacity of anastomotic 
tissue to synthesize collagen is increased shortly after operation19, it is unlikely 
that newly formed collagen determines wound strength during the first post­
operative days. In this period strength is derived from the suture-holding 
capacity of the existing collagenous network20. A t 3 days after operation, we 
find no differences among groups with regard to anastomotic hydroxyproline 
concentration or content. However, this finding does not preclude the 
possibility that in the diabetic group a limited and localized degradation of 
collagen fibrils, too small to observe with the methods currently used but 
greater than that in the control group, has occurred leading to a loosened 
structure of the matrix and reduced wound strength. We have found increased 
collagenolytic activity in intestinal anastomoses during the first days after 
operation21, and it has been reported that collagenase activity is enhanced 
in wounds from diabetic animals9.
After this period where old collagen determines strength, 
newly synthesized fibrils become increasingly important for restoring initial 
strength to the healing intestinal wall. Between 3 and 7 days after the 
operative procedure, the anastomotic hydroxyproline content increases, 
particularly in the ileum. This increase is not reduced in the diabetic group if 
compared with both control and transplant groups. Thus, loss of strength in 
the diabetic group is not caused by a diminished accumulation of collagen. 
Instead, it could result from a change in the quality of the collagen fibrils. It
is noteworthy that the acid solubility of anastomotic collagen is significantly 
enhanced in the diabetic group. This finding may indicate that the crosslinks 
formed under hyperglycemic conditions are either fewer in number or less 
stable and thus confer less strength to the healing tissue. Abnormal collagen 
crosslinking has been reported in young granulation tissue from strepto- 
zotocin-induced diabetic rats22. In our study, islet transplantation normalized 
the solubility of collagen in the 7-day-old anastomotic tissue. A  similar 
phenomenon was observed in subcutaneous implants where islet transplants 
have been reported to prevent hyperglycemia-induced decreased tissue collagen 
solubility23. It should be noted that in this case (streptozotocin-induced) 
diabetes reduces acetic acid solubility of newly formed granulation tissue, 
whereas in our experiments solubility of anastomotic collagen increases, again 
emphasizing the possible differences in the healing response of various tissues.
The increased incidence of anastomotic abscesses in the 
diabetic group, as compared with both the control and the transplant group, 
raises the question of whether reduced mechanical strength is secondary to 
abscess formation. Poorly controlled diabetic patients are increasingly 
susceptible to infection and induction of peritonitis (with concomitant abscess 
formation) has been shown to result in reduced strength of experimental 
intestinal anastomoses24. However, our data show that the presence of an 
anastomotic abscess is no prerequisite for impaired strength because, in both 
the ileum and colon, abscess-free anastomoses in the diabetic group are weaker 
than most comparable anastomoses in the control group.
In conclusion, uncontrolled experimental diabetes mellitus 
severely impairs anastomotic healing in the intestine. In contrast to reported 
data on skin repair, reduced wound strength is not accompanied by dimini­
shed accumulation of collagen. Pancreatic islet transplantation prior to surgery 
prevents the negative consequenses on intestinal repair.
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Chapter 5
V  m  uantitative microscopic 
analysis o f cellular 
and extracellular m atrix components in 
anastomotic healing in ileum and colon 
in normal and diabetic rats
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and Th i j s  Hendr iks
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S U M M A R Y
In a previous study we showed that in rats 
uncontrolled diabetes mellitus impairs early strength of 
intestinal anastomoses while, unexpectedly, collagen content 
and the capacity of fibroblasts to synthesize collagen were 
not reduced during healing. In the present study, we 
investigated if short-term, uncontrolled diabetes affects the 
cellular and extracellular matrix components of anastomoses 
in ileum and colon. Eighteen Wistar rats were rendered 
diabetic one week before operation by intravenous 
streptozotocin injection (50 mg/kg) resulting in non-fasting 
blood glucose levels of approximately 20 mmol/l. Another 
18 age-matched rats were used as controls. A ll rats 
underwent resection and received an anastomosis in both 
ileum and colon. Rats were killed 1, 3 or 7 days after 
operation. Cellular and architectural parameters of 
anastomotic healing were estimated in hematoxylin and 
eosin stained sections. Anastomotic collagen content was 
measured by image analysis in picrosirius red stained 
sections. Anastomotic necrosis, edema and epithelial 
recovery were not affected by diabetes. In diabetic rats the 
number of polymorphonuclear cells (pm ns) and macrophages 
were significantly increased in ileal anastomoses 1 and 3 
days after operation. In colonic anastomoses the number of 
pm n s was increased 1 and 7 days after operation. Repair of 
the submucosal-muscular layer in colonic anastomoses from 
diabetic rats was impaired 7 days after surgery, but in ileal 
anastomoses no difference was found. In the anastomotic 
area collagen deposition at postoperative days 1, 3 and 7 was 
not affected by diabetes. We conclude that in experimental 
diabetes in intestinal anastomoses mainly cells involved in 
the early phases of tissue repair are increased whereas 
deposition of collagen is not affected.
I N T R O D U C T I O N
Leakage of anastomoses is a severe complication in gastro­
intestinal surgery. Morbidity and mortality rates are still high despite advances 
in operative techniques and suture material. Therefore, basic research on the 
mechanisms of intestinal healing and its disturbances remains necessary. 
Healing of intestinal anastomoses and in particular the development of 
early postoperative anastomotic strength may be compromised by numerous 
technical, local and systemic factors1 . Diabetes mellitus is assumed to be such 
a detrimental factor2,3.
Dehiscence of intestinal anastomoses is mostly seen during 
the first week after operation. Immediate postoperative wound strength 
mainly depends on the ability of extracellular matrix components, particularly 
collagen fibers, to retain sutures4,5. After this initial period wound strength 
should be restored to the levels of uninjured tissue by deposition of new 
collagen fibers6, produced by fibroblasts under direction of both the cellular 
and humoral immune system. Consequently, disturbed connective tissue meta­
bolism may induce poor wound strength as has been shown in diabetic skin 
wounds where strength and collagen content are decreased7-12. In previous 
experiments we have found that early postoperative strength is reduced in 
intestinal anastomoses in streptozotocin-diabetic rats13-15. In contrast to the 
findings in skin loss of wound strength in intestinal anastomoses appears not 
to be accompanied by either a reduced capacity of fibroblasts to synthesize 
collagen or diminished deposition of collagen expressed as hydroxyproline 
levels13,14. Therefore, other mechanisms must underly the healing defect in 
the intestine. Obviously, elucidation of these mechanisms and searching for 
preventive measures are important in order to ensure optimal treatment of 
the diabetic patient.
Since little is known about the repair sequence in the 
intestine under diabetic conditions we performed the present microscopic 
study, especially to (i ) determine the collagen deposition in the anastomotic 
area by image analysis and (2) to estimate semi-quantitatively the number of
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cells involved removal of cell debris and renewal of tissue architecture during 
the first postoperative week of anastomotic healing in the ileum and colon of 
normal and streptozotocin-diabetic rats. Results from this study might 
elucidate why the strength of intestinal anastomoses is reduced in diabetic 
rats13-15.
[110]
M A T E R I A L S  A N D  M E T H O D S
Animals
Thirty-six, three months old male outbred Wistar/cpb:wu 
rats, weighing 301 ± 23 g (mean ± sd ), were obtained from our own colony. 
Animals were housed 2 per cage, fed standard chow (Diet a m  ii, Hope Farms, 
Woerden, The Netherlands) and had access to water a d  libitum. After an 
observation period of 1  week, rats were randomly divided into a control and 
diabetic group. The animals in the latter group were rendered diabetic (mean 
non-fasting pre-operative blood glucose over 20 mmol/l) 7 days before surgery 
by a single intravenous injection of streptozotocin (Sigma Chemical Co.,
St. Louis, m o , u s a )  at a dose of 50 mg/kg body weight. Streptozotocin was 
dissolved in citrate buffer (10 mmol/l, pH 4.5) at a concentration of 12.5 
mg/ml. Control animals received only citrate buffer. Body weight was recorded 
at the onset of the experiment, at operation and at death. Non-fasting glucose 
levels in blood collected from the tail vein of rats were measured at operation 
and at death with the use of glucose reagent sticks and a reflectance meter 
(Glucocard Memory, Menarini Diagnostics, Valkenswaard, The Netherlands). 
The study was carried out after approval by the Animal Ethical Review 
Committee of the Faculty of Medicine, University of Nijmegen.
Operative procedures
Seven days after injection of streptozotocin all animals 
received an anastomosis in both ileum and colon. Diabetic and control animals 
were operated alternately. Surgery was performed under semi-sterile conditions 
with the use of a Zeiss operating microscope. Rats were anesthetized using 0.5 
L/min o 2, 0.2 L/min n 2o  supplemented with 1.5-3%  isoflurane. The abdomi-
nal skin was shaved, disinfected with 70% (v/v) ethanol. The peritoneal cavity 
was opened by a median laparotomy of approximately 4 cm. After resection of 
a 1 cm ileal segment approximately 15 cm proximal to the ileocecal junction, 
an ileo-ileal end-to-end anastomosis was constructed with the use of eight 
interrupted single-layer inverting 8-0 Ethilon® (Ethicon, Norderstedt, 
Germany) sutures. For the colonic anastomoses a similar procedure was 
performed at approximately 3 cm proximal to the peritoneal reflection. The 
abdomen was closed with a running 4-0 Monocryl® (Ethicon, Norderstedt, 
Germany) suture for the musculofascial layer and staples for the skin.
Tissues and staining procedure
One, 3 and 7 days after surgery, a relaparotomy was 
performed under general anesthesia using 0.5 L/min o 2, 0.2 L/min n 2o  
supplemented with 1.5-3%  isoflurane. The abdomen was inspected macro- 
scopically for signs of infectious complications and intestinal samples of 
approximately 1  cm containing the entire anastomosis in the middle were 
carefully collected en bloc, opened at the mesenterial side, washed gently in 
0.9% (w/v) Nacl, spread out on a block of paraffin and immediately fixed in 
4%  (v/v) phosphate buffered formaldehyde, pH 7.3. Rats were killed by aortic 
puncture. The collected tissue samples were stored for 2-3 days at 4oc  in 4% 
(v/v) phosphate buffered formaldehyde, pH 7.3. Then two longitudinal strips 
of the ileal or colonic wall were taken, one at the mesenterial and one at the 
anti-mesenterial side. These specimens were dehydrated and embedded in 
paraffin. From each specimen, two adjacent paraffin sections of 4 |j.m in 
thickness were stained with hematoxylin and eosin (h & e ) . Another set of 
two consecutive sections were stained by picrosirius red to identify collagen 
fibers16’17.
Quantitative analysis
A  conventional binocular Zeiss light microscope was used 
with an ocular magnification of i0 x  and objectives 25/0.45 and 40/0.65 for 
examination of the h & e  sections. A  semi-quantitative scale as described by 
Biert et a l. 18 containing various parameters involved in wound healing, was 
used (Table 1). The amount of necrosis was expressed as none (0 points), only 
small patches (i point), some patches (2 points) or massive (3 points). In the 
anastomotic area accumulation of polymorphonuclear cells (pm n s), macro­
phages and lymphocytes was also assessed in terms of none or normal number
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Table 1 S c o r e s  u s e d  to  a n a l y z e  w o u n d  h e a l i n g  in i l e u m  and
[112]
Score
O
2
3
I
Necrosis____
None
Small patches 
Some patches 
Massive
PMN ________________
Normal number 
Slight increase 
Marked infiltration 
Massive infiltration
Lymphocytes_____
Normal number 
Slight increase 
Marked infiltration 
Massive infiltration
(0 points), slight increase (i point), marked infiltration (2 points) and massive 
infiltration (3 points). Edema, expressed as the ratio of maximum thickness of 
the wall at the anastomosis and the thickness of the normal intestinal wall as 
present at the end of the section, was established in terms of none (0 points), 
some ( i- i .5 x  normal thickness; i  point), marked (i.5-2x normal thickness;
2 points) and severe (> 2x normal thickness; 3 points). Healing of the mucosa 
was expressed as normal, i.e mucosa with restored glandular epithelium 
(0 points), intact mucosa with cubic epithelium but without glands (i point), 
mucosa only partially covered by cubic epithelium (2 points) and mucosa 
completely devoid of epithelial coverage (3 points). Submucosal-muscular 
repair was assessed in terms of good (0 points), average (i point), poor 
(2 points) or no (3 points) fibroblast stretching and bridging the anastomotic 
wound. This way, in each anastomosis two observations from the mesenterial 
and two from the anti-mesenterial side were obtained.
In the anastomotic area collagen measurements were performed by image 
analysis. Images were recorded by a 3-chip c c d  r g b  camera (DXC-325P, Sony) 
mounted on a conventional light microscope (Axioskop, Carl Zeiss), using a 
2.5x objective ( n a = 0 .0 7 5 , resulting pixel size 2.8x3.0 m2). Image acquisition 
and analysis were performed using a Vidasplus system (Kontron g m b h , Eching, 
Germany). A  warm-up time for camera and microscope of at least 30 min was 
applied. Microscopic images were digitized and the area positive for picrosirius 
red staining was recognized by segmentation in r g b  using fixed treshold 
values. The anastomotic area was interactively defined between the two 
inverted apposited muscular layers on the computer screen using a computer 
mouse. In most cases the area was triangularly shaped and easy to identify.
Both the total amount of pixels included and the amount of pixels positive for 
picrosirius red staining were calculated by the image analysis system. The ratio 
of picrosirius red positive and the total amount of pixels, multiplied by i00, 
yielded the percentual anastomotic collagen content. This percentage was not
colon sem i-quant i t a t ive ly
Score Macrophages Edema _ Mucosal epithelium Submucosal-muscular layt
0 Normal number None Normal glandular Good bridging
I Slight increase Some Normal cubic Average bridging
2 Marked infiltration Marked Incomplete cubic Poor bridging
3 Massive infiltration Severe Absent No bridging
only measured in the wound area but also in an area defined as an approxi­
mately 2 mm wide longitudinal intestinal segment with the anastomosis in 
the middle.
A  total number of 576 sections was analyzed. One half was 
used for picrosirius red and the remaining half for h & e  analysis. In each type 
of staining (n=288), half of the anastomotic specimens was ileum, the remai­
ning half colon. In each type of tissue (n=i44), half of the anastomoses was 
from diabetic, the remaining half from non-diabetic origin. W ithin each 
experimental group (n=72), an equal number of observations was performed on 
day i ,  3 and 7 after operation. Since adjacent tissue sections were analyzed for 
each type of anastomotic tissue, the number of observations on each of the 
three days was 24. Mean values for all paired observations were calculated to 
produce independent variables (n=i2). Statistical analysis of these data was 
performed using an unpaired two-sided M ann-W hitney-u test.
RESULTS
Blood glucose, body weight and macroscopic observations
At operation, 7 days after administration of streptozotocin, 
mean glucose levels had increased approximately fourfold (Table 2). On the 
first postoperative day hyperglycemia was less explicit due to starvation but 
was then restored to nearly pre-operative levels until death. During the entire 
experiment body weight, expressed as a percentage of initial weight, in dia­
betic animals was reduced as compared to controls. The number of animals
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Figure 1 An  o v e r v i e w  of  h e a l i n g  in c o l o n i c  a n a s t o m o s e s
Each panel shows a tissue segment with the anastomosis in the middle 
and the mucosal layer on top at a magnification of approximately 40x. 
The upper six panels are H&E-stained examples of control (left) and 
diabetic (right) anastomoses on day i (upper panels), day 3 (middle 
panels) and day 7 (lower panels) after operation. Both panels at the 
bottom are examples of picrosirius red-stained anastomoses from control 
rats 3 days (left) and 7 days (right) after operation.
Table 2 B l o o d  g l u c o s e ,  b o d y  w e i g h t  a nd  a b s c e s s  f o r m a t i o n
A t  operation 
Controls 
Diabetic rats
Animals
(n)
18
18
Blood glucose 
(mmol/l)
6.0 ± 0.7
21.0 ± 5.5 $
Body weight 
(%)
114 ± 7 
101 ± 6 $
Anastomotic abscesses 
ileum colon
(n) (n)
[1
Day 1
Controls 
Diabetic rats
4.5 ± 0.6 
12.1 ± 6.3
108 ± 5 
96 ± 5t
Day 3
Controls 
Diabetic rats
5.1 ± o .3 
15.0 ± 6.3$
102 ± 5
94 ± 7
Day 7
Controls 
Diabetic rats
5.8 ± 0.3 
i 7.9 ± 5.9$
116  ± 9 
105 ± 7*
Data on body weight are relative to value at injection (7 days prior to operation). Values are 
mean ± sd; *P<0.05, fP<0.0i, $P<0.005 versus controls.
with abscesses in the various groups is also given. Although abscesses were 
solely present in the ileum of diabetic animals, no significant difference 
(Fisher’s exact test, two-sided) with control animals was observed. One 
diabetic animal showed an ileus proximal to the ileal anastomosis at sacrifice 
on day 1. Two subphrenic abscesses were found in diabetic animals on day 3 
and 7. Subcutaneous abscesses of varying sizes were found at sacrifice in all 
diabetic animals at day 7.
Microscopic parameters
Figure 1  gives overview examples of anastomoses in the 
colon from control and diabetic rats at days 1, 3 and 7 after operation. No 
obvious architectural differences are observed between control and diabetic 
animals. This magnification allows no conclusions regarding cellular 
infiltration. The two bottom panels illustrate the increase of collagen with 
time in the true anastomotic area (see below).
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Figure 2 M i c r o s c o p i c  s c o r e s  in i n t e s t i n a l  a n a s t o m o s e s
Necrosis Edema
[116]
Score
1 3 7 
Ileum
i 3 7 
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Í  i - 1
Submucosal-muscular layer
% v1
40
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0
Epithelium
i 3 7 
Ileum
i 3 7
Colon
Days after operation
Data represent mean values ± sd (n=i2); O control rats; •  diabetic rats; 
*p <0.05, fP < o.o i, $p <0.005.
Figure 2 presents all data scored in the H&E-sections. 
Necrosis was present in both ileal and colonic anastomoses. The amount 
decreased with increased survival time without differences between diabetic 
and control rats. From the first postoperative day onwards, edema disappeared 
equally with time in diabetic and control rats. In the ileum pm n s were 
abundantly present on day i  after operation, and their number hardly 
decreased during the first postoperative week. In contrast, in the colon a 
transient increase in p m n  accumulation was seen until day 3. During the 
entire experimental period in both ileal and colonic anastomoses pm n  density 
was significantly more pronounced in diabetic rats than in controls. The 
opposite was true for lymphocytic infiltration in ileal anastomoses on the first
Figure 3 Col lagen in a nas tomot ic  segments
40
30
Percentage 
collagen 0
30 b
Vi fi ■ 1 1
Ileum
3
Colon
The percentage picrosirius red positive surface is given, both in the true 
wound area (a ) and in a 2 mm-wide section also containing adjacent 
uninjured tissue (b ). Data reperesent mean values ± sd (n=i2). W hite 
bars represent control rats; black bars represent diabetic rats; no 
statistical differences were observed.
postoperative day. Subsequently, the number of lymphocytes declined with 
time. A  similar decrease, without any difference between diabetic and control 
rats, was seen for lymphocyte infiltration in colonic anastomoses. On the first 
day after operation the number of macrophages in the ileal anastomoses was 
slightly increased in the diabetic group. Equal amounts of macrophages were 
found in colon of control and diabetic groups. In contrast to lymphocytes, the 
number of macrophages increased in both groups during the healing period 
studied. Repair of the mucosal epithelium started around day 3  in both colon 
and ileum and was equal in both groups. Likewise, the bridging of the sub­
mucosal-muscular area with connective tissue started on day 3 . Some delay 
in submucosal-muscular restoration on day 7 was observed in the colonic 
anasto-moses from the diabetic group, whereas no difference was found in 
ileal anastomoses. The total anastomotic area, measured in the picrosirius red 
stained sections and expressed in number of pixels, increased in time, in both 
ileum and colon. In diabetic animals the wound areas appeared to be somewhat 
smaller but the difference only reached significance in colon on day 3.
[1
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The deposition of collagen was quantified in two different 
areas. Figure 3a  shows the mean percentage collagen in the genuine anasto­
motic area. Very little collagen was present on the first three days after 
operation but thereafter massive collagen deposition became apparent, equally 
in normal and diabetic rats. W e also measured collagen in a 2  mm wide cross 
section with the anastomosis in the middle (such samples are invariably used 
for biochemical collagen analysis). Figure 3b  demonstrates that in this case 
changes in collagen deposition were much less explicit. Again no differences 
were observed between normal and diabetic animals. In addition to these 
quantitative data, no apparent differences between both groups were observed 
with regard to the spatial arrangement of collagen fibers in the submucosal- 
muscular layer.
D I S C U S S I O N
Diabetes mellitus is one of the systemic factors known to 
impair wound healing. N ext to metabolic changes, like hyperglycemia and 
insulin deficiency or resistance, diabetes also causes late complications such 
as nephropathy and angiopathy. These complications independently impair 
wound healing. To avoid the influence of these co-morbidities we, like others, 
made use of a short-term model for diabetes to study the repair of acute 
surgical wounds.
Restoration of tissue strength is an important aspect of 
wound healing. This process requires the deposition of adequate amounts of 
extracellular matrix components, particularly collagen fibers, in the wound 
area. A  number of experimental studies have revealed that in skin impaired 
collagen synthesis coincides with reduced wound strength during diabetes7-12.
Recently, we have also found severely reduced anastomotic 
strength in ileum and colon using the same short-term diabetic rat model as 
applied in the present study13- 15. However, biochemical analyses suggested 
that loss of strength is not accompanied either by a reduced capacity for
collagen synthesis or a reduced collagen content in the anastomotic segments. 
The biochemical measurement of collagen, as hydroxyproline, has been per­
formed in a 5 mm circular rim of the intestinal wall containing the suture 
line in the middle. This type of sampling unavoidably includes a significant 
volume of the uninjured intestinal wall. The findings of the present study are 
based on microscopic analysis of tissue sections. This approach enables a more 
accurate study of the various cell types and extracellular matrix components 
involved in the repair process. The use of tissue sections to measure the depo- 
siton of collagen also offers the advantage of precisely defining the wound area. 
Moreover, the method seems to be far more sensitive than hydroxyproline assay 
of tissue hydrolysates.
In our experiments we have used the picrosirius red staining 
method16,17 because it selectively stains collagen in high contrast to the back­
ground and allows measurement of the total amount of collagen by image 
analysis. However, by this method a distinction between the different types 
of collagen can not be made. Previous biochemical analyses in our laboratory 
have demonstrated that the collagen synthetic capacity in intestinal anasto­
moses already increases several hours after operation and reaches a maximum 
after 4 days19. Our current results (Figure 3a) show a detectable amount of 
collagen at day 3. This observation fits well to the concept that during the 
first postoperative days wound strength is primarily determined by the suture 
holding capacity of the existing submucosal collagenous network and then is 
taken over by newly formed collagen fibers4,5. In line with this is the obser­
vation that the amount of collagen increases rapidly between days 3 and 7.
If we compare the data obtained from the wound area (Figure 3 a) with those 
obtained in the area which also includes uninjured tissue (Figure 3b) the dif­
ference is clear. Changes in collagen density are much more pronounced in the 
former. Thus, by image analysis minor changes are far more easily detected. 
The fact that neither analysis shows any difference between control and dia­
betic rats strongly supports our earlier view that reduced accumulation of 
collagen cannot be the cause of diminished anastomotic strength under 
diabetic conditions.
Since the spatial arrangement of collagen fibers in the 
submucosal-muscular layer of both ileal and colonic anastomoses also appears 
to be similar in both groups, reduced wound strength must be due to other
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factors. One possibility might be that non-enzymatic glycation of proteins, 
resulting from hyperglycemia, induces structural changes in existing20 and 
newly-formed21 collagen fibers, thereby weakening their strength. Our earlier 
observation that the solubility of collagen in anastomotic segments from 
diabetic rats is enhanced points in this direction14.
[120]
Wound healing is the outcome of the coordinated action 
of several cell types. Currently, specific antibodies to mark these cells in rat 
tissues are not available. Therefore, we have identified these cells in h & e  
stained tissue sections. Some cells are involved in removal of cell debris, e.g. 
pm n s and macrophages, others, i.e. lymphocytes, reflect the immune reaction 
to tissue injury. As expected necrosis and inflammatory edema decrease in 
time. Diabetes appears not to affect these parameters. In contrast, the number 
of pm n s is significantly increased in anastomoses from diabetic rats. One and
3 days after operation in diabetic rats the number of macrophages exceeds the 
number in controls in ileal but not in colonic anastomoses. Diabetes is known 
to suppress the sensitiveness of pm n s for chemotaxis22’23, the ability of pm n s 
for phagocytosis24,25, and killing26, and regulatory functions of the macro­
phage27-29. The increased and sustained presence of pm n s and macrophages 
in the diabetic rats was therefore unexpected and might be due to increased 
chemotaxis evoked by elevated levels of chemoattractants, e.g. collagen 
degradation products, or facilitated diapedesis of the leukocytes. Recently, 
we have found an increased matrix metalloproteinase activity in anastomotic 
extracts of diabetic rats (see chapter 6). Both pm n s and macrophages are 
important sources of such enzymes30. Increased matrix metalloproteinase 
activity may cause localized degradation of collagen, which cannot be 
measured even with the sensitive method applied in the current study.
An intact cellular immune response, particularly of 
T-lymphocytes, is not necessary for the initial phase of wound healing but 
seems to be essential for a normal outcome of tissue repair31. In skin wounds 
lymphocytes reach a maximum approximately one week after injury32.
Our current results in intestinal wounds indicate that lymphocytes appear 
earlier and have almost disappeared at day 7  in both ileum and colon. This 
observation emphasizes that each tissue type may exhibit its own specific 
(temporal) variations to the repair sequence. Except for a slight delay in 
lymphocyte accumulation in the ileal anastomoses on the first postoperative 
day, no differences were observed between normal and diabetic rats.
One week after operation the mucosa is almost completely 
regenerated. In contrast, tissue repair remains more difficult to define in 
the submucosal-muscular layer. Three days after operation accumulation of 
fibroblasts is obvious. Fibroblasts at the oral and anal limb of the anastomoses 
do not meet until the 7th postoperative day. In addition, at that time 
stretching of fibroblasts and bridging of the gap between both limbs, 
expressing the phase of early wound remodeling, is not yet apparent in all 
specimens. In diabetic rats delayed remodeling has been observed in colonic 
anastomoses only. In spite of this delay collagen content measured in the 
current picrosirius red stained tissue sections does not differ from controls.
In conclusion, microscopic procedures were used to extend 
our previous biomechanical and biochemical observations during healing of 
ileal and colonic anastomoses in normal and short-term, uncontrolled diabetic 
rats. Image analysis revealed that the amount of collagen deposition in the 
wound area was not affected by diabetes mellitus. Semi-quantitative analysis of 
cells, involved in tissue repair showed that in diabetic rats the number of pm n s 
and macrophages was significantly higher. The data support the concept that 
intestinal repair and cutaneous healing react differently to diabetic conditions.
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S U M M A R Y
Diabetes causes impairment of wound 
healing. Early strength in intestinal anastomoses is severely 
reduced in diabetic rats, while collagen synthetic capacity is 
essentially unchanged. Since it has been suggested that enhanced 
protease activity may be instrumental in causing loss of strength 
in diabetic wounds, we compared matrix metalloproteinase 
(mmp) activity in intestinal anastomoses from normal and 
diabetic rats. Sixty W istar rats underwent resection and 
anastomosis of both ileum and colon. H alf the animals were 
rendered diabetic 7 days before operation by streptozotocin 
injection (50 mg/kg iv). Rats were killed at 1, 3 or 7 days after 
operation. mmp activities in extracts from uninjured intestine 
and 5 mm anastomotic segments were measured by quantitative 
gelatin zymography. Induction of diabetes significantly (p < 0 .05) 
increased the specific activity of several mmps in control 
segments removed at operation, particularly those of molecular 
weight of 40, 50 and 60 kDa in ileum and 50 kDa in colon.
After operation, profound changes were observed with time for 
mmp activities of 50 and 60 kDa, thought to represent mmp-2 , 
and of 66, 80, 105, 140, 220 and 260 kDa, thought to represent 
various forms of MMP-9. In many cases, specific activities were 
significantly higher in the anastomotic extracts from diabetic 
rats. Seven days after operation, total anastomotic activity of all 
mmps present was strongly and significantly elevated in ileum 
from diabetic animals. In colon, this was true for the 50, 60,
66, 105 and 260 kDa forms. The data clearly indicate that 
experimental diabetes leads to a sustained and strongly elevated 
presence of mmp activity, and thus to a greater potential for 
matrix degradation, in intestinal anastomoses. W e suggest that 
increased local matrix degradation, rather than reduced matrix 
accumulation, causes impaired anastomotic strength in the 
intestine previously observed during experimental diabetes.
I N T R O D U C T I O N
m m ps degrade a variety of extracellular m atrix components 
including collagen and are considered to be the major enzymes responsible for 
tissue rem odeling which is inherent to wound repair14. D uring normal wound 
healing in skin m m ps are expressed in specific patterns15,16. m m ps  are also
u
Leakage of intestinal anastomoses is a most severe com pli- [127]
cation in gastrointestinal surgery. Both m orbidity and m ortality increase many ^
fold in the aftermath o f an anastomotic disruption^2. In order to devise pre- '.g
ventive measures it is necessary to determine the factors w hich may lower ^
anastomotic strength and to establish the mechanism(s) responsible. Experi- ,| 
mental and clinical studies have shown that the diabetic state is accompanied 
by a delayed or reduced repair capacity. Experimental studies w ith  strepto-
zotocin-induced or genetically diabetic rodents demonstrate that cutaneous |
wound strength is decreased3-6. Biom echanical data indicate that diabetes leads . g
to structurally deficient wound healing, even when sugars are normalized w ith  ^
insulin6,7. Linear incisions in the gastrointestinal tract appear to be affected ^
sim ilarly8. Recently, we have established that early postoperative strength o f Hs
intestinal anastomoses is severely reduced in streptozotocin-diabetic rats9,10. ^
|
Post-operative anastomotic strength depends both on the |  
ability of the existing collagenous submucosal network to retain the sutures11
and on the deposition of newly-formed collagen fibrils12. In skin, diabetes- . g
impaired wound strength correlates w ith a deficiency in collagen deposition3-6. ^
§
It has been suggested that increased collagenase and gelatinase activity ^
contribute to this effect, although quantitative data are still lacking5,13. O ur 2
own findings indicate that anastomotic collagen synthetic capacity is essen- jS 
tia lly  unaffected in diabetic rats9 and that collagen accumulation, as measured
by hydroxyproline content9 or histochem ically by specific collagen staining in |
the actual anastomotic area (see chapter 5), is unimpaired. Therefore, we ^
speculate that the observed loss of anastomotic strength in diabetic rats may |
be caused by lim ited localized m atrix degradation facilitated by m atrix ■§
metalloproteinases (m m ps). I
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believed to play a role in the rem odeling o f intestinal anastomoses17. Previous 
experiments w ithin  our laboratory have indicated the increased presence of 
collagenase in ileal and colonic anastomoses18. B y means o f quantitative 
zymography, specific temporal patterns of various gelatin-degrading m mps 
have been found in extracts from anastomotic tissue from rat intestine19,20.
[128]
The current experiments aim to establish i f  indeed diabetes 
leads to increased presence of m m ps, and thus to a greater potential for m atrix 
degradation, in intestinal anastomoses. For this purpose, we have analyzed 
anastomotic tissue, obtained during the first w eek after operation, from 
normal and streptozotocin-diabetic rats by quantitative zymography.
M A T E R I A L S  A N D  M E T H O D S
Anim als
Sixty, three-m onth-old male outbred W istar/Cpb:wu rats, 
w eighing 272 ± 40 g (mean ± sd), were obtained from our own colony. 
Anim als were housed 2 per cage and fed standard chow (Diet am ii, Hope 
Farms, W oerden, The Netherlands) and water ad libitum. Rats were observed 
for 1  week prior to the experiment. The animals were randomly divided into a 
control and diabetic group (»=30 each). W ith in  each group 10 animals were 
killed at 1 , 3  and 7 days after surgery. Rats were rendered diabetic (mean non­
fasting blood glucose over 20 mmol/l) 7 days before surgery by a single intra­
venous injection of streptozotocin (Sigma Chem ical Co., St. Louis, mo, usa) 
at a dose of 50 m g/kg body w eight. Streptozotocin was dissolved in citrate 
buffer (10 mmol/l, pH 4.5) at a concentration of 12.5 mg/ml. Control animals 
received citrate buffer only. Body w eight was recorded at the onset of the 
experiment, at operation and at termination. N on-fasting glucose levels in 
blood collected from the tail vein of rats were measured at operation and at 
termination by means of glucose reagent sticks and a reflectance meter 
(Glucocard Memory, M enarini D iagnostics, Valkenswaard, The Netherlands). 
A ll animals received human care, and the study was carried out after approval
by the A nim al Ethical Review  Com m ittee of the Faculty of M edicine, 
U niversity of N ijm egen.
Anastomotic construction
O ne week after the streptozotocin (or buffer) injection both 
ileal and colonic anastomoses were constructed in each rat. D iabetic and 
control animals were operated alternately. Surgery was performed under semi­
sterile conditions using a Zeiss operating microscope. Rats were anesthetized 
using 0.5 L/min o 2, 0.2 L/min n 2o  supplemented w ith  1.5 -3 %  isoflurane. The 
abdominal skin was shaved, disinfected w ith  70%  (v/v) ethanol. The peritoneal 
cavity was opened by a median laparotomy of approximately 4 cm. A fter resec­
tion of a 1 cm ileal segment approxim ately 15 cm  proxim al to the ileo-cecal 
junction, an ileo-ileal end-to-end anastomosis was constructed w ith  the use of 
eight interrupted single-layer inverting 8-0 Ethilon® (Ethicon, Norderstedt, 
Germany) sutures. For the colonic anastomoses a similar procedure was 
performed at approxim ately 3 cm  proxim al to the peritoneal reflection. The 
abdomen was closed w ith  a running 4-0 Monocryl® (Ethicon, Norderstedt, 
Germany) suture for the musculofascial layer and staples for the skin. Rats 
were killed at either 1, 3 or 7 days after surgery. A  relaparotomy was perfor­
med under general anesthesia (the same as described above) and death was 
induced by bleeding after aortic puncture. Subsequently, the abdomen was 
inspected macroscopically for signs o f infectious complications. Intestinal 
samples of 5 m m  unit length, containing the entire anastomotic area in the 
m iddle, were prepared free, opened longitudinally, washed thoroughly in 
sterile 0.9%  (w/v) Nacl, weighed, and stored im m ediately in liquid nitrogen 
until further processing.
Preparation of tissue extracts and zymographic analysis
Tissue segments were pulverized in liquid  nitrogen in a 
Braun M icrodismembrator. The protein concentration was measured using a 
m odified Lowry protein assay21. A ll tissue samples were stored at -80°c until 
zymography. Extraction of m m p  activities from tissue was performed by sus­
pending approxim ately 2 m g o f the pulverized tissue in sample buffer at a 
concentration of 0.02 mg/^l. The sample buffer consisted of 0 .125 m  Tris-Hcl, 
pH 6.8, 17 .4 %  glycerol, 4 %  sodium dodecylsulphate (sd s) and 0.5%  brom ­
phenol blue. A fter m ixing thoroughly the samples were incubated successively 
at 37°c for 30 m in and at 60°c for 20 min. A fter centrifugation for a few
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seconds 5 |j.l samples were loaded on a vertical m ini gel (Bio-Rad laboratories, 
Richm ond, c a , usa). Collagenase type i (from clostridium histolyticum. Sigm a 
Chem ical, St. Louis, mo, usa) was electrophoresed on each gel as an internal 
standard. Gels were prepared by adding gelatin (type a: from porcine skin; 
Sigm a Chem ical, St. Louis, mo, usa) to a standard Laem mli 7 .5 %  (w/v) sds- 
polyacrylam ide m ixture22 in a final concentration of 2 mg/ml. The gels were 
cooled to 4 °c during electrophoresis. They were run at 15 mA/gel while 
stacking and at 20 mA/gel during the separating phase until the bromphenol 
blue dye front had reached the bottom  of the gel. A fter electrophoresis the gels 
were washed three times in 2 .5%  (v/v) Triton x-10 0  for 10 m in at room 
temperature. A fter washing tw ice in a buffer containing 50 mM Tris-Hcl, 5 
mM cacl2 and 0 .1%  Triton x-10 0 , pH 7.8, the gels were incubated overnight 
at 37°c in the same buffer, stained w ith  0.25%  (w/v) Coomassie Brilliant Blue 
in 40%  methanol plus 10%  acetic acid for 45 min, and destained (twice for 10 
min) in the same solution w ithout Coomassie Blue. Proteolytic activities were 
visualized by clear zones indicating lysis o f gelatin. Loading of the gels was 
such that enzyme activity was linear w ith gelatin lysis. Q uantitation o f the 
various enzyme activities, w hich were expressed as arbitrary units on the basis 
of lyzed area, was performed using a Sharp jx-3 3 0  scanner and Imagemaster 
i d  software (Amersham Pharmacia Biotech, Uppsala, Sweden). In-between 
comparison of values obtained on different gels was performed using the 
internal standard. The presence of true mmp activity was confirmed by 
adding 10 mM e d t a  or i  mM 1 ,1 0 ’ phenanthroline to the buffers used 
after electrophoresis.
Statistical analysis
Statistical analysis of data was performed using a two-sided 
M ann-W hitney-u  test, unless mentioned otherwise.
Table  1 C l i n i c a l  d a t a
Animals Blood glucose Body weight
A t  operation 
Controls 
Diabetic rats
(n)
30
30
(mmol/l)
6.0 ± 0.7
21.6 ± 5.5 $
(%)
i i 0 ± 5
100 ± 6 $
Anastomotic abscesses 
ileum colon 
(n) (n)
[1
Day 1
Controls 
Diabetic rats
10
10
5.1 ± 0.9 103 ± 6 0
7.7 ± 3.2 ns 97 ± 3 f  0
Day 3
Controls 
Diabetic rats
10
10
5.1 ± 0.6 
16.8 ± 7.3 $
102
95 ± 5
0
4 ns
0
3 ns
Day 7
Controls 
Diabetic rats
10
10
5.8 ± 0.43
17.3 ± 4.7 $
i i 0 ± 4
99 ± 7 $
0
2 ns
Data on body weight are relative to value at injection (7 days prior to operation). Values are 
mean ± sd; *P<0.05, fP<0.0i, $P<0.005, ns: non significant versus controls. The number of 
abscesses was statistically analyzed using a two-sided Fisher’s Exact test.
RESULTS
*
Clinical data
Data of the various groups are summarized in Table 1 .
The rats became hyperglycem ic soon after adm inistration of streptozotocin and 
developed clinical signs like polyphagia, polydipsia, diarrhea, polyuria and 
glucosuria w ithin the experimental period. A t operation, 7 days later, mean 
glucose levels had increased approxim ately fourfold. Steptozotocin-treatm ent 
impaired gain in body w eight, resulting in a significant difference in body 
w eight between the diabetic and control groups at the day of operation.
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F igure  1 G e l a t i n  z y m o g r a p h y  o f  t i s s u e  e x t r a c t s  f r o m  c o n t r o l  r a t s
_260 
_220
_140
— i0 5
_80
66 
_60
— 5°
40
10
Lanes a -d show examples from colon: control segment (a ) and 
anastomoses at day 1 (b ), day 3 (c ) and day 7 (d ) after operation. Lanes 
e-h  represent similar extracts from ileal tissue. Numbers give apparent 
molecular weight (kDa) for the activities observed.
Surgery induced transient w eight loss, w hich was com pletely restored on 
the seventh postoperative day, although the difference between control and 
diabetic animals persisted. The frequency o f abscess formation appeared to be 
greater in diabetic animals than in controls, particularly at 3  days after 
operation.
mmp activity
The mmp profile of intestinal tissue, obtained after gelatin 
zymography, changed considerably after anastomotic construction. N ext to 
qualitative changes in existing activities, additional activities were expressed. 
Figure 1 shows typical examples of zym ogram s obtained from control rats 
during the first w eek of healing and illustrates the position of the various mmp
260 
220
140
i0 5
80
66
60
50
40
Figure 2 Gelat in  zymography of extracts and human  gelat inases
Lane a : molecular weight marker; b : colonic anastomosis; c : ileal 
anastomosis; d : human m m p-2; e : human m m p-2 after activation with 
aminophenylmercuric acetate; f : human m m p-9; g : human m m p-9 after 
activation with aminophenylmercuric acetate. Numbers give apparent 
molecular weight (kDa) for the activities observed.
forms to be quantified. Incubation w ith  e d t a  com pletely inibits all activities 
(data not shown). Figure 2 depicts the position of the various activities in 
relation to the latent and active (aminophenylmercuric acetate-activated) forms 
o f both human recombinant mmp-2 and MMP-9.
Quantitative analysis of the zym ogram s allowed calculation 
o f the post-operative course of specific activities for the various mmps. Figure 3 
gives the mean values in uninjured and anastomosed ileal extracts, obtained 
from both the diabetic and the control groups. In control segments, removed 
at operation, hardly any actvity was present in the higher kDa region. Substan­
tial activities were found at 10, 50, 60 and 80 kDa. A ctivities at 40, 50 and 60 
kDa were significantly higher in the diabetic than in the control animals.
Diabetes and anas tom o t i c  hea l ing in the in test ine
Figure  3 S p e c i f i c  a c t i v i t i e s  o f  M M P  f o r m s  in i l e a l  e x t r a c t s
[134]
Specific
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?
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20 
I0
0
50 kDa ?
?
.I * X
7 0
Days after operation
?
3 3 7i
Values represent activities (mean ± sd , n = i0) for the separate molecular 
weight forms indicated (kDa), measured by quantitative zymography in 
extracts from control (day 0) segments and anastomoses at day i , 3 and 
7 after operation. Open symbols: control rats; closed symbols: diabetic 
rats. *P<0.05, fP<0.0i, $P<0.005
Postoperatively, profiles changed considerably. In the control rats the 66,
105, 140, 220 and 260 kDa forms increased transiently, the 105 kDa activity 
becom ing quantitatively most prominent. The elevation appeared to be more 
persistent in the diabetic rats, w hich resulted in significantly higher specific 
activities at day 7 for the 66, 105 and 260 kDa forms. In addition, the acti­
vities present at 40, 50, 60 and 80 kDa increased considerably between day 3 
and day 7 in the diabetic but not in the control animals, again resulting in 
significantly higher m m p  activities 7 days after operation. N o  relation was
Figure 4 Specif ic  act iv i t ies  of M M P  forms in co lon ic  extracts
25
20
IS
I0
5
0
Specific
activity
(units/mg
protein)
I 5
I0
5
0
10 kDa
a
0 I
[1
Days after operation
3 7
Values represent activities (mean ± sd, n=i0) for the separate molecular 
weight forms indicated (kDa), measured by quantitative zymography in 
extracts from control (day 0) segments and anastomoses at day i , 3 and 
7 after operation. Open circles: control rats; closed circles: diabetic rats. 
*p<0.05, fP<0 .0 i ,  $p<0.005.
found, for any of the m m p s , between activity and presence of anastomotic 
abcesses (Pearson’s correlation coefficients varying between -0.20 and +0.12).
In colon (Figure 4) the high molecular activities were also 
absent at operation. They remained largely absent in control animals, but 
during the early postoperative days peak concentrations were found in diabetic 
rats. The 105 kDa form, which showed the highest postoperative specific 
activity of all mmps, remained strongly elevated and significantly higher in
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50
Ileum
Figure  5 A c c u m u l a t e d  M M P  a c t i v i t y  in  i n t e s t i n a l  e x t r a c t s
150
SO
Specific 
activity 
(units/mg O 
protein) 150
100
Colon Í T
i 3
Days after operation
For each extract, the combined activity of all molecular weight forms 
present on the zymogram is calculated. Data represent mean values ± sd 
for control segments (day o, n = 3o) and anastomoses (n=io).
Open bars: control rats; closed bars: diabetic rats. *p <0.05, fP<o.oo5.
00
0
diabetic than in control rats, both at day 3 and day 7. Also, the m m ps at 50, 
60, 66 and 80 kDa showed higher specific activities - and more pronounced 
changes w ith  tim e - in the diabetic animals. A ctivities at 40 and 10 kDa 
remain almost absent w ithout any difference between both groups. A s in 
ileum , no correlation was present between the separate m m p  activities and 
the presence o f anastomotic abcesses (Pearson’s correlation coefficients varying 
between -0.18 and +0.31).
In order to obtain a gross estimation of overall ‘m atrix-degrading potential’ 
for each control segment and anastomosis, we added the specific activities for 
each individual mmp form together. Figure 5 again illustrates the presence of 
a considerably elevated proteolytic activity in anastomoses from diabetic 
animals. In the colon, activity appeared maximal on day i ,  w hile in the ileum  
specific activity increased strongly from day 3 onwards.
Figure 6 Total M M P  act iv i ty  in in test ina l  extracts
6oo
400
Total 
activity 
(units/ 0 "" 
anastomosis) j-50
$
U i .
5o
Ileum
Colon
r *
260 220 140 105 80 66 6o 50 40 10
kDa
'S
o
[137]
Total activities of mmp forms in extracts from anastomotic tissue 7 days 
after operation. Values represent mean ± sd (n=io) total activity present 
in the 5 mm segments for the separate molecular weight forms 
indicated. Open bars: control rats; closed bars: diabetic rats. *p<0.05, 
fP < o.o i, $p<0.005.
W e also measured the total activity present in each 
anastomosis for the individual mmps. Figure 6 shows the data for 7 days old 
anastomoses. M ost of the activity was found in the 50, 60, 8o and 105 kDa 
bands. W ith  very few exceptions, anastomotic mmp activities were significant­
ly  higher in diabetic animals than in the control rats. In colon, total activities 
for the various molecular w eight forms were on average tw ice higher in dia­
betic animals. In ileum , the relative increase for some mmps, notably those at 
50 and 80 kDa, was far greater. Similar differences, though less uniform  and 
significant m ainly in colonic anastomoses, were found on days i  and 3  (data 
not shown).
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D I S C U S S I O N
Diabetes m ay lead to compromised wound healing.
A  reduced or delayed developm ent of wound strength is believed to be a 
potential cause o f surgical com plications. The present results clearly show an 
enhanced and prolonged presence o f m m p  activity in intestinal anastomoses 
from diabetic rats. W e suggest that this excessive m atrix-degrading potential 
affects early postoperative anastomotic strength by localized degradation of the 
supporting connective tissue.
In gastrointestinal surgery, the ultim ate com plication of 
impaired wound strength is anastomotic leakage. K now ledge of all factors 
which m ay reduce strength is essential for the surgeon in order to decide i f  he 
should forgo construction o f a prim ary anastomosis because the risk for this 
potentially devastating com plication is too h igh . It has been a long-standing 
belief that diabetes is such a detrim ental factor23. Some clinical studies indeed 
show a significant relation between diabetes and the occurrence of anastomotic 
leak24,25 w hile others don’t2. It should be emphasized that in these retrospec­
tive studies no effort has been made to differentiate between either degree of 
severity or degree of control o f the disease. Experimental studies w ithin  our 
laboratory have clearly demonstrated that poorly-controlled diabetes severely 
affects anastomotic strength, both in the ileum  and the colon, in the early 
postoperative period9, even if  postoperative blood glucose control was optim i­
zed10. Thus, establishing the mechanism(s) responsible for the loss of anasto­
m otic strength under diabetic conditions is an important objective. This is 
especially true for the first days after operation when wound strength is 
relatively low, even under optim al conditionsi2.  Since clinically significant 
anastomotic leakage almost invariably occurs w ithin the first postoperative 
week we have focused our investigation on this period
W ound strength prim arily depends on an equilibrium  
between m atrix, and particularly collagen, deposition and degradationi2,26. 
Previous biochem ical9 and histochem ical (see chapter 5) analyses have 
established that reduced anastomotic strength in the intestine from
streptozotocin-diabetic rats is not accompanied by either dim inished accumu­
lation of collagen in the wound area or significantly lowered collagen synthetic 
capacity in anastomotic tissue. Thus, the quantity of collagen seems unaffec­
ted, although the quality of the fibrils may be changed since anastomotic 
collagen solubility is increased in the diabetic animals27. Loss of anastomotic 
bursting strength9,10’27 may be caused by minor and very localized collagen 
degradation resulting in loosening o f the pre-existing connective tissue layer. 
Such a minor loss o f collagen could very w ell remain undetected by the bio­
chemical and histological analysis methods employed in those studies. The 
present data show that the enzymatic tools necessary for m atrix degradation 
are increasingly available in the anastomotic area from diabetic rats.
Rem oval of extracellular m atrix structures is an important 
component of tissue remodeling inherent to tissue repair. Transient and typical 
changes have been described for various m m ps and tissue inhibitors of metal- 
loproteinases (t im ps), their specific physiological inhibitors15,16. M ost studies 
have been performed on wound fluid and extracts from skin wounds. 
Transiently increased activity has been reported for the collagenases m m p- i 15,28 
and m m p-829. However, changes appear to be most explicit for the gelatinases 
m m p -2 and, in particular, MMP-930"32. Immunofluorescence studies show 
increased im m unoreactivity for m m p- i , MMP-3 and both gelatinases in colonic 
anastomoses in rabbits17,33.
G elatin zym ography is w idely used to examine the presence 
o f m m p  activity. A lth ough  the method is most sensitive by far for the gelatin­
ases, other m m ps like m m p- i  and MMP-3, i f  present in h igh enough concentra­
tions, w ill also be detected. Unequivocal identification of the various m olecu­
lar w eight forms is only possible by im m unoblotting, for which specific and 
h igh ly  sensitive antibodies are required. W e did not have suitable rat anti­
bodies at our disposal. Therefore, our identification of the various m m ps must 
be regarded as tentative. In the anastomotic extracts, the highest total and 
specific activity is found in the 50, 60, 80 and 105 kDa bands. Postoperative 
changes are most explicit for the 105 kDa form, w hich is absent in uninjured 
intestine. MMP-9 is the enzyme associated w ith  acute tissue injury. W e suggest 
that the 105 kDa band represents proMMP-9, which is often found at approxi­
m ately 92 kDa but also at higher apparent molecular w eights34. Both 80 kDa 
and 66 kDa bands we regard as active forms of MMP-932 and the 140, 220 and
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260 kDa forms as its m ultim er or enzym e-inhibitor complexes35. The 60 kDa 
and 50 kDa bands are thought to represent the latent and active forms of m m p- 
2, respectively32. A ccepting this identification, our data clearly indicate a 
supranormal and sustained presence of both MMP-9 and m m p-2 in ileal and 
colonic anastomoses o f diabetic animals. It is also noteworthy that induction of 
diabetes apparently leads to increased levels of m m p-2 in uninjured intestine, 
as evidenced by the significantly higher specific activities observed on day 0 at 
60 kDa (in ileum) and 50 kDa (in both ileum  and colon). A t  this m oment, we 
prefer to name the bands found at 40 and 10 kDa only as unspecified m m p  
activity, since identification would be rather speculative.
H ow  can diabetic conditions lead to increased expression of 
m m p-2 and MMP-9 in healing wounds? In general, MMP-9 has been associated 
w ith  neutrophils, monocytes and macrophages whereas m m p -2 has been 
associated w ith  m atrix cells. To our knowledge, there are no data in the 
literature w hich would indicate that m m p  expression in these cells is affected 
by h igh glucose per se. The mechanisms that regulate m m ps in the wound 
environment depend on several factors, including the number and cell types 
that m igrate into the wound region, transcriptional activation of m m p  genes 
by resident cells, extracellular activation of secreted proenzymes, and local 
concentrations of t im p  and plasma proteinase inhibitors such as a-m acroglo- 
bulin. Injury triggers an organized and extremely com plex cascade of cellular 
and humoral events that ultim ately result in a healed wound. N ext to cell- 
m atrix and cell-cell interactions, the m u ltip licity  of cytokines and grow th 
factors produced26 m ay affect transcription, secretion and activation of 
m m ps36,37. Diabetes is known to affect expression of inflam m atory cytokines38 
and grow th factors5 during experimental wound repair. A n  altered equilibrium  
between mediators m ay therefore contribute to increased production and 
activation of m m p s . In addition, we have found that anastomoses from diabetic 
rats contain substantially higher numbers o f neutrophils and, in ileum , macro­
phages (see chapter 5). Thus, an increased number of inflamm atory cells may 
also be instrumental in causing the enhanced presence of m m p  activity in the 
anastomotic extracts from diabetic animals.
O ur data unequivocally demonstrate that extracts from 
wound tissue, obtained during the first postoperative week in diabetic rats, 
contain supranormal levels of m m p  activity. W h ile  the m ultiple forms
visualized by gelatin zym ography partly represent proenzymes or enzym e­
inhibitor complexes w hich probably are inactive in vivo, there is also a clear 
and significant increase in the 8o and 50 kDa bands, which presumably 
represent active mmp-9 and mmp-2, respectively. Thus, under diabetic 
conditions, the m atrix-degrading potential is enhanced in injured intestine. 
Taken together w ith  prior data from our laboratory, this finding implicates 
enhanced m atrix degradation, rather than reduced m atrix synthesis, as the 
prim ary cause for impaired anastomotic strength under these conditions. 
Recent evidence suggests that, under normal conditions, mmp inhibition can 
improve wound strength39. I f  the same is true for diabetic healing mmp 
inhibitors could become significant in the clinical treatment of the diabetic 
patient w hich has to undergo intestinal surgery.
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S U M M A R Y
Untreated diabetes reduces wound 
strength: a concomitant reduction in collagen deposition has 
been found in cutaneous wounds but not in intestinal 
anastomoses. This raises the question if collagen synthesis in 
fibroblasts from  skin and intestine reacts differently to the 
diabetic state. Fibroblast lines were established from  healthy 
rat skin and ileum . D iabetic rat serum was collected from 
hyperglycem ic rats 3 days after intravenous injection of 
streptozotocin (200 mg/kg). Fibroblast cultures were grown 
to confluency in fetal calf serum and maintained in various 
concentrations of glucose, insulin, normal or diabetic rat 
serum. Collagen synthesis was measured by incorporation of 
[3H]-proline into Collagenase-D igestible-Protein. Collagen 
synthesis in fibroblasts from both skin and ileum  was not 
affected by increasing glucose concentrations. Insulin 
strongly and specifically stim ulated collagen synthesis 
in skin fibroblasts whereas in ileum  fibroblasts only a 
nonspecific increase of total protein synthesis was observed. 
In skin fibroblasts, diabetic rat serum stimulated collagen 
synthesis to a significantly lesser extent than normal rat 
serum, whereas in ileum  fibroblasts stim ulation by serum 
was far less explicit and no difference was observed between 
normal and diabetic serum. The fact that ileum  fibroblasts 
respond less strongly to culture in diabetic serum than skin 
fibroblasts m ay explain our prior finding that wound 
collagen accumulation in intestinal anastomoses is virtually 
unaffected during diabetes and supports the existence of 
tissue-specific healing responses.
I N T R O D U C T I O N
<s
O
D efective connective tissue m etabolism  may cause a number [147]
o f complications in diabetic patients, including poor wound healing1. N ext to g
w ell known manifestations as (chronic) ulcera, diabetes w ill also reduce initial J
strength of fresh wounds. This has been known for some tim e for skin 
wounds2,3 and recently we have established that early postoperative strength of 
intestinal anastomoses is severely lowered in streptozotocin-diabetic rats4-6. To 
a large extent wound strength depends on collagen and restoration of strength
- to the level of uninjured tissue - depends on the deposition o f newly formed 
collagen fibrils7. In cutaneous wounds, diabetes is thought to lower wound 
strength by a defective accum ulation o f collagen2,3,8-10. In our experiments 
w ith  intestinal anastomoses the impaired developm ent of anastomotic strength 
was not accompanied by lowered levels of wound collagen4,5. Moreover, 
the collagen synthetic capacity in the wound area appeared to be essentialy jg
unaffected in diabetic animals4. These data indicate that the mechanisms ^
underlying loss o f wound strength under hyperglycem ic conditions may be &
different for skin and intestine.
©
•is
In the wound area fibroblasts are responsible for collagen g
synthesis. In fact, the number o f fibroblasts can be taken as a measure for t-S
repair11. A lth ough  all wounds probably heal by the same basic mechanisms, "1
repair in distinct tissues m ay be affected differently under negative conditions . g
-SÏ
like diabetes. Presumably, these differences may exist at the level of - regula­
tion of - fibroblast collagen production.
The present study was undertaken to test the hypothesis 
that fibroblasts from skin and intestine may react differently to stim uli asso­
ciated w ith  the diabetic state. For this purpose, we measured collagen - and 
total protein - synthesis in skin and ileum  fibroblasts from the rat and inves­
tigated the effects of increasing concentrations of glucose and insulin. In addi­
tion, we examined the effects of culturing the fibroblasts in the presence of 
serum obtained from diabetic rats. The results show that clear differences exist 
between cells from both tissues.
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M A T E R I A L S  A N D  M E T H O D S
Materials
A ll supplies for cell culture were purchased from Life Tech­
nologies (Breda, The Netherlands). L-[2,3(n)-3H]proline (1,96 Tbq/mmol) was 
purchased from Am ersham  International (Buckingham shire, u k ). Collagenase 
(type 7, chrom atographically purified on a G200 gel filtration column), 
porcine insulin (m w  5733) and streptozotocin were obtained from Sigm a 
(St. Louis, m o , u sa). A ll  other reagents were of analytical grade (Merck, 
Darm stadt, Germany). Roswell Park M em orial Institute m edium  (rpm i 
1640, D utch m odification), containing 11  mmol/l D-glucose, was used in 
experiments where insulin concentrations in the culture m edium  were varied 
or diabetic rat serum (see below) was added; rpm i 1640 w ithout D-glucose was 
used as the basal m edium  for experiments where glucose concentrations were 
varied. Insulin was freshly dissolved (to a concentration of i .5 x i0 '4 mol/l) 
in Puck Saline a  buffer containing 7 .5 %  (w/v) NaHC03 (pH 8.2) and diluted 
further w ith  rpm i m edium. A ll solutions used in cell culture experiments 
were sterilized by passage through a 0.2 |j.m filter.
Serum
Three-week-old male outbred W istar/cpb:w u rats, w eighing 
80-100 g, were obtained from our own colony (N ijm egen, The Netherlands). 
The animals were allowed free access to water and standard chow (Diet am ii, 
H ope Farms, W oerden, The Netherlands). Diabetes was induced by intrave­
nous injection under ether anesthesia of 200 m g/kg streptozotocin dissolved 
in citrate buffer (0.01 mol/l, pH 4 .5 )12. Three days afterwards, blood was 
withdrawn from the abdominal aorta under ether anesthesia using Corvac 
tubes (Sherwood M edical, ‘s-Hertogenbosch, The Netherlands). Blood glucose 
levels varied between 20 and 25 mmol/l. A fter 10 m in blood was put on 4°c, 
centrifuged for 10 m in at 1100 x  g  and diabetic rat serum (drs) was stored at 
-20°C. A  similar procedure was performed in rats that received buffer only to 
obtain normal rat serum (nrs). A nim al use was approved by the A nim al 
Ethical Review  Com m ittee o f the Faculty o f M edicine, U niversity of 
N ijm egen.
Cell cultures
Fibroblast lines were derived from explants of skin and 
ileum  punch biopsies from approxim ately 3 weeks old nondiabetic outbred 
male W istar/cpb:w u rats from our own colony (N ijm egen, The Netherlands), 
w eighing 80-90 g. The explants were allowed to adhere to the surface of a 175 
cm 2 flask w ith rpm i 1640 m edium , supplemented w ith  40 |J.g/ml gentam icin,
2 mmol/l L-glutam ine, im M  Na-pyruvate and 10%  (v/v) heat-inactivated fetal 
calf serum (f c s) at 3 7°c in a 5%  CO2, 95%  air hum idified atmosphere and 
fibroblasts were allowed to grow  out. O n ly  cells between third and ninth 
passage were used. C ell cultures were daily tested m icroscopically for 
mycoplasmal contamination.
Assay of collagen synthesis
Assay of collagen production by steady state, visually 
confluent fibroblasts was assessed over a 24 h period by L-[2,3(n)-3H]proline 
incorporation into collagenous protein. Freshly trypsinized fibroblasts were 
plated in 24-w ell 1.5 cm 2 tissue culture plates at a density of approximately 
3 x i0 4 cells/well in 1.0 m l rpm i 1640 m edium  plus 10%  (v/v) f c s . For each 
experimental condition, 6 wells were used: four wells for the actual measure­
m ent of [3H]proline incorporation and tw o wells for a cell count at the com ­
pletion of the incubation period. Three days after plating the m edium  was 
removed from confluent cells and the w ell was washed once w ith serum-free 
rpm i 1640. The m edium  was then replaced by rpm i 1640 m edium  supple­
mented w ith ascorbic acid (50 |j.g/ml) plus glucose or insulin and/or n r s  or 
d r s . A fter 24 h the m edium  was replaced by the same experimental m edium  
plus ascorbic acid (50 |j.g/ml), B-aminopropionitrile (50 |j.g/ml) and, in the four 
wells for measurement of collagen, 2 |j,ci /ml L-[2,3(n)-3H]proline for the final 
24 h of culture. A fter the labeling period, fibroblasts in the nonradioactive 
wells were washed and trypsinized. C ell numbers were counted using a zm  
C oulter Counter® (Coulter Electronics, M ijdrecht, The Netherlands). A  0.2 
m l solution, containing 25 mmol/l ethylenediam inetetraacetic acid (e d t a ), 10 
mmol/l N-ethylm aleim ide (n e m ), i  mmol/l phenylm ethylsulfonylfluoride 
(pm sf) was added to the radioactive wells and the total content was collected 
in tubes. The wells were washed tw ice w ith  i  m l 50 mmol/l Tris-Hcl pH 7.6, 
containing i  mmol/l proline. The wash solutions were added to the suspension 
containing cells and 0.2 m l bovine serum album in (4.25%  w/v) was added.
The final suspension was freeze/thawed 3 times and proteins were precipitated
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w ith  50% (w/v) trichloroacetic acid (t c a ). The radioactive protein was 
separated from free L-[2,3(n)-3H]proline by 3 washes w ith 5%  (w/v) t c a  
containing 1 mmol/l proline at 4 °c .
The final sediment was dissolved in 0.75 m l 0.2 mol/l NaOH 
and neutralized by the addition of 0.3 m l 1 mol/l h e p e s  and 0.3 m l 0.15 
mol/l h cI. A liquots from this solution (0.1 ml) were counted to determine the 
incorporation in total protein. In order to quantitate proline incorporation into 
collagen 0.2 m l 20 mmol/l Tris-Hcl pH 7.6  containing 50 mmol/l c a c l2 and 
0.1 m l collagenase (27 iu) were added to a 0.5 m l aliquot of the solubilized 
sample and the m ixture was incubated for 3 h at 37 °c. The digestion was 
terminated by the addition of t c a  and tannic acid up to final concentrations of 
15 %  (w/v) and 0 .75%  (w/v), respectively. A fter centrifugation (10 000 x  g  for 
10 min) a 1 m l aliquot of the supernatant was counted in a liquid scintillation 
analyzer. The same procedure was followed w ithout the addition of collage­
nase. Subtraction o f the counts released during this control incubation from 
those released in the presence o f collagenase yielded the collagen-specific 
incorporation, w hich w ill be referred to as collagenase-digestible protein (cdp). 
Subtraction of the radioactivity in the cd p  fraction from that in total protein 
yields the incorporation into noncollagenous protein (ncp). Incorporation into 
cd p  and n cp  is quantified per w ell and per cell.
The relative collagen synthesis was calculated w ith  the form ula13 that takes 
into account the enrichment of proline in collagen compared to other proteins, 
where d.p.m . is disintegrations per minute:
Relative collagen synthesis (%) =
d.p.m . in c d p
---------------------------------------------------------  x 100%
(d.p.m. in n c p  x 5.4) + (d.p.m. in c d p )
Statistical analysis
Data were tested for significance (p <0.05) w ith  an unpaired 
t-test for equal variance.
Figure 1 Effect of glucose on collagen and noncollagen protein synthesis
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Visually confluent rat skin and ileum fibroblasts were incubated for 48 
hours with various glucose concentrations in the presence of 1% nrs. 
Results are expressed as d.p.m. per cell for absolute collagen synthesis 
(cdp), synthesis of noncollagenous protein (Ncp) and as percentage for 
the relative collagen synthesis (rcs). Data are given as mean values ± sd 
of four cultures. Significant difference with results obtained in 5 mmol/l 
glucose: * p<0.05, f?<0.0i, $p<0.005.
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0 0
RESULTS
A lth ough  data from single experiments are reported, all 
experiments were repeated, w ith  similar results, w ith  at least tw o cell lines 
which had been independently isolated from different rats.
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Figure  2 Effect of insulin on co llagen and noncollagen protein synthesis
[152]
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Effect of insulin on collagen and noncollagen protein synthesis in 
visually confluent rat skin and ileum fibroblasts were incubated for 48 
hours in serum-free medium with various insulin concentrations.
Results are expressed as d.p.m. per cell for absolute collagen synthesis 
(cdp) and synthesis of noncollagenous protein (ncp) and as percentage 
for the relative collagen synthesis (rcs). Data are given as mean values ± 
Sd of four cultures. Significant difference with results obtained without 
added insulin: $P<0.005.
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The effects of various glucose concentrations added to 
culture m edium  enriched w ith  1 % n r s  are presented in Figure 1 . Increasing 
glucose concentrations from 5 mmol/l, used as normal value, up to 30 mmol/l 
did not significantly influence absolute collagen synthesis in cultures of 
fibroblasts from rat skin. The complete absence of glucose from culture 
m edium  of skin fibroblasts resulted in a significant (p< 0.005), though minor 
(12% ), reduction o f the absolute collagen synthesis i f  compared to culture in 
m edium  containing 5 mmol/l glucose. As a result of increased noncollagenous 
protein synthesis, a significant (P<0.005) reduction (with 24% ) in relative
8o 
6o 
4o
Figure 3 Effect of serum on absolute collagen synthesis
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Absolute collagen synthesis was measured in visually confluent rat skin 
(a) and ileum (b) fibroblasts using various concentrations pooled nrs 
(open circles) and drs (black circles). Bar at o% serum represents 
synthesis in the absence of serum. Cells were incubated for 48 hours. 
Results are expressed as x io 3 d.p.m. per well. Circles represent mean 
values ± sd of pooled (n=7) rat serum tested in four cultures. Statistical 
significance nrs versus drs: $P<o.oo5.
[1
2o
o
collagen synthesis was observed in skin fibroblasts cultured w ith  3 o  mmol/l 
glucose. In ileum  fibroblasts, both absolute and relative collagen synthesis 
appeared to be com pletely insensitive to variations in glucose concentrations.
Insulin
Insulin strongly and significantly stim ulated absolute 
collagen production in a dose-dependent manner, up to approxim ately 8-fold 
at a concentration of i o -5 mol/l (Figure 2) in skin fibroblasts cultured in 
serum-free m edium . A lth ough  noncollagenous protein synthesis also increased, 
the effect was at least partly specific for collagen since a strong stim ulation of
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F igure  4 E f f e c t  o f  2 %  r a t  s e r u m  s y n t h e s i s
(dpm/cell)
(dpm/cell)
RCS
(%)
CDP
I (dpm/cell)
8 i-  ? H 8
6 :: • • ¡ 'i 6
• . •s
• •
4 M 4
2 Skin Ileum 2
NCP
(dPm/cell)
RCS
(%)
NRS DRS NRS DRS
3
2
2
Visually confluent rat skin and ileum fibroblats were incubated for 48 
hours with 2% rat serum. Results are expressed as d.p.m. per cell for 
absolute collagen synthesis (c d p ) and synthesis of noncollagenous protein 
(n c p ) and as percentage for the relative collagen synthesis (r c s ).
Each dot represents the mean value from 4 cultures obtained with serum 
from one individual rat. Statistical significance n r s  versus d r s : $P<o.oo5.
the relative collagen synthesis was also observed. Collagen synthesis in ileum  
fibroblasts was stim ulated to a far lesser degree. Here, basal synthesis in the 
absence of insulin remained higher and the increase in the highest concentra­
tion was only 2-fold. Moreover, this effect appeared to m erely result from an 
increased total protein synthesis as can be concluded from the absence of any 
difference in relative collagen synthesis.
Serum
The effect o f increasing concentrations of pooled rat serum 
in the culture m edium  is depicted in Figure 3 . In skin fibroblasts, addition of 
n r s  stim ulated collagen synthesis to a significantly higher extent than the 
addition of d r s .  In contrast, collagen synthesis in ileum  fibroblasts appeared
to be relatively independent of the serum concentration and there was no 
difference between n r s  and d r s .
These data were confirmed in an experiment where serum, individually 
collected from 7 control and 7 diabetic rats, was added to the culture m edium  
in a final concentration of 2% . In skin fibroblasts (Figure 4), the absolute 
collagen synthesis was significantly lower in d r s  than in n rs : 0.77 ± 0.16 
versus 1.25 ± 0 .17  d.p.m./cell (mean ± sd; p<0.005). This effect is specific for 
collagen since the synthesis of noncollagenous protein remained unaffected 
and, as a consequence, the relative collagen synthesis was also reduced in d r s  
(4.76 ± 0.63 versus 6.88 ± 0.90% ; P<0.005). In ileum  fibroblasts neither 
absolute nor relative collagen synthesis was affected by the presence of d rs .
D I S C U S S I O N
Diabetes impedes cutaneous wound healing severely by 
producing a major decrease in wound collagen synthesis3,8,10,14. Diabetes also 
compromises healing o f intestinal anastomoses in rats but not from a dim ini­
shed collagen production4,5. Since fibroblasts are the main source of wound 
collagen, this apparent difference between tissues suggests that fibroblasts 
from skin and intestine react differently to the diabetic state. The current in  
vitro results confirm this hypothesis.
Diverse effects of h igh glucose levels on collagen synthesis 
in  vitro have been described depending on the cell types studied. Elevated 
glucose levels increase synthesis of most types of collagen in cultured rat15,16 
and calf15,17 glom erular mesangial cells, calf glom erular endothelial and 
epithelial cells15,17, rat costal cartilage12 and rat heart endothelial cells18, but a 
decrease has been reported in cultured human gin gival fibroblasts19. Very 
conflicting effects of h igh  glucose on skin fibroblasts have been described. 
Fisher et a l.2° found an almost 50 per cent reduction of collagen synthesis at a 
glucose concentration o f 25 mmol/l, compared to control levels o f 5 mmol/l, 
in human skin fibroblasts cultured in the absence o f serum, but only if 
ascorbic acid was administered. This decrease was nonspecific since the
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hydroxyproline-am ino acid ratio remained constant, indicative for a fall of 
total protein synthesis. O n the other hand, V illee and Powers21, adding 
ascorbic acid and i  % nonessential amino acids to the culture m edium , 
described a strong and dose-dependent specific stim ulation of collagen 
production in human skin fibroblasts by glucose. Finally, K jellstrom 22 and 
M aquart et a l.23 only found an aspecific stim ulation of total protein synthesis, 
including collagen, by h igh glucose in human skin fibroblast cultures w ith 
ascorbic acid and fetal calf serum. O ur experiments w ith  glucose were per­
formed in culture m edium  supplemented w ith  ascorbic acid and i  % n r s  
to reproduce the most physiological state. O ur observation that fibroblasts 
survived and even produced normal (for ileum) and near normal (for skin) 
levels of collagen under almost glucose-free conditions for 48 hours (calculated 
glucose concentration 0.05 mmol/l, due to the presence o f i%  rat serum) is of 
particular interest, since the absence of glucose m ust induce profound meta­
bolic changes. Increasing glucose concentrations only affected noncollagenous 
protein production and therefore the relative collagen synthesis in the skin 
fibroblast cultures at a glucose level of 30 mmol/l. N either collagen nor non- 
collagenous protein production in rat ileum  fibroblasts was influenced by 
increasing glucose concentrations. So far, no literature exists on the effect of 
h igh glucose concentrations on collagen synthesis in ileum  fibroblasts. H igh  
glucose levels, as can be the case in diabetes, do not result in specific differen­
ces in absolute collagen production between skin and ileum  fibroblasts. O n ly  a 
minor decrease in noncollagenous protein production in skin but not in ileum  
fibroblasts is present.
Insulin stimulates grow th and protein production in  vivo. 
However, the exact effect of insulin on collagen synthesis in  vitro remains 
unclear since some investigators20,2i conclude that insulin has no effect on 
collagen or protein production of human fibroblasts, whereas others found a 
potent and specific stim ulatory effect on collagen production in cultured rat24 
and human25 skin fibroblasts and human lung fibroblasts26 if  insulin was 
administered to serum-free m edium . O ur experiments were conducted in 
serum-free m edium  to study the effect of insulin per se. Insulin stim ulated 
both absolute and relative collagen synthesis of skin fibroblasts strongly and 
dose-dependently. W ith  regard to the absolute collagen synthesis, rat skin 
fibroblasts were more sensitive to this stim ulation than ileum  fibroblasts. 
A ddition  o f 10"8 mol/l insulin to the cultures stimulated collagen synthesis
In conclusion, impaired healing in diabetic skin, 
characterized by reduced accumulation of wound collagen, m ay be associated 
w ith  changes in fibroblast functions. Lack of insulin and other deficiencies in 
d r s  could account for reduced collagen synthesis, whereas a h igh  glucose level 
alone does not. D efective healing of ileal (and colonic) anastomoses in 
streptozotocin-diabetic rats was not accompanied by reduced collagen levels or 
lowered synthesis. The current results indicate that indeed collagen production 
in ileum  fibroblasts appears relatively refractory to factors associated w ith  the
approxim ately 3-fold in rat skin fibroblasts whereas no effect was found in 
ileum  fibroblasts. Increasing concentrations of insulin further stimulated
collagen synthesis in rat skin fibroblasts, whereas in ileum  fibroblasts a ^
nonspecific stim ulation of both collagenous and noncollagenous protein ^
synthesis was observed. It can therefore be concluded that the absolute or *o
relative absence of insulin, such as is the case in diabetes, m ay exert a specific [157]
inhibition of collagen synthesis in rat skin fibroblasts but not in ileum  g
fibroblasts. J
Serum is frequently added to culture m edium  to stim ulate 3^
cell grow th and protein production. Com pounds of serum and their subse- 2
quent effects can not be defined precisely because of its natural origin. N on- 
collagenous protein synthesis in our studies w ith  skin fibroblasts was indeed 
stim ulated by n r s  and drs but the increase in collagen synthesis was strongly 
and specifically reduced by d r s . These results partly fit to the observations of 
Spanheimer24,27, who reported that collagen synthesis in cultured rat skin 
fibroblasts decreased dram atically by exposure to d r s , even to levels far below 
those found in serum-free m edium. Because increasing serum concentrations 
enhanced the inhibitory effect he proposed the presence of an active inhibitor.
This factor could very well be a protein-like substance since the effect disap­
peared i f  only the low-m olecular fraction or heat-treated diabetic serum was 
added to the cell culture24. A ddition  of serum from diabetic rats that had been 
treated w ith  insulin to the cell cultures com pletely normalized collagen syn­
thesis whereas d r s  supplemented w ith  insulin in  vitro did not27. In our dose­
effect experiments a positive correlation was found suggesting a shortage of 
stim ulating factor(s) instead o f the presence of active inhibitors in d rs . A  . g
shortage of insulin in d rs can not be the sole explanation, since insulin in our 
experiments also affected noncollagenous protein synthesis and d r s  does not.
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diabetic state. These data emphasize that different mechanisms m ust be 
responsible for reduced wound strength observed in intestine and skin during 
poorly controlled diabetes.
[158]
The authors are grateful to B.M. de Man and R.M.L.M. Lomme for expert technical 
assistance.
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S U M M A R Y  A N D  G E N E R A L  D I S C U S S I O N
Impaired healing of intestinal anastomoses w ill increase 
the chance of leakage, w hich com plication is associated w ith  additional 
m orbidity, m ortality and health care costs. A lth ou gh  patients have experienced 
much benefit from great advances in gastrointestinal surgery, particularly w ith 
respect to techniques and materials, the frequency of anastomotic dehiscence 
remains high, up to more than 10 per cent, and has not decreased over the last 
decades. K now ledge of risk factors for anastomotic leakage m ay predispose 
the surgeon toward a staged procedure instead of construction of a prim ary 
anastomosis. Thus, know ledge of these factors and of the mechanisms which 
may reduce anastomotic strength, is essential for optim al treatment of the 
patient undergoing gastro-intestinal surgery. A lth ou gh  it is generally accepted 
that diabetes is such a risk factor, little  clinical and experimental proof is 
available. These considerations are described extensively in chapter i , which 
also introduces pertinent issues regarding diabetes and the wound healing 
sequence.
This thesis describes the effects of streptozotocin-induced 
diabetes in rats, a model for type-i diabetes, on healing of anastomoses in 
ileum  and colon. Diabetes was induced one week - and in one study 9 days - 
before operation to avoid the late complications of the disease, w hich indepen­
dently can affect anastomotic repair. Intravenous adm inistration of streptozo- 
tocin in a dosage of 50 mg/kg body w eight, invariably resulted in non-fasting 
blood glucose levels o f approxim ately 20 mmol/l, which is a four-fold increase 
compared to normal values. Both normal and diabetic rats underwent resection 
of a i  -cm  segment o f ileum  and colon. Subsequently, an end-to-end anasto­
mosis was constructed. H ealing was assessed at day i ,  3 and 7 after operation. 
This early post-operative period is crucial since wound strength is low: 
clinically, anastomotic leakage almost invariably occurs w ithin  the first post­
operative week. Parameters for repair were anastomotic bursting pressure, 
collagen content and solubility, collagen synthetic capacity, m atrix metallopro- 
teinase activity, and macroscopic and microscopic aspects of the healing 
wound.
The effect of uncontrolled diabetes on anastomotic strength 
is described in chapters 2, 3 and 4. D evelopm ent of anastomotic strength in 
both ileum  and colon was invariably and severely impaired by uncontrolled 
diabetes. Three days after operation, the bursting pressure in diabetic rats was 
strongly reduced - more than 70 per cent in ileum  and 25-60 per cent in colon
- as compared to controls. A t the 7th  postoperative day, rupture in the anasto­
m otic segm ent from normal rats almost invariably occurred outside the suture 
line, indicating that the true anastomosis had grown stronger than the 
adjacent bowel wall. However, at this tim e point most ileal segments from 
diabetic rats still ruptured w ithin  the suture line, also indicating impaired 
developm ent of anastomotic strength. A ltogether, anastomoses in ileum  
appeared to be affected more strongly by the detrim ental influence o f diabetes 
than those in colon.
In chapter 3, the effect of w ell-controlled diabetes on ana­
stom otic strength in rats is reported. For this purpose, an insulin treatment 
strategy was developed. Twice daily subcutaneous injection of ultralente 
insulin, in dosages that were adapted individually for each rat on the basis 
o f the actual blood glucose level and body w eight, was required to obtain 
non-fasting blood glucose levels between 4.0 and 10.0 mmol/l. If  this regimen 
was started 4 days before operation and continued during the experiment, 
anastomotic bursting pressures in both ileum  and colon at days 3 and 7 after 
operation were com pletely normalized. However, i f  adm inistration of insulin 
was delayed until the day of operation, bursting pressures remained signifi­
cantly reduced at day 3 in colon and day 7 in both ileum  and colon, as com ­
pared to values found in the groups that also received preoperative insulin. 
Thus, complete prevention of impaired healing requires pre-operative blood 
glucose control.
Chapter 4 describes another study concerning the effect of 
blood glucose control on anastomotic healing. Here, one week after the induc­
tion of diabetes isogenic pancreatic islet transplantation was performed. Blood 
glucose levels normalized w ithin 1 day after transplantation. Intestinal anasto­
moses were constructed 2 days after transplantation. Anastom otic bursting 
pressures in the transplant groups appeared significantly improved to levels 
found in normal rats in colon at day 3 and ileum  at days 3 and 7 after 
operation. A lth ough  transplantation of pancreatic islets did not com pletely
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restore the reduced bursting pressure in the 7-days-old colonic anastomoses, a 
significant im provem ent was found as compared to values from  the uncon­
trolled diabetic group. These results again indicate that diabetes-induced 
im pairm ent of anastomotic strength can be reversed by preoperative norm ali­
zation of blood glucose levels, despite the fact that here an additional surgical 
procedure is required for this purpose.
Early anastomotic strength (as measured at day 3 after 
operation) is prim arily determ ined by the suture-holding capacity of the 
existing collagenous network in the submucosal layer. Subsequently, newly- 
formed collagen fibers restore the strength of the bowel w all (as measured at 
day 7 after operation). Loss of suture-holding capacity can result from  a 
reduced number of collagen fibers in the submucosal network, in w hich the 
sutures are anchored, or increased degradation of these collagen fibers im m e­
diately after construction of the anastomosis. Impaired collagen synthesis in 
the proliferative phase w ill reduce subsequent wound strength.
First, the capacity of uninjured and anastomosed ileum  and 
colon from normal and diabetic rats to synthesize collagen was determined 
(chapter 2). For this purpose, the ex vivo incorporation of radioactive-labeled 
proline into collagen was measured in intestinal explants. A t  3 and 7 days 
after operation, collagen synthesis was strongly stim ulated in both ileal and 
colonic anastomoses as compared to uninjured intestine. In uninjured ileum, 
diabetes reduced the collagen synthetic capacity, but a normal stim ulation was 
observed in ileal anastomoses. In colon, collagen synthesis was not reduced in 
control explants and anastomoses at day 7. However, the collagen synthetic 
capacity in 3 days old colonic anastomoses was significantly lower in diabetic 
rats than in control rats. Since this difference persisted i f  collagen synthesis 
was expressed as a percentage o f total protein synthesis, it is - at least to a 
certain degree - specific for collagen and does not merely reflect reduced 
protein synthesis in general. N ext, collagen - analyzed as hydroxyproline 
concentration (|j.g/mg dry w eight) and content (^g/unit tissue length) - was 
measured in tissue segments of 5 m m  length containing the anastomosis in 
the middle. From 3 to 7 days after operation, increasing hydroxyproline levels 
were found in both ileum  and colon, coinciding w ith  the gain in anastomotic 
strength observed during this period. However, no differences were found 
between control and diabetic rats w hich could explain the lower anastomotic
bursting pressure in the latter (chapters 2 and 4). Also, pancreatic islet trans­
plantation did not influence hydroxyproline levels either. The results obtained 
from  the measurements of hydroxyproline levels showed a relatively high 
variation between animals. It is therefore noteworthy that little  inter-experi­
m ental variance was found between the different rat strains used for the 
experiments described in chapter 2 and 4, respectively. The variation in 
the outcome of this biochemical assay on homogenized tissue precludes the 
detection of minor, but potentially im portant, differences in hydroxyproline 
content between control and experimental groups. In addition, collection of 
samples for this assay unavoidably includes a significant volum e of the non­
injured intestinal w all, w hich further hampers detection of small changes in 
the true wound area.
In order to m eet this potential problem , a new and com ­
pletely different m ethod of quantifying the amount of anastomotic collagen 
was applied (chapter 5). Here, collagen in the true anastomotic area from 
tissue sections was determ ined m icroscopically using a computer-assisted 
image-analysis system. A lth ough  measurements are performed in only a few 
tissue sections instead of the entire anastomosis, this method offers the great 
advantage over biochem ical analysis of precisely defining the anastomosis.
The results show that true wound collagen was absent on day 1 and only 
just measurable at day 3. Between days 3 and 7 an enormous increase in 
the volum e of anastomotic collagen fibrils was seen, m uch stronger than that 
observed by means of the hydroxyproline assay. However, as w ith  the latter, no 
differences were found between control and diabetic animals. Altogether, the 
data on collagen support the thesis that the impaired developm ent o f strength 
in diabetic animals is not caused by a major reduction in wound collagen.
This result appears in contradiction w ith  published data on skin wounds and 
subcutaneous wound chambers where streptozotocin-induced diabetes leads to 
reduced strength together w ith significantly lowered deposition of wound 
collagen. Apparently, cutaneous and intestinal wound m atrix m etabolism  react 
differently to the diabetic state.
Anastom otic strength is not only determ ined by quantita­
tive aspects o f wound collagen metabolism. Q ualitative characteristics, in 
terms o f collagen crosslinking, may also play a role in the restoration of wound 
strength. Since the extent of interm olecular crosslinks is inversely related to
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the solubility of collagen in dilute acids, collagen solubility in acetic acid 
was quantified in 5 m m  tissue segments from ileal and colonic anastomoses 
at 7 days (chapter 4). Uncontrolled diabetes increased solubility slightly  but 
significantly, suggesting decreased crosslinking o f collagen at this tim e point. 
This change in quality may contribute to the loss of wound strength.
[166]
Early anastomotic strength depends on the suture-holding 
capacity of the existing matrix. Thus, local -  and quantitatively minor -  m atrix 
degradation m ay lead to a loosening of m atrix integrity and to a reduced 
bursting pressure, as observed in the anastomoses of diabetic rats 3 days after 
operation. D egradation of extracellular m atrix is mediated by a fam ily of 
proteolytic enzymes, the m atrix metalloproteinases (mmps). W e identified and 
quantified various mmp activities in both control explants and 1-, 3- and 7- 
days-old anastomoses from ileum  and colon using gelatin zymography. The 
results are described in chapter 6. Induction of diabetes significantly increased 
the specific activity of several mmps in control segments removed at operation. 
A fter operation, profound changes were observed w ith  tim e for mmp  activities 
of 50 and 60 kDa, thought to represent m m p- 2 , and of 66, 80, 105, 140, 220 
and 260 kDa, thought to represent various forms o f MMP-9. In many cases, 
specific activities were significantly higher in the anastomotic extracts from 
diabetic rats. Seven days after operation, total anastomotic activity of all mmps 
present was strongly and significantly elevated in ileum  from diabetic animals. 
In colon, this was true for the 50, 60, 66, 105 and 260 kDa forms. The data 
clearly indicate that experimental diabetes leads to a sustained and strongly 
elevated presence of mmp activity, and thus to a greater potential for m atrix 
degradation, in intestinal anastomoses. W e suggest that increased local m atrix 
degradation, rather than reduced m atrix accumulation, lowers early anasto­
m otic strength in the intestine during experimental diabetes.
It has already been mentioned that the strength of skin 
wounds in diabetic rats is invariably reduced and that this phenomenon is 
generally attributed to decreased collagen deposition, seem ingly indicating 
a difference between cutaneous and intestinal repair. Since fibroblasts are the 
main source of collagen, the effect of diabetes-associated factors on collagen 
synthesis in fibroblasts from both rat ileum  and rat skin have been compared 
in vitro (chapter 7). Collagen synthesis in fibroblasts from both skin and ileum  
remained unaffected by glucose concentrations up to 30 mmol/l. Insulin
stim ulated collagen synthesis in skin fibroblasts in a dose-dependent manner, 
w hile in ileum  fibroblasts only a nonspecific increase o f total protein synthesis
Qq
was observed. In skin fibroblasts, collagen synthesis was strongly stim ulated ¡j.
by normal rat serum, whereas diabetic rat serum stim ulated collagen synthesis ^
to a significantly lesser extent. In ileum  fibroblasts stim ulation by serum was 'o
less explicit and no difference was found between normal and diabetic serum. [167]
This last result may explain the prior finding that collagen content and g
synthesis in intestinal anastomoses appear not to be significantly affected §
by diabetes in vivo. In general, these data show that isolated fibroblasts 
from skin and ileum  react differently to the diabetic state and, although the "g
interpretation from in vitro experiments should be cautious, that tissue-specific §
healing responses indeed may exist.
'8
ID
N ext to the investigations concerning anastomotic strength |
and collagen m etabolism , the healing response has also been studied microsco- |
pically (chapter 5). Various microscopic parameters essential to wound repair 
were scored sem i-quantitatively in hem atoxylin and eosin-stained sections 
from ileal and colonic anastomoses at 1, 3 and 7 days after operation. The 
number of polym orphonuclear cells was significantly increased in both ileal 
and colonic anastomoses from diabetic rats. Moreover, diabetes increased the 
number of macrophages in ileal anastomoses. A t  the first postoperative day 
the presence of lym phocytes was reduced slightly  in ileal anastomoses from 
diabetic animals. Necrosis and edema were not affected by the diabetic state.
Likewise, diabetes did not impair regeneration of the epithelial layer, but 
healing of the submucosal-muscular layer was delayed significantly in colonic 
anastomoses at day 7 after operation. These data only yield information on the 
presence of various cells, and not on their functional properties. The increased 
presence of inflam m atory cells in anastomoses from diabetic rats can be inter­
preted as a truly  increased inflam m atory response but also as a compensation 
for impaired function. Still, both polym orphonuclear cells and macrophages 
are known sources for mmp  activity and their increased presence in diabetic 
wounds m ight explain the elevated mmp activities described before in 
anastomotic extracts from diabetic rats.
In all experiments anastomotic abscesses were found in 
animals w ith  uncontrolled diabetes, particularly 3 days after operation in 
the ileum. A lth ough  it is believed that peritonitis or abscesses w ill reduce
Diabetes and anas tom o t i c  hea l ing in the in test ine
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anastomotic strength by increasing m atrix degradation, in our experiments the 
presence of an abscess was neither invariably related to decreased strength nor 
associated w ith  increased expression o f anastomotic mmp activity. Abscesses 
m ight w ell reflect the increased susceptibility to infections in poorly control­
led diabetic subjects. However, no conclusion can be drawn from the present 
studies as to the question if  abscess formation is a cause or a consequence of 
deficient repair. Reduced strength was also found in the absence o f an anasto­
m otic abcess. Since intra-abdominal abscess formation is an adverse advent in 
clinical practice often requiring additional surgical procedures, it should be 
emphasized that insulin treatment prevented this process, again most signifi­
cantly so i f  administered preoperatively (chapter 3). A  beneficial effect of 
pancreatic islet transplantation was also found although to a lesser extent 
(chapter 4).
U ncontrolled diabetes led to loss of body w eight. This can 
be due to both m alnutrition and dehydration. M alnutrition is probably 
transiently present after operation. Serum album in and protein levels were 
only slightly  reduced in diabetic animals at postoperative day 3, and had 
returned to normal levels at day 7 after operation (chapter 2). A ccording to the 
literature, several weeks of starvation w ould be necessary to impair intestinal 
healing. Such a degree of m alnutrition was certainly not present in our short­
term model of diabetes, and this factor is therefore unlikely to explain the 
negative effect of diabetes observed in our studies. Likewise, data from the 
literature suggest that i f  loss o f body w eight was to be fu lly  due to dehydra­
tion, its extent would be insufficient to cause impaired repair. Potential toxic 
side-effects of streptozotocin are unlikely to impair healing because blood 
glucose control by either adm inistration of insulin or pancreatic islet trans­
plantation reversed this effect.
In conclusion, the studies presented in this thesis have 
supplied the follow ing answers to the questions formulated at the end of 
chapter 1:
- U ncontrolled diabetes, induced one week before operation, 
severely reduces early anastomotic strength in the intestine.
- This loss of strength can be prevented by treatment w ith 
insulin or pancreatic islet transplantation, although com ­
plete prevention requires preoperative blood glucose control.
- Impaired strength appears not to be caused by reduced 
collagen accumulation but more lik ely  results from 
increased localized degradation of existing collagen fibrils 
and changed crosslinking of newly-formed anastomotic 
collagen.
A lth ou gh  the first tw o answers are unequivocal, the last 
one, regarding the underlying mechanism(s), is partly speculative and there­
fore incomplete. Further research w ith  the present model could, for instance, 
be directed at the quality of collagen fibrils formed under hyperglycem ic 
conditions. Fibril strength is determined by fibril composition. Different types 
of collagen form  fibrils of different strength. W h ile  the uninjured intestine 
contains predom inantly collagen type i , next to substantial amounts of 
collagen types ii i  and v , it is well known that the m atrix w hich is laid down 
during early wound healing generally shows a changed ratio between the 
various collagen types. It could be that diabetes, although not affecting the 
total amount of collagen produced, influences this ratio and thereby tissue 
strength. Analysis o f the different types o f collagen present in the wound area, 
on both the mRNA and protein level (using specific probes and antibodies), 
w ill answer the question i f  such a mechanism contributes to impaired healing. 
Another issue concerns the postulated occurrence of local m atrix degradation 
by increased levels of various m m ps. Im m unolocalization studies o f the 
distribution of the relevant mmps under diabetic and normal conditions, 
preferably using antibodies w hich discrim inate between pro-enzymes and their 
active forms, may supply further insight in this respect. A lso, experiments 
w ith  specific inhibitors of mmp activity would most likely  be helpful to 
elucidate the role of this class of enzymes.
W ith in  the present model, chemical induction of diabetes 
resulting in an approximate four-fold increase in blood glucose, impairs the 
healing of intestinal anastomoses constructed one week later. A  logical 
question that follows is if  there exists a dose-response relationship between 
increasing blood glucose and decreasing anastomotic strength, or in other 
words: what is the m inim al persisting elevation in blood glucose that w ill lead 
to loss of early wound strength? A nd also: Is the length of the pre-operative 
period of poor blood glucose control a factor in the eventual outcome?
It would be most interesting to answer the question whether the expected
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detrim ental effects of a prolonged period of hyperglycem ia on intestinal 
healing can be com pletely prevented by intensive blood glucose control 
im m ediately before operation, and i f  so, how long this period of preoperative 
insulin treatment m ust m inim ally be. The answers to these questions, which 
can be adressed both in heriditary and chem ically induced diabetic models, 
w ill be quite relevant in delineating the potential problem  for the diabetic 
patient.
Before data from animal experimental studies can be 
implem ented in clinical practice, the true clinical problem  m ust be defined. 
The current conclusions from experimental research certainly justify clinical 
studies. Since reliable clinical data are absent, a prospective, randomized 
clinical trial into the effect o f diabetes and degree o f blood glucose control on 
the incidence of anastomotic leakage (and anastomotic complications in 
general) would be necessary. I f  a prospective study seems unfeasible for both 
ethical and practical reasons (for instance: the number o f patients necessary 
m ight be prohibitive), a retrospective study w ould be second best. However, 
such retrospective risk analyses have already been performed w ithout uniform 
conclusions. Certainly, poor docum entation of peri-operative blood glucose 
levels and HbAic values and (the presence of) co-m orbidities have contributed 
to the conflicting results and w ill possibly influence the outcome of a new 
retrospective analysis. Thus, clinical research is certainly indicated but 
difficult to perform.
The data generated in our studies m ust therefore also 
be regarded as an incitem ent for future research, both clinical and 
pre-clinical, for the ultim ate benefit of the diabetic patient who has 
to undergo gastrointestinal surgery.
Chapter 9
o amenvatting en discussie
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S A M E N V A T T I N G  EN D I S C U S S I E
Een verstoord genezingsproces vergroot de kans op lekkage 
van darmnaden. Een dergelijke com plicatie gaat gepaard met een toename 
van m orbiditeit en m ortaliteit en derhalve van kosten in de gezondheidszorg. 
H oewel patiënten zeker baat hebben gehad van de ontw ikkelingen binnen de 
gastro-intestinale chirurgie, met name wat betreft technieken en materialen, 
b lijft de frequentie van naadlekkage hoog en kan oplopen tot boven de io  
procent. D it percentage is gedurende de laatste decennia niet gedaald.
Kennis over risicofactoren voor naadlekkage en processen die kunnen leiden 
tot verminderde naadsterkte is van essentieel belang voor de chirurg die moet 
beslissen of het verstandig is om na een darmresectie de continuïteit direct te 
herstellen of prim air moet worden overgegaan tot het aanleggen van een stoma 
om vervolgens in een latere fase pas een darmnaad aan te leggen. H oewel 
algemeen wordt verondersteld dat diabetes een risicofactor voor naadlekkage 
vorm t, bestaat hiervoor w einig klinisch en experimenteel bewijs. Deze materie 
vorm t, tezamen met een beschrijving van de wondgenezing en de voor ons 
onderzoek relevante aspecten van diabetes, de inhoud van hoofdstuk i  .
D it proefschrift beschrijft de effecten van diabetes, 
geïnduceerd met behulp van streptozotocine in de rat, op de genezing van 
naden in ileum  (dunne darm) en colon (dikke darm). Diabetes werd i  week - 
en in één studie 9 dagen - voor operatie geïnduceerd om de late complicaties 
van deze aandoening, die een onafhankelijk nadelig effect op de genezing van 
darmnaden kunnen hebben, te voorkomen. Streptozotocine werd intraveneus 
toegediend in een dosering van 50 mg/kg lichaam sgewicht, hetgeen onveran­
derlijk resulteerde in niet-nuchtere bloedsuikerwaarden van ongeveer 
20 mmol/l, een viervoudige toename ten opzichte van de normale waarden.
In zowel controle- als diabetische ratten werd een i  cm  groot segment uit 
ileum  en colon genomen. D e continuïteit van de darm werd hersteld door 
‘end-to-end’ een naad aan te leggen. D e wondgenezing werd beoordeeld op 
de eerste, derde en zevende dag na operatie. Juist deze vroege postoperatieve 
periode is van groot belang omdat de wondsterkte laag is: naadlekkage treedt 
in de kliniek bijna altijd op gedurende de eerste week na operatie. Parameters
voor genezing waren de wondsterkte (gemeten als de barstdruk), gehalte 
en oplosbaarheid van collageen (gemeten als hydroxyproline), de collageen- 
productiecapaciteit de m atrix-m etalloproteinase-activiteit en macroscopische 
en microscopische aspecten van de wond.
H et effect van onbehandelde diabetes op de naadsterkte 
wordt beschreven in de hoofdstukken 2, 3 en 4. Onder deze condities was 
de ontw ikkeling van naadsterkte in zowel ileum  als colon steeds ernstig 
verstoord. D rie dagen na operatie was de barstdruk sterk afgenomen - met 
meer dan 70 procent in ileum  en m et 25-60 procent in colon - in vergelijking 
m et de normale situatie. O p  de zevende postoperatieve dag barstte het darm ­
segm ent in de controleratten bijna altijd buiten het wondgebied, hetgeen 
aangeeft dat de naad zelf sterker geworden is dan de aansluitende darmwand.
In de diabetische ratten barstten de meeste ileum segm enten echter nog steeds 
binnen het w ondgebied, hetgeen im pliceert dat de ontw ikkeling van naad- 
sterkte was achtergebleven. N aden in het ileum  bleken in het algemeen sterker 
aangedaan door de schadelijke invloed van diabetes dan die in het colon.
In hoofdstuk 3 worden de effecten van gecontroleerde 
diabetes op de ontw ikkeling van de naadsterkte beschreven. H iertoe werd een 
behandelstrategie met insuline ontw ikkeld, waarbij een langwerkend insuline- 
preparaat tweemaal per dag onderhuids werd geïnjecteerd. D e doseringen 
werden individueel voor iedere rat aangepast op geleide van de actuele bloed- 
suikerwaarde en lichaam sgewicht. A lleen op deze wijze bleek het m ogelijk  om 
de niet-nuchtere bloedsuikerwaarden tussen de 4.0 en 10.0 mmol/l te houden. 
Indien dit behandelschema 4 dagen voor de operatie werd gestart en werd 
voortgezet tot het einde van het experiment, normaliseerden de barstdrukken 
van naden in zowel ileum  als colon volledig. Echter, indien de toediening van 
insuline werd uitgesteld tot de dag van operatie bleven de barstdrukken op 
dag 3 in het colon en op dag 7 in zowel ileum  als colon significant lager dan 
in de groepen die ook preoperatief insuline ontvingen. Volledige preventie 
van de verstoorde genezing vereist dus preoperatieve regulering van het bloed­
suikergehalte.
H oofdstuk 4 beschrijft een additionele studie naar het effect 
van bloedsuikerregulering op de genezing van darmnaden. H ier werd een 
w eek na de inductie van diabetes een isogene transplantatie met eilandjes van
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Langerhans uitgevoerd. Bloedsuikerwaarden normaliseerden binnen één dag na 
transplantatie. Twee dagen na transplantatie werden de darmnaden aangelegd. 
In deze getransplanteerde groepen vertoonden de naden in zowel colon op dag 
3 als ileum  op dag 3 en 7 na operatie een normale barstdruk. H oewel de barst- 
druk van de naden in het colon van getransplanteerde ratten zich 7 dagen na 
operatie niet volledig had hersteld, werd toch een significante verbetering 
gevonden in vergelijking met de onbehandelde diabetische groep. Deze resul­
taten bevestigen dat de verstoorde naadsterkte ten gevolge van diabetes kan 
worden voorkomen door preoperatieve correctie van de bloedsuikerwaarden, 
zelfs als hiertoe een extra chirurgische ingreep nodig is.
Gedurende de eerste dagen van de genezing wordt de naad- 
sterkte met name bepaald door de mate waarin het bestaande netwerk van 
collageenfibrillen in de submucosa in staat is om de hechtingen te verankeren. 
Vervolgens wordt de sterkte van de darmwand geleidelijk hersteld door nieuw ­
gevormde collageenfibrillen. D e capaciteit om hechtingen te verankeren kan 
verminderen indien het aantal collageenfibrillen waarin de hechtingen worden 
geplaatst op het m oment van opereren al is afgenomen of als de afbraak van 
bestaande collageenfibrillen direct na het aanleggen van een naad toeneemt.
In de proliferatiefase van de wondgenezing verm indert de wondsterkte indien 
de collageensynthese afneemt.
Als maat voor de collageensynthese werd de collageen- 
productiecapaciteit in ileum  en colon van zowel normale als diabetische ratten 
bepaald (hoofdstuk 2). Deze werd ex vivo gem eten, aan de hand van de inbouw 
van radioactief gelabeld proline in collageen, in biopten van intacte darm (seg­
menten uitgenom en tijdens de operatie) en in biopten die de naad bevatten. 
Drie en 7 dagen na operatie werd een sterk verhoogde collageensynthese 
gevonden in zowel ileum - als colonnaden. Diabetes verminderde weliswaar 
de capaciteit tot het synthetiseren van collageen in controlesegmenten uit 
ileum , maar in de naad werd een zelfde toename gevonden als onder normale 
condities. In colon werd geen verschil gevonden tussen controle- en diabeti­
sche ratten in de collageensynthese van intacte darm en darmnaden op dag 7 
na operatie, maar 3 dagen na operatie was de collageensynthese wel significant 
verlaagd in de naden van diabetische ratten. O m dat dit verschil b leef bestaan 
als de collageensynthese werd uitgedrukt als percentage van de totale eiwit- 
synthese, is het - tenm inste in een bepaalde mate - specifiek voor collageen en
weerspiegelt het niet een algehele reductie van de eiwitsynthese. Vervolgens 
is de hoeveelheid collageen gem eten in darmsegmenten van 5 m m  lengte 
met de naad in het midden. H iertoe werd de hydroxyprolineconcentratie 
(|j.g/mg droog gewicht) en het hydroxyprolinegehalte (|J.g/lengte-eenheid 
darmsegment) bepaald. Van 3 tot 7 dagen na operatie werd een toename 0
van de hoeveelheid hydroxyproline gevonden in zowel ileum - als colonnaden; [175]
in deze periode nam de naadsterkte eveneens toe. Een verschil in hydroxypro- 
lineconcentratie of -gehalte tussen controle- en diabetische ratten, dat de g
lagere barstdrukken in de laatste groep zou kunnen verklaren, werd echter niet 
gevonden (hoofdstukken 2 en 4). Transplantatie met eilandjes van Langerhans 
beïnvloedde evenmin het hydroxyprolinegehalte in de darmnaden. D e resul­
taten van de hydroxyprolinebepalingen lieten een relatief grote variatie tussen |
o»
de dieren onderling zien. O m  die reden is het opm erkelijk dat slechts een 
kleine inter-experimentele variatie gevonden werd tussen de verschillende 
rattenstammen die gebruikt zijn ten behoeve van de experimenten beschreven 
in hoofdstukken 2 en 4. D e variatie in de uitkom sten van deze biochemische 
bepalingen maken het m oeilijk om  een eventueel klein, maar m ogelijk 
belangrijk, verschil in hydroxyprolinegehalte tussen controle en experimentele 
groepen te detecteren. Bovendien bevat het materiaal dat voor deze bepaling 
nodig is onverm ijdelijk een hoeveelheid weefsel dat niet uit het wondgebied 
afkom stig is, hetgeen de detectie van kleine veranderingen in het feitelijke 
w ondgebied bem oeilijkt.
8
O m  dit m ogelijke probleem  te omzeilen, werd een nieuwe 
en geheel andere methode toegepast om de hoeveelheid collageen in de 
darmnaad te bepalen (hoofdstuk 5). H ierbij werd de hoeveelheid collageen in 
de feitelijke darmnaad microscopisch gem eten in weefselcoupes m et behulp 
van een gecomputeriseerd beeldanalyse-systeem. H oewel dergelijke m etingen 
worden verricht in slechts enkele weefselcoupes u it de gehele darmnaad, heeft 
deze methode het grote voordeel boven de biochemische analyse dat het 
w ondgebied heel specifiek kan worden gedefinieerd. D e resultaten laten zien 
dat collageen in de wond afwezig is op dag i  en m inim aal meetbaar is op dag 
3 na de operatie. Tussen dagen 3 en 7 na de operatie neemt de hoeveelheid 
collageen in de darmnaad sterk toe, in een grotere mate dan gesuggereerd 
w ordt door de uitkom sten van de biochemische analyse. O ok hier werd 
echter geen verschil tussen controle- en diabetische dieren geconstateerd.
De gegevens van beide onderzoeksmethoden ondersteunen de stelling dat de
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gestoorde opbouw van sterkte van de darmnaad in diabetische dieren niet 
veroorzaakt wordt door een significante reductie in de hoeveelheid collageen 
in het w ondgebied. D it  gegeven lijk t in tegenspraak met gepubliceerde data 
over huidwonden en wondkamers, waarin streptozotocine-geïnduceerde 
diabetes leidt tot een verm inderde weefselsterkte welke samengaat met een 
verminderde inbouw van collageen in de wondm atrix. B lijkbaar reageert het 
m atrixmetabolism e in wonden van huid en darm verschillend op de condities 
welke worden geïnduceerd door onbehandelde diabetes.
D e sterkte van een darmnaad wordt niet alleen bepaald 
door de kwantitatieve aspecten van het collageenmetabolisme in de wond. 
K w alitatieve kenmerken, zoals het aantal onderlinge verbindingen tussen de 
individuele collageenfibrillen, kunnen eveneens een rol spelen in het herstel 
van de wondsterkte. O m dat het aantal crosslinks tussen de m oleculen om ge­
keerd evenredig is aan de oplosbaarheid van collageen in verdunde zuren, 
werd de oplosbaarheid van collageen in azijnzuur 7 dagen na operatie in 
5 m m  lange darmnaad segmenten bepaald (hoofdstuk 4). H et bleek dat 
onbehandelde diabetes de oplosbaarheid significant verhoogt, hetgeen een 
verminderde mate van crosslink-vorm ing suggereert op dit tijdstip. Deze 
kwalitatieve verandering kan bijdragen aan de verminderde wondsterkte.
H et is reeds eerder gesteld dat de sterkte van een darm ­
naad in de vroege postoperatieve periode met name bepaald wordt door de 
capaciteit van de bestaande extracellulaire m atrix om de hechtingen te ver­
ankeren. Een lokale afbraak in de m atrix kan derhalve leiden tot een verlies 
aan m atrixintegriteit en tot een verminderde barstdruk, zoals gevonden werd 
in darmnaden van diabetische ratten 3 dagen na operatie. D e extracellulaire 
m atrix wordt afgebroken door een groep enzymen die bekend staan onder de 
naam matrix-metalloproteinases (mmps). D e activiteit van verschillende mmps 
werd geïdentificeerd en gekwantificeerd in zowel intacte darm als in darm ­
naden in ileum  en colon op dagen i , 3 en 7 na operatie met behulp van 
gelatine zymografie. D e resultaten hiervan worden beschreven in hoofdstuk 6. 
D e inductie van diabetes verhoogde de specifieke activiteit van verschillende 
mmps in de controlesegmenten die tijdens operatie werden verwijderd. N a 
operatie werden aanzienlijke veranderingen aangetroffen in MMP-activiteiten 
met een m olecuulgrootte van 50 en 60 kDa (waarschijnlijk m m p- 2) en 66, 80, 
105, 140, 220 en 260 kDa (waarschijnlijk diverse moleculaire vormen van
m m p- 9). In veel gevallen waren de specifieke activiteiten in darmnaden van 
diabetische dieren significant verhoogd. Zeven dagen na operatie waren alle 
MMP-activiteiten in ileumnaden uit diabetische ratten sterk en statistisch T
significant verhoogd. In het colon was dit ook zo voor de activiteiten met een ^
m olecuulgrootte van 50, 60, 66, 105 en 260 kDa. Diabetes leidt derhalve tot 
een verlengde periode van verhoogde MMP-activiteit in het wondgebied, en [177]
dus tot een verhoogde potentie tot matrixafbraak. Een verhoogde lokale 
matrixafbraak, en niet een verminderde matrixaanmaak, lijk t derhalve bij te 8
dragen aan de verm inderde sterkte van darmnaden in diabetische ratten.
8
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Zoals reeds is verm eld, bevestigen tal van onderzoeken dat VS
de sterkte van huidwonden in diabetische ratten is verminderd en dat dit |
wordt veroorzaakt door een verlaagde collageenproductie. O m dat fibroblasten |
de belangrijkste producent zijn van collageen, werd het effect van factoren, die 
geassocieerd zijn m et diabetes, op de collageensynthese van fibroblasten 
afkom stig uit ileum  en huid van ratten vergeleken in celkweken (hoofdstuk 7).
De productie van collageen in fibroblasten afkom stig van zowel huid als ileum  
werd niet beïnvloed wanneer de glucoseconcentratie in het kw eekm edium  
varieerde tussen 0 en 30 mmol/l. Insuline stimuleerde de collageensynthese 
specifiek en dosis-afhankelijk in huidfibroblasten, terw ijl in ileumfibroblasten 
slechts een aspecifieke stim ulering van de totale eiwitsynthese werd gevonden.
In huidfibroblasten werd de collageensynthese sterk gestim uleerd door serum 
afkom stig van normale ratten, terw ijl serum afkom stig van diabetische ratten 
een veel minder uitgesproken effect liet zien. D e stim ulering door serum in 
ileum fibroblasten was veel minder sterk zonder enig verschil tussen serum 
afkom stig van normale en diabetische ratten. Deze laatste bevinding uit de 
celkweekstudies past heel goed bij de observatie in de dierexperimenten dat 
diabetes het gehalte en de productie van collageen in darmnaden nauwelijks 
beïnvloedt. D e huidige gegevens tonen aan dat geïsoleerde fibroblasten uit 
huid en ileum  verschillend kunnen reageren op diabetische condities. Hoewel 
voorzichtigheid betracht moet worden bij extrapolatie van gegevens uit cel- 
kweekstudies naar in vivo situaties, lijk t het erop dat het reactiepatroon van 
onderscheiden weefsels op een zelfde prikkel tijdens de wondgenezing kan 
verschillen.
In aanvulling op de studies naar sterkte en collageenmeta- 
bolisme van de darmnaad, is de genezingsreactie van de darm tijdens diabetes
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eveneens microscopisch geanalyseerd (hoofdstuk 5). Verscheidene microsco­
pische parameters voor w ondgenezing werden sem i-kw antitatief vastgelegd op 
basis van de analyse van weefselcoupes, gekleurd met hem atoxyline en eosine, 
uit ileum - en colonnaden verzameld 1, 3 en 7 dagen na operatie. H et aantal 
neutrofiele granulocyten was statistisch significant verhoogd in zowel ileum- 
als colonnaden van diabetische ratten. Bovendien was het aantal macrofagen in 
ileumnaden verhoogd. O p de eerste dag na operatie was het aantal lym focyten 
enigszins verm inderd in ileumnaden van diabetische ratten. D e hoeveelheid 
necrose en oedeem werd niet beïnvloed door diabetes. H et herstel van de 
epitheliale laag werd evenmin verstoord, maar de genezing van de submucosa 
en spierlaag was significant vertraagd in colonnaden uit diabetische ratten op 
dag 7 na operatie. Deze resultaten geven informatie over de aanwezigheid van 
verscheidene celtypes maar zeggen niets over hun functionele eigenschappen. 
D e versterkte aanwezigheid van ontstekingscellen in darmnaden van diabe­
tische ratten kan duiden op een echte toegenom en ontstekingsreactie maar ook 
op een compensatiemechanisme voor een verminderde functie. N eutrofiele 
granulocyten en macrofagen zijn bronnen van MMP-activiteit en hun toege­
nomen aanwezigheid in de naden van diabetische ratten zou de verhoogde 
MMP-activiteit, zoals beschreven in hoofdstuk 6, kunnen verklaren.
In alle experimenten werden abcessen gevonden rond de 
darmnaden van dieren met onbehandelde diabetes, met name in het ileum
3 dagen na operatie. H oewel er aanwijzingen bestaan dat peritonitis en 
abcessen een negatief effect hebben op de naadsterkte, omdat de matrixafbraak 
toeneemt, kon in onze experimenten geen relatie worden aangetoond tussen de 
aanwezigheid van een abces enerzijds en verminderde sterkte o f toegenom en 
MMP-activiteit anderzijds. Abcessen kunnen een u iting zijn van de toegeno­
men gevoeligheid voor infecties. U it de huidige studies kan echter niet 
geconcludeerd worden of abcesvorming een oorzaak of een gevolg is van 
verstoorde wondgenezing. Verminderde naadsterkte werd ook gevonden 
zonder dat een naadabces aanwezig was. O m dat de vorm ing van een abces na 
een darmoperatie in de klinische praktijk  een ernstige com plicatie is waarvoor 
vaak additionele chirurgische ingrepen noodzakelijk zijn, dient te worden 
benadrukt dat goede regulering van de bloedsuikerspiegels m et insuline 
begonnen vóór operatie dit kan voorkomen (hoofdstuk 3). Transplantatie met 
eilandjes van Langerhans had eveneens een positief effect, hoewel in mindere 
mate (hoofdstuk 4).
Inductie van diabetes leidde tot verlies aan lichaam sgewicht. 
D it kan worden veroorzaakt door ondervoeding en uitdroging. M ogelijkerw ijs 
is er tijd elijk  sprake van ondervoeding in diabetische ratten omdat op dag 3 na 
operatie het album ine- en eiwitgehalte enigszins verlaagd waren. Zeven dagen 
na operatie waren deze waarden echter volledig genormaliseerd (hoofdstuk 2). 
Volgens literatuurgegevens is een vastenperiode van meerdere weken nood­
zakelijk om de genezing van darmnaden te verstoren. Een dergelijke mate 
van ondervoeding is zeker niet aanwezig in ons korte-term ijn-m odel. H et is 
daarom zeer onwaarschijnlijk dat deze factor bijdraagt aan het negatieve effect 
van diabetes dat in onze studies is waargenomen. Hoewel uitdroging het 
proces van wondgenezing eveneens kan verstoren, is de mate waarin dit feno­
meen optreedt in onze experimenten volgens literatuurgegevens onvoldoende 
om de gestoorde wondgenezing te verklaren. D e verstoorde wondgenezing 
wordt evenmin veroorzaakt door toxische neveneffecten van streptozotocine 
omdat bloedsuikerregulatie met insuline en eilandjes van Langerhans de 
verstoring voorkwamen.
In conclusie kunnen, aan de hand van de beschreven 
resultaten, de volgende antwoorden worden geformuleerd op de vragen gesteld 
aan het einde van hoofdstuk i :
- Onbehandelde diabetes, geïnduceerd een week voor operatie, 
verm indert de opbouw van de sterkte van darmnaden in 
ernstige mate.
- D it verlies aan sterkte kan worden voorkomen door 
behandeling met insuline of transplantatie met eilandjes van 
Langerhans. O m  het negatieve effect volledig op te heffen is 
preoperatieve bloedsuikerregulering noodzakelijk.
- D e verminderde sterkte lijk t niet te worden veroorzaakt 
door een verminderde accumulatie van collageen, maar is 
waarschijnlijk een gevolg van een toegenom en lokale 
afbraak van bestaande collageenfibrillen en veranderde 
crosslink-vorm ing van nieuw gevorm d collageen in de 
darmnaad.
De eerste twee antwoorden zijn ondubbelzinnig, maar het 
laatste antwoord met betrekking tot de onderliggende mechanismen is deels
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speculatief en daarom incompleet. Toekom stig onderzoek met het huidige 
diermodel kan meer inzicht geven in de kwalitatieve aspecten van collageen- 
fibrillen die worden gevorm d onder hyperglycem ische omstandigheden. De 
sterkte van een fibril wordt bepaald door zijn samenstelling. D e onderscheiden 
collageentypes vorm en fibrillen van verschillende sterkte. D e intacte darm ­
wand bevat met name type i collageen en tevens aanzienlijke hoeveelheden 
type ii i  en v  collageen. H et is bekend dat de onderlinge verhoudingen 
veranderen in de nieuw gevormde matrix. H oewel diabetes de totale hoe­
veelheid collageen dat wordt gevorm d niet beïnvloedt, kunnen veranderde 
verhoudingen wel resulteren in verminderde sterkte. O m  een antwoord te 
geven op de vraag of een dergelijk mechanisme een oorzaak is voor de verstoor­
de genezing, is een nadere analyse van de diverse types collageen op zowel 
mRNA- als eiwitniveau (met specifieke probes en antistoffen) noodzakelijk. Een 
ander aspect betreft de toegenom en lokale afbraak van m atrix ten gevolge van 
de verhoogde MMP-activiteit. Meer inzicht in de rol van de diverse mmps onder 
diabetische en normale om standigheden kan worden verkregen m et behulp 
van aanvullende studies, bij voorkeur met antilicham en die pro-enzymen en 
actieve vormen van elkaar onderscheiden. Eveneens kunnen experimenten met 
specifieke remmers van MMP-activiteit zinvol zijn om de rol van deze enzymen 
verder op te helderen.
In het huidige model, waarbij sprake is van verviervoudigde 
bloedsuikerwaarden, is de genezing van darmnaden een w eek na chemische 
inductie van diabetes verstoord. Een logische vraag die hieruit vo lg t luidt: 
bestaat er een dosis-respons relatie tussen bloedsuikerwaarde en sterkte van de 
darmnaad. Anders geformuleerd, wat is de m inim ale bloedsuikerwaarde die 
leidt tot een verlies aan wondsterkte? En tevens, wordt de sterkte van de 
darmnaad beïnvloed door de duur en mate van preoperatieve bloedsuiker- 
regulatie? H et zou m et name interessant zijn om de vraag te beantwoorden 
of intensieve bloedsuikerregulatie vóór operatie na een lange periode van 
hyperglycem ie de te verwachten nadelige gevolgen op darmnaadgenezing 
volledig kan voorkomen en, indien dat het geval is, hoe lang die periode van 
preoperatieve behandeling met insuline m inimaal moet duren. D e antwoorden 
op deze vragen, die zowel in erfelijke als chemisch geïnduceerde diermodellen 
voor diabetes kunnen worden onderzocht, zullen relevant zijn om het 
potentiële probleem  voor de diabetes-patiënt in kaart te kunnen brengen.
Voordat gegevens afkomstig van dierexperimenten kunnen 
worden geïmplementeerd in de klinische praktijk, dient het werkelijke klini­
sche probleem te worden gedefinieerd. De huidige conclusies uit experimen­
teel onderzoek rechtvaardigen klinische studies. Omdat betrouwbare klinische 
gegevens niet beschikbaar zijn, is een prospectief-gerandomiseerde klinische 
trial naar het effect van diabetes en de mate van bloedsuikerregulatie op de 
incidentie van naadlekkage (en naadproblemen in het algemeen) noodzakelijk. 
Indien een prospectieve studie niet haalbaar is uit ethische en praktische over­
wegingen (bijvoorbeeld omdat het benodigde aantal patiënten erg groot is), is 
een retrospectieve studie een tweede keus. Hoewel dergelijke retrospectieve 
studies reeds zijn verricht, hebben deze niet geleid tot eenduidige conclusies. 
Slechte documentatie van peri-operatieve bloedsuiker- en HbAic- waarden en 
(de aanwezigheid van) co-morbiditeiten, die wondgenezing nadelig kunnen 
beïnvloeden, heeft ongetwijfeld bijgedragen aan de tegenstrijdige conclusies 
en zal waarschijnlijk de uitkomsten van een nieuwe retrospectieve analyse 
beïnvloeden. Klinisch onderzoek is dus zeker geïndiceerd, maar moeilijk 
uitvoerbaar.
De resultaten zoals beschreven in dit proefschrift moeten 
daarom ook worden gezien als een aanzet voor het verrichten van meer experi­
menteel en klinisch onderzoek ten behoeve van de patiënt met diabetes die een 
darmoperatie moet ondergaan.
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Stellingen behorende bij het proefschrift
D iabetes and anastomotic 
healing in the intestine
An exper imental  study
M .H .J.V e r h o f st a d
s t e l l i n g e n
1 . Onbehandelde diabetes mellitus vermindert de sterkte van 
een genezende darm naad in ernstige mate.
(dit proefschrift)
2. Het nadelige effect van diabetes mellitus op de genezing van 
darmnaden kan volledig worden voorkomen indien behandeling 
met insuline ook pre-operatief geschiedt.
(dit proefschrift)
3. Het nadelige effect van diabetes mellitus op de genezing van 
darmnaden kan worden voorkomen met een transplantatie 
van eilandjes van Langerhans.
(dit proefschrift)
4. De gereduceerde sterkte van darmnaden ten gevolge van diabetes 
mellitus wordt niet veroorzaakt door verminderde collageensynthese.
(dit proefschrift)
5. Onbehandelde diabetes mellitus verhoogt de activiteit van matrix- 
metalloproteinases tijdens de genezing van darmnaden.
(dit proefschrift)
6. De barststerkte van een darmnaad is een betere maat 
voor genezing dan de treksterkte.
7. Kanker is niets anders dan uit de hand gelopen wondgenezing.
8. Bevolkingsonderzoek naar diabetes is zinvol.
10.
11.
12 .
13.
14.
1 5 .
16.
17 .
9 - Bedrust, routinematig voorgeschreven bij ziekte, is zelden zinvol.
(Allen C. et al. Lancet 1999, 354: 1229-33)
Spot-diagnosis you should hate, until you are a surgeon great.
(Zeta, The diagnosis of the acute abdomen in rhyme. 1955; London: Lewis)
De waarnemer neemt voor waar wat hij waarneemt 
(J.A. Deelder)
Het Douglas-abces bij de man bestaat niet.
‘Metabole optimalisering’ is de meest efficiënte manier om 
het wachtlijstprobleem bij chirurgische patiënten met 
co-morbiditeiten aan te pakken.
De kwaliteit van een gesprek wordt niet bepaald door hetgeen 
is gezegd, maar hetgeen ervan is begrepen.
Iedere doctorandus is verplicht promovendus.
Het is niet de kunst om te publiceren, maar om geciteerd te worden.
In tegenstelling tot hetgeen algemeen wordt aangenomen is 
een suikeroom meestal slechts een diabetes patiënt.
‘s-Hertogenbosch, oktober 1999
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